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The heritable stability of the natural multicopy plasmid, ColE1, can
be greatly reduced by the formation of plasmid mul timers via
homologous recombination. Wild-type ColE1 carries a 233bp site, cer. 
which when present in direct repeat ( as is the case in a ColE1
dimer), acts as a substrate for a site-specific recombinase which 
efficiently resolves plasmid multimers to monomers. This 
monomerisation function is strongly correlated with an increase in 
plasmid stability. Current evidence suggests that ColE1 segregates 
randomly, and that cer-specifio monomerisation serves to enhance 
stability by maximising the number of independently segregating
plasmid copies ( Sherratt jet al, 1984; Summers & Sherratt, 1984). The 
233bp cer site represents the only ColE1 sequence necessary for cer- 
specific recombination, however the available evidence makes it appear 
highly improbable that this locus also encodes the cer-specific
recombinase; on this assumption the recombinase would require to be 
host encoded. A procedure was devised for the selection of coli K12 
mutants defective in cer-specific recombination ( Xer“). Using this 
procedure a total of 11 independent xer mutants have been isolated 
from Tn5-mutagenised populations; of the 11 xer lesions, six are
genetically linked to an inserted copy of, Tn5, whilst two appear to be 
unlinked spontaneous mutations, the remaining 3 mutants are 
uncharacterised.
This collection of mutants has been employed to clone the wild- 
type xer genes by genetic complementation. This has revealed that the 
11 mutants fall into two complementation groups; two mutants are 
complemented by the cloned xerA gene, whilst the remaining nine are 
complemented by a clone of the xerB gene. High resolution mapping of 
the xerA and xerB loci indicates that they are quite discrete, mapping 
to 70.5 and 96.5 minutes respectively on the E. coli K12 linkage map.
The xerA gene was delineated to within a 920bp Sphl/AccI fragment,
and the DNA sequence of this fragment determined. Sequence analyses
revealed the presence of a 156 codon open reading frame (ORF) which 
would encode a polypeptide with a predicted molecular weight 
equivalent to 17.2KDa; the expression of this ORF has been confirmed
insertion of Tn5 in Jthe mutant allele xerA3 which, coupled with a 
deletion analysis of the locus, provides convincing evidence that this 
156 codon ORF must represent the xerA gene.
The xerB locus ( a 1.9 2 Kb Hindlll fragment) has also been 
sequenced and the xerB gene identified as a 503 codon open reading 
frame which encodes a polypeptide with a predicted molecular weight 
equal to 55.3KDa. Interestingly there are several features of the DNA 
sequence flanking 'the xerB gene which indicate that it may be 
transcribed as part of a polycistronic mRNA, with at least one other 
gene immediately downstream of xerB: whether or not this downstream
gene encodes an Xer-related function remains to be determined. The 
XerB protein has also been visualised in minicell expression studies, 
* and has been over-expressed in whole cells to a level of 5% of total 
cell protein. The XerB protein has been purified to homogeneity and 
its identity confirmed by N-terminal peptide sequencing. This purified 
material has been used to raise anti-XerB antisera which might now be 
employed to investigate several features of XerB including its 
expression, cellular location(s), and function(s).
The sequences of the xerA and xerB genes (and their products), 
coupled to the genetic map positions of both loci, indicate that we 
have identified two entirely novel coli functions involved in site- 
specific recombination at the ColE1 cer locus. The precise role(s) the 
two proteins play in cer-specific recombination, and in the biology of 
E. coli remain to be determined.
(xti)
/CHAPTER 1
INTRODUCTION
1
1.1 GENERAL IKIRODPCTIQH
Bacterial plasmids may be defined as extrachromosomal covalently 
closed circles of duplex DNA, capable of autonomous replication, and 
stable maintenance within their host. However, beyond this basic 
similarity they are a very heterogenous group. As a class, . they vary 
in size from less than 5Kb to more than 100Kb, and in copy number from 
1 or 2 per chromosome equivalent to over 100. They also vary 
enormously at the genetic level, both in terms of the number of genes 
they carry and the types of functions they encode. Many plasmid 
encoded functions are considered to be non-essential for either 
plasmid maintenance or host viability, such esoteric functions may 
however confer a selective advantage to the host under bizarre 
environmental conditions; for example the ability to utilise toluene 
and/or xylene as carbon and energy substrates as conferred by the TOL 
plasmid of Pseudomonas putida. or the resistance to various anti­
biotics conferred by the R-plasmids (Broda,1979). On the other hand, a 
number of plasmid encoded functions may be regarded as having a direct 
affect on the maintenance of a plasmid within a population even in the 
absence of any obvious environmental pressure. For example, the 
conjugal transfer mechanisms of many large plasmids, eg. F, R100
etc., permits horizontal spread of the replicon into plasmid free 
cells. Another example being plasmid based bacteriocin production, 
and reciprocal bacteriocin immunity, which enables plasmid containing 
cells to select against closely related plasmid free cells by the 
release of a bacteriocin to the environment.
Despite their enormous diversity all plasmids share certain
functional requirements, the most obvious of which being that they 
must possess a site which is recognised, either by plasmid or host 
specified factors, as an origin for initiation of DNA replication. It 
is this property of natural plasmids that has been exploited in the 
construction of many of the cloning vectors commonly used today, for 
example pBR322 (Sutcliffe, 1979) and pUC8 (Vieira and Messing, 1982) 
which are both recombinant plasmids whose origin of replication is 
derived from the natural plasmid pMB1 (a close relative of ColE1). A 
general trend in the construction of many plasmid-derived cloning
vectors has been to delete, either specifically or at random, as much 
DNA sequence as possible which is non-essential for replication per 
se. A striking consequence of this approach is the inherent
instability of most cloning vectors; plasmid stability being a
2
measure of the frequency with which plasmid-free segregants are 
generated from a population of plasmid-containing cells when growing 
under non-selective conditions. In marked contrast natural plasmids 
are extremely stable under the same growth conditions. Thus, by 
inference, most natural plasmids appear to encode functions which 
promote their stable inheritance by all daughter cells at division. 
Such stability functions are of considerable biological interest since 
they may aid our understanding of fundamental plasmid biology, and in 
turn may pave the way for a new generation of stable plasmid cloning 
vectors which could potentially yield significant economic ( and 
environmental) benefits, especially in large scale industrial 
fermentations.
1.2 STABLE PLASMID MAINTENANCE
Whilst I have previously described "plasmid stability" as a 
measure of the frequency with which plasmid free segregants arise, it 
is instructive to differentiate this measurable parameter from the 
concept of "stable maintenance" of a natural plasmid such as ColE1, F, 
or pSC101 etc.. The former requires only that every cell carries one 
or more plasmids, whilst the latter asserts that a plasmid is main­
tained at a relatively constant copy number ( N per chromosome- 
equivalent) throughout the population, the number maintained being 
dependent on the plasmid concerned, for example for F N=1, and for 
PSC101 N=5 (Timmis, 19 81) whilst for ColE1 N=15 (Durkacz and Sherratt, 
1973)- Stable plasmid maintenance has two key components;
1. Copy number control in phase with cell growth and division.
2. Segregation of plasmid copies between daughter cells.
1.3 COPY NUMBER CONTROL
As previously intimated, a given plasmid species tends to be 
maintained at a characteristic mean copy number within a population. 
In order to maintain this ( presumed) "Optimal" copy number it appears 
that plasmids have evolved complex replication control mechanisms 
capable of monitoring copy-number and reacting to correct any 
deviations from the norm. In all systems which have been extensively 
characterised the control of replication is at the level of 
inititiation and involves a negative feedback loop, often employing a
3
number of negative regulators. Several classes of negative regulators 
have been identified, these include;
1) Small RNA molecules e.g. RNA1 ( ColE1; Tomizawa et alf 1981), or 
CopA ( R1; Stougaard et alT 19 81).
2) Small polypeptides e.g. Rom ( ColE1; Twigg & Sherratt, 1980; 
Tomizawa & Som, 1984), or CopB ( R1; Molin .§£. al, 1981).
3) Accessory binding sites which apparently titrate-out replication 
initiation factors e.g. the direct repeats found near the 
replication origins of F and P1 ( Tolun & Helinski, 1981) and ;
Chattaraj et al, 1984). ---------
A negative-feedback circuit provides a means whereby, in principle, 
the plasmid copy number may be monitored via a simple "Inhibitor 
dilution" model. Briefly this model asserts that the constitutive 
expression of a plasmid-borne repressor of replication provides a 
measure of the plasmid copy concentration ( via gene dosage); too few 
copies results in a low inhibitor concentration which permits 
replication, whereas too many copies produce a level of inhibitor 
which prevents further initiation of replication. Perhaps the best 
studied example of such a control circuit is that of the ColE1 family 
of small multicopy plasmids.
Replication of ColE1 ( 6646bp) is unidirectional from a single 
replication origin. Replication from this origin does not require any 
plasmid encoded proteins; initiation is dependent on an RNA primer 
synthesised by host RNA polymerase, whilst DNA synthesis per se is 
initiated by host DNA polymerase I. The process also requires a number 
of other host functions including DNA polymerase III, plus the 
products of the dnaB.-Cr -G, and -Z genes ( for review see Scott, 
1984).
The initiation process itself is dependent on the synthesis of 
pre-primer RNA. This transcript is initiated at a point 555 bp 
upstream from the origin of DNA synthesis, this transcript may 
continue through the replication origin resulting in several sizes of 
transcript (Scott, 1984). However, some of the nascent pre-primer 
transcripts hybridise to the DNA template near the origin, the 
resultant DNA-RNA hybrid then serves as a substrate for RNAase H which
/
1.4 REPLICATION CONTROL IN ColE1
cleaves the pre-primer RNA to generate Primer-RNA (RNAII), DNA 
polymerase I then initiates DNA synthesis on the free 3' hydroxyl 
group of RNAII (Itoh and Tomizawa, 1980; Masukata and Tomizawaf 1984).
The formation of the DNA-RNA hybrid near the origin is critical 
for RNAase H processing, and thus for the initiation of DNA synthesis. 
However, this hybridisation is under the negative control of a 108 
nucleotide ColE1 encoded RNA, termed RNA1. RNA1 is transcribed from 
the opposite strand to primer-precursor RNA, but from wholly within 
the primer-precursor sequence ( see Fig. 1.1), therefore RNA1 is 
complementary to a 108 nucleotide portion of primer-precursor RNA , 
thus the two RNA species are capable of inter-molecular base pairing 
, along the entire length of RNA1. The basis of RNA1 inhibition of DNA 
replication appears to be that the binding of RNA1 to the nascent 
primer-precursor RNA in some way alters the secondary structure of the 
nascent transcript such that it can no longer form a stable DNA-RNA 
hybrid near the origin, thus RNAase H processing is prevented 
(Lacatena and Cesareni, 1983; Tomizawa and Itoh, 1982).
1.4.2 m  INTERACTION BETWEEN M A I  AND PRIMER-PRECURSOR M A
The RNA1 sequence, and by necessity the complementary 108 
nucleotide portion of primer-precursor RNA, are capable of extensive 
intra molecular base pairing to form a tRNA-like hairpin-loop 
structure (shown diagrammatically in Fig. 1.1). The existence of this 
structure has been demonstrated in vitro by mapping the sites at which 
various double-, and single-, strand specific ribonucleases cut 
purified RNA1 (Tomizawa, 1984). Furthermore, the significance of this 
tertiary structure jjn vivo has been demonstrated using a series of 
point mutations which destabilise the stem structures and result in 
defective RNA1, incapable of inhibiting RNAase H processing (Lacatena 
and Cesareni, 1983). In addition, such mutational analyses have 
demonstrated that as few as seven nucleotides, all present in the 
loops of the RNA1 secondary structure, may determine the specificity 
of the RNA1/Primer-precursor RNA interaction. A number of independent 
point mutations in . the loop structures of RNA1 result in an RNA1 
capable of interacting effectively with it s homologous primer- 
precursor RNA, but not capable of inhibiting processing of a wild-type 
primer-precursor, despite 107 out of 108 nucleotides being 
complementary. Such mutant RNA1 sequences result in ColE1 derivatives 
which are compatible with one another. In addition to RNA1, a second
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negative regulator of copy number is encoded by ColEl type plasmids; 
the 63 amino-acid RNA One Modulator (Rom) protein (previously 
designated "Rop" ). Deletion of the pMB1 rom gene results in a 5-7 
fold increase in plasmid copy number (Twigg and Sherratt, 1980). ROM 
catalyses the initiation of stable binding between RNA1 and primer- 
precursor ( Fig 1.1), but has no influence on the subsequent rate of 
propagation of ribonucleotide base-pairing (Tomizawa and Som, 1984).
1.4 PLASMID SEGREGATION
A dichotomy is apparent between low copy-number plasmids and 
multicopy plasmids with respect to the mode of plasmid segregation 
„ employed, therefore these two classes will be considered seperately.
1.4.2 SEGREGATION OF LOW COPY NUMBER PLASMIDS
The remarkable stability of plasmids with copy numbers as low as 
1 or 2 per chromosome suggests that such plasmids may be actively 
partitioned between daughter cells at division (Jacob, 1963). Indeed 
there now exists evidence for such "Active partition" in a number of 
plasmids including NR1 (Mika et al, 1980), R1 (Nordstrom et al. 1980), 
F (Ogura and Hiraga, 1983), and pSC101 (Meacock and Cohen, 1980). In 
the case of pSC101 a plasmid locus designated par ( partition) has 
been found to complement partition deficient plasmid mutants when 
present in cis. but not in trans (Meacock and Cohen, 1980); the locus 
is also capable of increasing the stability of unrelated plasmids 
derived from p15A and R1 replicons (Meacock and Cohen, 1980; Nordstrom 
et al, 1981). The requirement for a cis locus is a common feature of 
all active partitioning systems reported. The par sequence is presumed 
to interact with some secondary component which is itself actively 
partitioned; the identity of this structure is uncertain, however 
candidates include the chromosomal body on the basis that several 
plasmids have been observed to co-sediment with it (Worcel and Burgi, 
1974; Kline and Miller, 1975; Kline et al, 1976). Alternatively the 
par site may interact with a membrane attachment site, a hypothesis 
supported by the observation that the par region of pSC101 associates 
with the outer membrane fraction of Escherichia coli. as does that of 
the plasmid R1 (Gustafsson et al, 1983). There is as yet no evidence 
that any trans acting plasmid encoded products are required for the 
active partitioning of pSC101 (Tucker et al. 1984). However the 
situation is more complex in the coli sex factor, F. This plasmid
6
has also been shown to carry a specific site ( s o p C ) . required in cis 
for active partitioning, however in this case the presence of the s o p C 
locus is not in itself sufficient to confer a par+ phenotype./Ogura 
and Hiraga (1983) have demonstrated that a further two plasmid loci 
are required, s o p A and s o p B . both of which specify trans acting 
elements. The products of the s o p A and 3 o p B loci are believed to be 
polypeptides of molecular weights equal to 41-44KDa and 36-37KDa 
respectively (Ogura and Hiraga, 1983; Wehlmann and Eichenlaub, 1980; 
Komai et alf 1982). Ogura and Hiraga have reported that the 37KDa 
protein encoded by the s o p B locus binds specifically to the s o p C DNA 
sequence together with two host proteins of 75KDa and 33KDa 
respectively. On this basis they have proposed a putative model for 
the active partitioning of F plasmid (Ogura and Hiraga, 1983). However 
the identification of the 75KDa and 33KDa host proteins, with respect 
to their cellular role and location, may prove to be a major step 
forward in the understanding of active partitioning mechanisms.
The active partitioning of a unit copy number plasmid, such as F, 
poses no conceptual difficulties, it simply requires one round of 
plasmid replication after which the products are partitioned between 
the daughter cells. However many actively partitioned plasmids have 
copy numbers greater than 2 at cell division ( e.g. pSC101), and in 
these cases the net effect of the active mechanism is uncertain. 
Novick et al (1975) proposed the Equipartition model in which every 
individual plasmid within the dividing cell is a substrate for the 
partition apparatus, and that the mechanism itself ensures an equal 
distribution between daughter cells; this hypothesis being based on 
the curing kinetics of a plasmid mutant temperature-sensitive for 
replication, under restrictive conditions of temperature. However, 
using a similar experimental principle, but modified detection 
techniques, Hashimotoh-Gotoh and Ishii (1982) obtained curing kinetics 
which led them to propose the Single Site Inheritance model for 
partition. In this model only two members of the cell's plasmid 
complement are actively segregated, the remainder being free to 
segregate randomly by diffusion. These alternative hypotheses are of 
some considerable consequence with respect to our understanding of the 
process(es) involved in active partitioning, however the experimental 
data available to date cannot unequivocally discriminate between them 
( see Nordstrom, 1984).
7
The process of active partitioning, as we currently understand it, 
cannot ensure plasmid stability unless plasmid replication can keep 
pace with cell division. Whilst unit copy number plasmids wotild be 
most vulnerable to such instability, current evidence suggests that at 
least one such plasmid has evolved counter measures of a most dramatic 
nature. The F plasmid encodes two polypeptides which act 
antagonistically to prevent host cell division until after plasmid 
replication has taken place. The first polypeptide ( the LetD 
protein), acts as an inhibitor of cell division, whilst the second 
(LetA) is synthesised after plasmid replication and acts as a 
suppressor of LetD, thus triggering cell division (Miki £t .al, 1984a; 
Miki et al, 1984b). It has been suggested that the plasmid R1 might 
exert a similar control on cell division however this is as yet 
unsubstantiated (Gustafsson et ait 1983).
1.4.3 PARTITION -QE MULTICOPY JELASMU2S
There have been no substantiated reports of active partitioning 
systems in high copy number plasmids, and the available data oune, 
consistent with the "Random segregation" model proposed by Durcacz and 
“Sherratt ( 1973). This model proposes that the plasmid population 
within a dividing cell segregates in a purely random fashion as a 
consequence of free diffusion of all plasmid copies throughout the 
cytoplasm. Clearly the probability of generating a plasmid free 
segregant (P0) can then be calculated using the binomial distribution 
and is equal to 21“s ( where s is equal to the number of independently 
segregating units present at cell division). If a single plasmid 
molecule represents the segregating unit, then a copy number of 15 per 
chromosome equivalent should ensure stable inheritance since at cell 
division a minimum of 30 plasmid copies should be present per cell, 
resulting in PQ= 2”2  ^( i.e. 1.9 x 10”  ^plasmid-free segregants per 
cell division). The obvious prediction of this model is that as copy 
number increases then there should be a concomitant increase in 
stability. Paradoxically, many plasmid cloning vectors have copy 
numbers far in excess of that of ColE1 and yet are grossly unstable ( 
Timmis, 1981; Summers & Sherratt, 1984). This anomaly is accounted 
for, at least in part, by the formation of plasmid multimers jja vivo 
via homologous recombination. Evidence suggests that plasmid copy 
number is controlled via an "origin-counting" mechanism which does not 
differentiate between say 20 monomers and 10 dimers ( Summers &
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Sherratt, 1984; Jones, 1985) . Therefore the formation of plasmid 
multimers does not reduce the number of plasmid copies ( replication 
origins) present, but it does reduce the number of independently 
segregating units. Summers & Sherratt ( 1984), have demonstrated a 
direct correlation between multimerisation and instability for the 
cloning vector PACYC184.
In a recombination-proficient strain plasmid cloning vectors are 
extensively multimerised to produce dimers, trimers, tetramers etc.. 
On the other hand ColE1 remains predominantly monomeric even in hyper- 
recombinogenic strains. It has been shown that ColE1 carries a site, 
designated cer (ColE1 Resolution), at which a site-specific 
recombinase acts to promote the efficient resolution of plasmid 
multimers to monomers, thus maximising the number of independently 
.segregating plasmid copies. This site has been shown to effectively 
stabilise heterologous cloning vectors ( such as PACYC184) when 
present in cis: such stabilisation being strongly correlated with an 
increase in the proportion of monomeric plasmid forms ( Summers & 
Sherratt, 1984). The functional cer locus has been localised to within 
279bp Hpall/Taal fragment ( ColE1 co-ordinates 3687-3966bp) which 
represents the sole ColE1 sequence necessary for cer-specific 
recombination ( Summers .et al, 1985). Similar sites to cer have been 
identified in other closely related multicopy plasmids including 
CloDF13 ( crl: Haakaart e£ 1984), Q.olK ( ckr: Summers et. al.
1 985), pMB1 ( Sherratt et. aJL, 1986), and ColA ( Morion et. al. 
manuscript in preparation); all of which share considerable sequence 
similarity to cer ( Fig. 1.2). This sequence similarity implies that 
these five multicopy plasmids are likely to share very similar 
multimer-resolution mechanisms. Analagous resolution systems have also 
been identified in a number of low copy-number plasmids including P1 ( 
loxP/Cre; Austin et al, 1981), R46 ( per: Dodd & Bennet, 1986), and F 
(rfsF/D-protein; Lane e£ .al, 19 8 6).
1.5 SITE-SPECIFIC RECOMBINATION
The significance of site-specific DNA re-arrangements in, and 
between, the genomes of a diverse range of organisms has only recently 
begun to be appreciated ( for review see Sadowski, 1986). Such re­
arrangements represent important steps in the development of many 
organisms ranging from bacteriophages to higher mammals. The range of 
functions dependent upon site-specific recombination is continually
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Figure 1.2 Optimal Alignment of ColE1 cer with the analagous sites 
from pMB1, ColK, ColA, and CloDF13; ( Greene et iLL, 1981; Summers et 
al. 1985; Leung et al. 1985; Morion .&£jaL, in preparation; Hakkaart et 
al. 1984). The cer sequence begins at ColE1 co-ordinate 3731 bp and 
ends at the taal site at 3966bp. (.) indicates sequence identity; (-)
indicates a gap inserted to maximise homology. The cross-over region, 
promoter P1, and several ColE1 co-ordinates are indicated.
expanding and includes;
1) Integration and excision of temperate phage genomes e.g. Lambda (
Weisberg & Landy, 1983)
2) The resolution of co-integrate structures formed during the
transposition of class II transposons such as Tn3 ( Arthur &
Sherratt, 1979; Reed, 1981).
3) The switching of flagellar antigens in S.tvphimurium (Simon et. al. 
1980).
4) Control of type I fimbriation in JL. coli ( Klemm et. .§1, 1986).
5) Switching of host ranges in bacteriophages Hu and P1 ( van de
Putte et. ai, 1 980; Iidaet..al, 1982).
6) Maintenance of faithful segregation in for example P1 ( Austin .et
alr 1981), and ColE1 ( Summers and Sherratt, 1984). Also in the 
maintenance of the multicopy 2 micron circle of S. cerevisiae ( 
Futcher, 1986; Volkert & Broach, 1986).
7) The expression of nitrogen fixation genes during heterocyst
differentiation in cyanobacteria ( Golden .et al, 1985).
8) The generation of diversity of antibodies ( Bernard ejt al.
1978), and of the T-cell receptors of the immune system ( 
Gascoigne et al, 1984).
Site-specific recombination at a functional level is quite independent 
of generalised ( Homologous) recombination. The process requires two 
interacting sites which may be identical, as in the case of Tn3 
resolvase (Grindley .§£ j*X, 1982), or may be heterologous as in the 
case of the Lambda Int system ( Weisberg & Landy, 1983). Recombination 
between these "Special sites", requires a "site-specific" recombinase 
( and in some cases additional accessory factors). In a}.l systems 
characterised in detail the recombination reaction is conservative, 
involving no net synthesis or loss of DNA, ( Sadowski, 1986), and does 
not require any high energy co-factors. Instead the recombinase forms 
a covalent intermediate with one of the DNA termini upon strand- 
breakage ( either a phospho-serine of phospho-tyrosine linkage) and in 
this the recombinase appears to conserve the energy of the phospho- 
diester bond for subsequent re-ligation of the phospho-diester 
backbone. Finally, all known site-specific recombinases appear to act 
stoichiometrically, as opposed to catalytically, for reasons which 
remain uncertain.
10
Site-specific recombination may be either inter- or intra-molecular. 
Intermolecular recombination results in the fusion of DNA sequences, 
e.g. phage lambda integration into the bacterial chromosoml. The 
product(s) of an intramolecular reaction depend upon the relative 
orientation of the participating sites: most sites, though 
superficially symmetrical, tend to possess an inherent asymmetry which 
imparts a polarity to the site, and thus a directionality to the 
recombination reaction. When two sites are present direct repeat then 
recombination between them results in the excision of the intervening 
sequence plus one copy of the site ( this reaction is often termed 
"Deletion" or "Resolution"; e.g. the resolution of co-integrates by 
Tn3 resolvase). Alternatively, recombination between two sites in 
inverted repeat results in the inversion of the sequence between the 
sites ( e.g. the Mu Gin system). Some recombination systems exhibit a 
remarkable discrimination in the directionality of the reactions they 
will perform; e.g. the transposon resolvases will catalyse the intra­
molecular resolution reaction between directly repeated res sites, but 
are unable to promote either inversion between inverted copies of res, 
or inter-molecular fusion reactions ( Krasnow & Cozzarelli, 1983; 
Reed, 1981). This bias towards the resolution reaction is consistent 
with the biological function of the resolvases ( Arthur & Sherratt,
1979). The range of complexity found in various site-specific 
recombination systems is best illustrated by consideration of a few 
examples.
1.5.2 LAMBDA INTEGRATION AND EXCISION
Lambda integrative recombination was the first site-specific 
recombination system to be reproduced in vitro ( Nash, 1975). The 
recombining sites, attP ( 240bp) and attB ( 25bp), are distinctly 
heterologous; they share a 15bp core sequence ( 0), but this is 
flanked by unique arms in each att site designated P, P*, B, and B1 ( 
attP= POP1, attB= BOB'; Weisberg & Landy, 1983). Strand exchange 
occurs within the 15bp of homology to generate two hybrid sites attR ( 
BOP’), and attL ( PO.B’) ( Mizuuchi el. al., 1 975). Integrative 
recombination requires the phage encoded Int recombinase ( 40KDa; 
Nash, 1975), plus the E. coli "Integration Host Factor" ( IHF) ( Nash 
et al. 1977; Kikuchi & Nash, 1978). The interactions between Int, IHF 
and the att sites are complex; Int has been shown to specifically bind 
to 4 seperate regions within attP ( Hsu jet al, 1980), whilst IHF binds
to a further 3 discrete locations ( Craig & Nash, 1984).
Excisive recombination occurs between the hybrid sites and 
requires both Int and IHF, plus the phage encoded Xis protein ( 
Guarneros & Echols, 1970). Xis has been shown to bind the P arm of 
both attR and attP (Yin .§£ 1985). Binding of Xis to attP inhibits
integrative recombination.
The role of IHF in Int-specific recombination appears to be as an 
accessory factor since low-efficiency recombination can proceed in its 
absence ( Lange-Gustafson & Nash, 1984). IHF is a hetero-dimeric DNA 
binding protein, comprising two polypeptide sub-units in equimolar 
ratios; the alpha peptide ( the 10.5KDa product of the himA gene which 
maps at 38 mins), and the beta peptide ( 9.5KDa product of the hip 
gene located at 20.5 mins), for review see Weisberg and Landy (1983). 
Whilst IHF was first discovered via its role in Lambda Int-specific it 
has subsequently been found to be intimately involved in an apparently 
diverse range of biological functions including the regulation of 
expression of a number of genes and operons including Lambda ell ( 
Hoyt ejt al, 1982), the early operon of phage Mu ( Goosen & van de 
Putte, 1 984), and also the yaJL, ilv. and xvl genes of E. coli ( Friden 
et al. 1984; Friedman et al, 1984). IHF has also been found to be 
involved in the conjugal transfer of R100, in that it appears to be 
required for the normal expression of the plasmid tra genes ( Dempsey, 
1987). Gamas et. al (1986) have also reported that IHF is involved in 
the stable maintenance of pSC101, perhaps at the level of promoting 
initiation of DNA replication. In the cases of pSC101 replication and 
Lambda integration, it has been suggested that IHF operates by so 
affecting the local topology of the region as to favour the 
subsequent/concomitant interaction of other proteins, in the formation 
of complex protein:DNA assemblies necessary to promote efficient 
recombination or initiation of DNA replication.
1.5.3 THE loxP/Cre SYSTEM OF PI
P1 in the prophage state behves as an autonomously replicating 
episome, and is maintained at a copy number of 1-2 per chromosome 
equivalent ( Ikeda & Tomizawa, 1968). The stable maintenance of P1 is 
due, at least in part, to a site-specific resolution function 
analagous to ColE1 cer. This recombination system requires only two 
copies of the loxP site plus the phage encoded Cre protein ( 35KDa; 
Austin et al, 1981). No other phage or host components are required
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Figure 1.3 Comparison between PI loxP. Lambda attPf and the yeast FLP 
sequence. The core sequence of lambda attP (o) where crossing-over 
takes place is indicated by the boxed region (lr r J )- The inverted 
repeats of loxP and FLP are highlighted by boxed arrows. Homologous 
bases are indicated by large type ( after Hoess and Abremski, 1984).
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for recombination either iji vivo or In vitro ( HoessAbremski, 
1984). The 34bp loxP site is relatively simple, comprising tv^ o 13bp 
inverted repeats hyphenated by an 8bp spacer region. The polarity of 
the site, and thus the directionality of the reaction, is conferred by 
this 8bp region. Cre has been shown to bind to two domains within 
loxP. each comprising one 13bp repeat plus the contiguous 4bp of the 
spacer region ( Hoess & Abremski, 1984). Occasionally P1 undergoes 
Cre-mediated integration into the bacterial chromosome at a specific 
site designated loxB ( Sternberg .et al. 1981).
Despite the apparent difference in complexity between 1ox/Cre and 
the lambda int systems the loxP site exhibits significant sequence 
-similarity to lambda attPf and even more so to the Flp site in the 
yeast 2-micron circle ( Fig. 1.3; Hoess & Abremski, 1984). Further­
more, significant similarities have been identified in the amino-acid 
sequences of the lambda Int, Cre and Flp proteins, together with those 
of the integrases from phages P2, 186, P22, Phi 80, and P4 ( Argos et 
al. 1986; Dorman & Higgins, 1987). The observed homologies might 
indicate that this group of recombinases may be analagous, if not 
homologous; the group has been termed the nIntegrase family" ( Argos 
et al. 1986).
1.5.4 JM IHYERIASES
Site-specific DNA inversions are usdd as biological switches in 
a number of systems. The most fully characterised being the G-segment 
inversion in phage Mu, and the H-segment inversion in tvphimurium: 
at the molecular level these two systems share many common features. 
The H-segment inversion is catalysed jji vitro by the 21KDa Hin 
recombinase plus two additional factors, Fis ( Factor for Inversion 
Stimulation) and HU ( the major Histone-like protein) ( Johnson et 
al. 1986; Johnson & Simon, 1987; Kahmann et aJ, 1985). The consequence 
of inversion in vivo is to connect, or disconnect, the promoter for 
the H2 flagellin gene, thus serving to activate or inactivate H2 gene 
expression ( Fig. 1.4). The cis requirements for Hin inversion include 
two 26bp recombination sites, hixL and hixRr plus a 60bp enhancer 
sequence which stimulates recombination 200 fold ( Johnson & Simon, 
1987). Intriguingly, the enhancer element is present within the coding 
sequence of the hin gene, and is thus situated within 200bp of hixL ( 
see Fig. 1.4). However the enhancer-like properties of this region can 
be demonstrated by the fact that it continues to enhance recombination
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Figure 1.4 Schematic representation of the Hin and Gin inversion 
systems.
A. The H2-promoter is shown in the ON position in which it initiates 
transription of the H2 gene. Hin mediated inversion between hixL and 
hixR uncouples H2 from its promoter, thus switching H2 expression OFF.
B. The ^ and J1 genes are transcribed from promoter P. The £ gene has a 
constant 5’ region (Sc), but may have one of two different 3f coding 
regions ( Sv or S'). Inversion between gixL and gixR above would fuse 
the S’ variable region to the SQ constant region, thus creating an 
alternative C-terminal coding sequence. Inversion aljso serves to 
switch on either U or U’ by transcription from promoter P.
when present up to 4Kb from the hix sites, and does so in either 
orientation ( Johnson & Simon, 1987). The Fis protein ( 12KDa)^binds 
to two sites within the enhancer sequence and is essential for 
enhancer function; Fis has many similarities to IHF and may stimulate 
recombination in an analagous fashion ( Kahmann e£. .al, 1985). The HU 
protein is a second accessory factor which stimulates Hin recombina­
tion in vitro by a further 1 0-fold. HU is a heterodimeric protein 
which binds DNA non-specifically. It has been suggested that HU may 
coat DNA and may, in doing so, ease the torsional stresses inherent in 
the bending of DNA to bring two recombination sites into juxtaposition 
( Johnson et. al, 1986; Johnson & Simon, 1987). HU is also required for 
-the initiation of strand exchange during Mu transposition jji vitro ( 
Craigie et al, 1985), and has also been shown to be involved in oriC- 
specific DNA replication ( Dixon & Kornberg, 1984). In both these 
cases a role for HU in the formation of topologically complex 
protein:DNA intermediates has been suggested.
The H-segment appears to belong to a family of closely related 
invertible segments including the Mu G-segment, the P1 and P7 C- 
segments ( all of which change alter the phage’s host-range), and the 
cryptic P-segment on the coli chromosome. The respective 
invertases Gin, Cin, and Pin, all share extensive sequence similarity 
to Hin at the amino-acid level, and all cross complement one another. 
The sequence similarity extends to the Tn3 and Gammadelta resolvases, 
but these do not functionally complement the inversion systems ( 
Plasterk & van de Putte, 1984; Simon etjl, 1980). The gin gene also 
contains an enhancer region whose function depends upon Fis binding, 
this sequence has been designated sis ( sequence for inversion 
stimulation; Kahmann e£ al, 1985).
The formation of a highly ordered nucleo-protein complex as an 
intermediate in site-specific recombination has been proposed for a 
number of systems. The formation of such a structure may play a 
crucial role in maintaining the fidelity ( and perhaps the 
directionality) of the recombination reaction ( Boocock e£ al. 1987; 
Gellert & Nash, 1987). '
The expression of type I fimbriae in jjX coli is subject to phase 
variation, i.e. a cell is either completely fimbriated or ’bald”. The 
phase variation being the result of a genetic switch occurring at a
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Figure 1.5 Organization of tbe fin genes.
The fimB gene product controls the switching of the 300bp region 
into the on position with the promotor pointing into fimA, 
whereas the fimE gene produot is responsible for switohing the 
3 0 0 bp region into the off position with the promoter pointing 
away from fimA.
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frequency of 10“3 per generation ( Eisenstein, 1981). This genetic 
switch has recently been discovered to be the result of a^site- 
specific inversion of a 3 0 0 bp segemnt of the coli chromosome ( 
Abraham et alf 1985; Klemm, 1986). The invertible segment contains the 
promoter for the fimA gene which encodes the major structural 
component of type I fimbriae. Thus fimA expression is switched on or 
off in a fashion analagous to H2 gene expression in S. tvphimurium ( 
Fig. 1.5). The inversion is apparently controlled by two proteins 
whose genes are located immediately upstream of the invertible 
fragment ( see Fig. 1.5). The products of these two genes regulate the 
directionality of the inversion switch; FimB and FimE directing the 
■switching of the fimA promoter into the "On" and "Off" orientations 
respectively ( Klemm, 1986). The fim genes map to 98 mins. on the K-12 
linkage map ( Brinton e_t al, 1961). The flu gene ( 43 mins.) also 
apears to be involved in the fimA switch, however its precise role 
remains obscure ( Diderichsen, 1980; Klemm, 1986).
The fimB and fimE genes are highly homologous at the DNA sequence 
level; they encode polypeptides of 200 and 198 residues respectively, 
which in-turn exhibit extensive homology in their amino-acid sequences 
( Klemm, 1986). On the basis of this homology it has been proposed 
that the two genes arose out of a gene-duplication event ( Klemm, 
1986). It has been subsequently noted that the FimB and FimE proteins 
share striking similarities to the major conserved regions identified 
amongst the "Integrase family” of site-specific recombinases ( Dorman 
& Higgins, 1987). It therefore seems probable that the FimB and FimE 
proteins are infact recombinases; if so then this use of a pair of 
antagonistic invertases would represent a quite novel system.
1.6 cer-SPECIFIC RECOMBINATION
Very little is currently understood regarding the mechanism(s) of 
cer-specific recombination. At a functional level, the system requires 
the presence of two directly repeated copies of the 279bp ( 
Hpall/Taal) cer site. The cer site has more recently been de-lineated 
to within a 233bp region of ColE1 running from co-ordinate 3733bp to 
the Tad site at 3966bp; the actual cross-over site having been 
further defined to within a 3 5 bp region of cer ( 3906-3942bp) ( 
Summers e£ al, 1985; Summers & Sherratt, manuscript in preparation). 
Recent evidence suggests that at least part of this 233bp region need 
be present in only one of the two participating sites; progressive
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ExoIII deletions into the left-hand end of cer produced a series of 
deleted-sites which will recombine with a copy of the wild-typ^ site, 
but not with another copy of the deleted-site. Progressive deletions 
into the 2 3 3 bp cer region show a concomitant decrease in the 
efficiency with which they will recombine with a wild-type site; the 
smallest fragment which retains this partial activity being D3793 ( a 
173bp region from 3793-3966bp), the next deletion in the series, D3800 
( 3 8 0 0-3 9 6 6 bp), removes a further 7 bp at which point recombination 
with a wild-type site is abolished ( see Fig. 1.2; Sherratt et al. 
1986; Summers & Sherratt, manuscript in preparation). It has been 
noted that the region of cer required in only one copy ( i.e. from 
'3733-3793bp), contains a series of A+T and G+C rich regions which 
alternate with a periodicity of approximately 1Obp; this periodicity 
is conserved in the sites of related plasmids even though the primary 
sequence of this region shows considerable "divergence" ( see Fig. 
1.2). Such sequence periodicity underlies the bending of DNA around 
nucleosomes ( Drew & Travers, 1985); it has been suggested that the 
loss of this "bendable" sequence may be responsible for the observed 
reduction in recombination efficiency ( Summers & Sherratt, manuscript 
in preparation).
Finally note that the cer site contains a consensus promoter 
sequence, P1 ( see Fig. 1.2); transcriptional fusion experiments have 
confirmed that this promoter is indeed active in vivo. The 
significance, if any, of such transcription is unclear, but it is 
interesting to note that the loss of the - 3 5 region of P1 in D3800 is 
correlated with the complete abolition of recombination at that site. 
However, a site-directed mutation in the -10 region of P1 which 
reduces transcription 18-fold, has no apparent affect on recombination 
efficiency ( Summers & Sherratt, manuscript in preparation); an 
alternative explanation for the affect of the 7bp difference between 
D3793 and D3800 will be presented later.
1.6.2 THE cer-SPECIFIC RECOMBINASE
The small size and limited coding potential of the cer site make 
it seem unlikely that the recombinase is encoded by it. The largest 
potential cer-encoded polypeptide would be 70 residues in length, 
encoded by a potential gene running from 3966—3 7 5 6bp; this compares 
with the smallest known site-specific recombinases which are at least
2.5 fold larger ( e.g. the 185 residue Tn3 resolvase). Leung et al
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(1985), introduced a frame-shift mutation into this potential "gene" 
at position 3 9 0 1bp ( 2 2 codons into the reading frame), but f*und no 
reduction in recombination efficiency. Furthermore, when one compares 
the DNA sequence of the cer site to those of the highly "conserved" 
loci from related plasmids ( Fig. 1.2), then one finds a number of 1 
and 2 bp insertions/deletions which indicate that no protein coding 
gene has been conserved amongst all five sites. This led to the 
proposal that the jcgjr-specific recombinase might be encoded by the E. 
coli chromosome, at a locus designated xer ( chromosomally encoded 
recombinase; Summers ejt jajL., 1985). Whilst a number of host-encoded 
accessory factors ( e.g. IHF, Fis etc.) are involved in various site- 
'specific recombination systems, in all cases known the recombinase per 
se is encoded by a locus adjacent to the site at which it acts, thus a 
host encoded cer-specific recombinase would represent a novel system.
The existence of coli Xer function(s) was first demonstrated by 
Gill Stewart ( 1986), who isolated two mutants defective in cer- 
specific recombination ( DSX1 and DSX2). The mutant selection 
procedure involved the transformation of a mutagenised population with 
the chimaeric plasmid pKS4*l1; this plasmid is essentially a pseudo­
dimer consisting of one replication origin, but two copies of cer with 
a resistance marker ( cat) inserted between them. When a wild-type 
strain ( Xer+) is transformed with this plasmid then site-specific 
recombination between the cer sites results in the resolution of 
PKS441 into two discrete circular products, pi|42 and p^43; this 
effectively isolates the cat gene from the plasmid replication origin 
( Fig. 1.6). Thus Xer+ transformants remain chloramphenicol sensitive, 
whereas Xer“ transformants fail to resolve p K S W  and can therefore be 
selected by virtue of their resistance to chloramphenicol. Note that 
the pKS4iJ1 used in these experiments was recovered from the strain 
) W54M5; this strain was found to exhibit a "partial" Xer phenotype,
i.e. it did not completely resolve a 2-cer plasmid after trans­
formation and thus maintained a mixture of resolved and unresolved 
plasmid. The 2-cer form could therefore be gel-purified for use in the 
mutant selection procedure: this extremely laborious task was of 
course overcome after the isolation of the first Xer“ mutant ( 
Stewart, 1986).
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Figure 1.6 Diagrammatic representation of the Xer-Dependent 
Resolution of the 2-cer reporter plasmid p K S W
1.7 PROJECT AIMS
/
1. To increase the number of independently isolated xer mutants.
2. To use^these mutants to clone the xer gene(s) by complementation
and thus identify a minimum number of complementation groups.
3. To characterise the cloned gene(s), and investigate the nature of 
the encoded function(s).
/CHAPTER 2
MATERIALS AND METHODS.
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Table 2.1 Bacterial Strains
/
Strain Genotype Source/Referenc
DS903 recFllH. thi. leuB6. his4. thrl. DroA2 D.J. Sherratt
ar^E, Ra.1^2, sudEHH. tsx3. rDsL31t aralk
DS902 As DS903 but recA13. ArgE+, RecF+ D.J. Sherratt
DS941 As DS903 but lacl^ ZAM15 D.J. Sherratt
DS9M2 As DS903 but A(lacDro) D.J. Sherratt
DS947 As DS9^2 but SupO D.J. Sherratt
CSH26 arar thi. A( lacDro) Hiller ( 1972)
JM101 sudEt thi A  (lac pro), Yanisch-Perron
( F*. traD36, DroAB. lacl^ ZAM15) et. .al ( 1985)
DSX1 As DS903 but xerB8 ( formerly xerl) Stewart ( 1986)
DSX2 As DS903 but xerBQ ( formerly xer2) Stewart ( 1986)
CSX1 As CSH26 but xerA3 ( formerly Xer3) This work
CSX2 As CSH26 but xerA3 ( " X3.2) it
CSX3 As DS903 but xerA3 ( " X3.D) it
CSXM As DS947 but xerB1 n
CSX5 n it it xerB2 it
CSX6 n n M xerB3 it
CSX7 ti ti n xerB4 it
CSX8 n it it xerB5 n
CSX9 it it it xerB6 it
CSX 10 it it it xerB7 it
CSX11 15 ii it xerA5 it
CSX16 As JM101 but xerA3 n
CSX17 As DS9*H but xerB1 ti
CSX18 As JM101 but xerB1 it
CSX20 As DS941 but xerB2 it
CSX21 it n it xerB4 n
CSX22 it ti n xerB5 it
Table 2.2 Plasmids
Plasmid Marker^ s)
ColE1 Colicin E1
PBR322 Apr, Tetr
pUC8 Apr
PUC9 it
PUC18 it
PUC19 1
PACYC184 Cmr, Tetr
PCB101 Cmr
PCB18B Cmr
PCB19B ti
pBAD Apr
PMC1871 Tetr
PKS450 Apr
PKS451 n
PKS492 ti
PKS493 ti
PKS455 Apr, Cmr
PGS30 Apr
PGS36 it
PGS38 1
PCS80 Apr,Tetr,Km]
pCS100 Apr
PCS110 Apr
pcsm 1
pCS112 it
pCS118 Cmr
PCS119 1
PCS120 1
pCS121 1
PCS124 Apr
PCS125 ’ n
pCS126 1
PCS127 n
PCS130 1
PCS131 ti
PCS132 n
pXB1 Apr, Knir
Description
Naturally occurring 
Derived from pMB1 
Derived from pBR322
ti 
ft 
I
Derived from p15A 
Lambda dv replicon 
Derived from pCBlOl
it
ptac expression vector derived 
from pKK223 
contains lacZ gene cartridge 
pUC9 plus 377bp Hpall cer fragment
it
pUC18 plus 279bp cer fragment
it
Derivative of pKS450 containing 2 cer
sites flanking the cat gene
pAT223 + EcoRI/Hindlll xerA fragment
pBR322 + SphI xerA fragment
pUC19 + Sphl/AccI xerA fragment
pBR322::Tn5
306bp Hpall Rom+ fragment from ColE1 
cloned into Narl site of pUC8 
pCS100 + xerB as a 3Kb BamHI fragment 
PUC18 + xerB as a 2.8KB SphI fragment 
PUC18 + xerB as a 1.9Kb Hindlll fragment 
pCB19B + 1.9KB Hindlll fragment from pCS112
1 it ti 1 it ti
pCB18B + I647bp EcoRI/Hindlll fragment 
PCB18B + 274bp EcoRI/Hindlll fragment 
PUC19 + 829bp Hindlll/Mlul fragment 
PUC19 + 1092bp Hindlll/Mlul fragment 
pBAD + 1.9Kb Hindlll fragment from pCS112
ti 1 it it it it
AccI deletion derivative of pCS112 ( xerEf*-) 
Kpnl deletion derivative of pCS112 
HincII deletion derivative of pCS112 
5.2Kb BamHI fragment from xerB1 
cloned into pBR322
Source/Ref.
D. Sherratt 
Sutcliffe (1979) 
Vieira & Messing (1982)
n
Norrander et jil (1983)
it
Chang & Cohen (1978) 
Boyd & Sherratt (1986) 
A.C. Boyd
it
A.C. Boyd
Shapira et al (1983) 
D.K. Summers 
11 
n 
n
Stewart (1986) 
Stewart (1986) 
Stewart (1986) 
Chapter 4 
This work
Chapter 5
it
11
This work
n
Chapter 5'
ti
it
it
Chapter 7
ti
Chapter 5
it
ti
1
Table 2.2 eont.
/
Plasmid Marker( s) Description Source/ Ref.
PCS202 Cmr,Tetr Lambda dv-based 2 cer reporter plasmid: 
deletion marker = Tetr
Chapter 3
PCS203 Cmr Xer-deletion derivative of pCS202 i»
PCS208 Tetr,IPTGs PAT153 based 2 cer reporter plasmid: 
deletion marker = ptac-mob5
This work
PCS209 Tetr;,IPTGr Xer-deletion derivative of pGS208
pCS210 Tetr,LacZ+ PACYC184 based 2 cer reporter plasmid: 
deletion marker = lacZ
Chapter 4
pCS211 Tetr Xer-deletion derivative of pCS210 ti
*pCS300 Apr,Tetr,Kmr PBR322 + the xerA3 allele it
pCS349 Cmr pCB19B + Sphl/AccI xerA fragment ti
Table 2.3 Bacteriophages /
Phage Description Source/Reference
P1kc Generalised transducing phage M. Masters
Lambda NK467 Suicide vector for Tn5 mutagenesis N. Kleckner
M13mpl8 Cloning vector derived from M13 Morrander jet al (1983)
M13mp19 " " M 1 " »
mCS301 M13mp19 + 3.4Kb Sphl/PstI fragment from pCS300 Chapter 6
mCS304 M13mpl8 + 1Kb Sphl/PstI fragment from pCS300 ”
mCS305 M13mp19 + 0.8Kb Dral/PstI fragment from mCS304 1
mCS320 M13mp19 + Sphl/AccI xerA fragment from pGS36 n
mCS112 M13mp19 + 1.9Kb Hindlll fragment frcxn pCS111 Chapter 7
mCS113 ■" " " " n " "
mCS114 " + 0.9Kb Hindlll/SstI fragment from PCS124 "
mCS115 " + 0.7Kb Hindlll/Bglll fragment from PCS112 "
mCS1l6 HincII deletion derivative of mCS113 M
mCS117 Kpnl deletion derivative of mCS113 n
mCS1l8 AccI deletion derivative of mCS113 "
2.1 Bacterial strains. The bacterial strains - used were all
derivatives of Escherichia coli K-12 and are listed in table 2.1.
Genotype and phenotype symbols are those recommended by Bachman gl jl!
(1976) and Novick gt al (1976).
2.2 Plasmids. The plasmids used and constructed in this study are
listed in table 2.2 and their nomenclature follows that of Novick gt. 
al (1976).
2.3 Bacteriophages. The bacteriophages used and constructed during 
this work are listed in table 2 .3 .
2.4 Chemicals.
CHEMICALS 
General chemicals
Media
General biochemicals 
Agarose 
X-gal, IPTG 
Radiochemicals 
10 X core buffer 
Antibiotics 
Restriction enzymes 
En^hance
2.5 Culture media.
L-Broth: 10g tryptone, 5g yeast extract, 5g NaCl, 1g Glucose, 20mg 
thymine, made up to 1 litre in distilled water and adjusted to pH7.0 
with NaOH.
L-Agar: As L-Broth without glucose and the addition of 15g/l agar.
Iso-sensitest Broth: 23.4g Iso-sensitest Broth made up to 1 litre
with distilled water.
SOURCE
B.D.H., Hopkins and Williams, Kochlight
Laborotories, May and Baker
Difco, Oxoid
Sigma, Pharmacia
BRL
BRL
NEN
BRL
Sigma
BRL, Boerhinger mannheim 
Dupont
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Iso-sensitest Agar: 31.4g Iso-sensitest Agar made up'to 1 litre with
distilled water.
/■
Minimal Agar: 7g K2HP0]j, 2g KH2P02j, 4g NH^SC^, 0.25g trisodium
citrate, 0 .1g MgSOjj.7^ 0 , 17.5g agar, made up to 1 litre in distilled
water.
Davis-Mingioll (DAM) Salts (14): 28g KgHPOjp 8g KH2 P0|j, 4g (NH2|)2S01},
1g sodium citrate, 0.4g MgS0ij.7H20, made up to 1 litre with distilled 
water.
DAM Minimal Medium: 25ml D&M salts, 5ml 20$ casamino acids, 250ul 20$
glucose, 0.5ml vitamin B1 (1mg/ml), made up to 100ml with distilled
water.
M9 Salts (X10): 6g Na2HP0jp 3g KHgPOjp 0.5g NaCl, 1g NH^Cl in 1 litre
of distilled water.
M9 Minimal Medium: 10ml M9 salts, 2ml glucose (20$ w/v), 0.1ml 1M
MgCl2, 0 .1ml 100mM CaCl2, 0.1ml (1mg/ml) vitamin B1, 2.5ml 20$
casamino acids, made up to 100ml with distilled water.
3XD Minimal Media: 150ml phosphate concentrate, 10ml 10$ NH^Cl, 6ml
10$ MgS02j.7H2 0 , 10ml 0.1$ Glycerol, 3ml 0.05M CaCl2, 15g casamino
acids, 797ml distilled water. Phosphate concentrate and CaCl2 added 
slowly after autoclaving.
210-Medium: D&M minimal medium, casamino acids ( 1$), glucose ( 0.2$), 
X-Gal ( 25mg.l“1), Tetracycline ( 7mg.l“1).
Phage Buffer: 7g Na2HP0jj, 3g KH2P0^ , 5g NaCl, 0.25 MgSOi,, 15mg
CaCl2 .2H2 0, 1ml 1$ gelatin made up to 1 litre in distilled water.
Phosphate concentrate: 30g KH2P0jj (anhydrous), 70g Na2HP0jj
(anhydrous) made up to 1 litre in distilled water.
21
Supplements: When required, supplements were added’to minimal media
at the following concentrations:
■/
glucose 2mg/ml amino acids 40ug/ml thymine 50ug/ml 
thiamine vitamin B1 20ug/ml casamino acids 1$
2.6 Sterilisation. All growth media were sterilised by autoclaving at 
120°C for 15 minutes; supplements, gelatin solution and buffer 
solutions at 108°C for 10 minutes and CaCl2 at 11 i|°C for 10 minutes.
2.7 Buffer solutions.
Electrophoresis
10 X E Buffer: 48.4g Tris-HCl, I6.4g NaAc, 3.6g Na2EDTA.2H20, made up
to 1 litre in distilled water, pH adjusted to 8.2 with acetic acid.
10 X TBE Buffer pH8.3: 109g Tris-HCl, 55g Boric Acid, 9-3g
Na2EDTA.2H20, made up to 1 litre in distilled water; pH is 8.3.
10 X Laemmli gel buffer: 144g Glycine, 30g Tris-HCl made up to 1
litre in distilled water. When diluted, 10ml 10$ SDS (w/v) was added 
for every 1 litre of 1 X concentration.
Single Colony Gel Loading Buffer: 2% Ficoll, 1% SDS, 0.01$
Bromophenol blue, 0.01$ Orange G in Buffer E. — ----
Protein loading buffer: 5$ SDS, 50$ Glycerol, 0.01$ Bromophenol blue,
50mM Tris ( pH 6 .8 ), made up to 5$ beta-mercaptoethanol immediately 
prior to use.
Horizontal Agarose and Polyacrylamide Gel Loading Buffer: 25$ (w/v)
sucrose, 0.06$ Bromophenol Blue, 10mM Tris-HCl (pH8.0).
Vertical Agarose Gel Loading Buffer: 1$ Ficoll, 0.5$ SDS, 0.06$
Bromophenol Blue, 0.06$ Orange G in 1 X TBE.
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Restriction and Ligation Buffers:
10 X Low salt: 100mM Tris-HCl pH7.5, 100mM MgSCfy, 10mM DTT.'Stored at
M°C.
10 X Medium salt: 500mM NaCl, 100mM Tris-HCl pH7.5, 100mM MgSOjj, 10mM
DTT. Stored at H°C.
10 X High salt: 1M NaCl, 500mM Tris-HCl pH8.0, 100mM MgCl2, 10mM DTT.
Stored at 4°C.
10 X Smal Buffer: 200mM KC1, 100mM Tris-HCl pH8.0, 100mM MgCl2, 10raM
DTT. Stored at 4°C.
10 X Ligation Buffer: 660mM Tris-HCl pH7.6, 6 6mM MgCl2, 100mM DTT.
Stored at -20°C.
AmM ATP: Dissolve 60mg of ATP in 0.8ml distilled water. Adjust to
pH7.5 with 0.1M NaOH, made up to 1ml with distilled water; Stored at 
-20°C in aliquots and thawed once only.
TE Buffer: 10mM Tris-HCl, 1mM EDTA; pH8.0.
All these buffers were stored for long term at -20°C.
Protein sample buffer: 10$ Glycerol, 0.01$ Bromophenol blue, 5$ B-
mercaptoethanol, 3$ SDS, 0.625M Tris-HCl pH8.0. Stored at room
temperature.
10 X Nick Translation Buffer: 500mM Tris-HCl pH7.2, 100mM MgSO^, 1mM
DTT, 500ug/ml BSA; stored at -20°C
20 X SSC: 3M NaCl, 300mM trisodium citrate pH7.0
Wash Buffer: 5mM NaH2 P01|, 1mM Na2EDTA, 0.2$ SDS pH7.0
Phenol All phenol used in the purification of DNA contained 0.1$ 8-
hydroxyquinoline, and was buffered against 0.5M Tris-HCl pH8.0.
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BirAboil^Doly Is 50mM Glucose, 25mM Tris-HCl pH8.0, 10mM EDTA; add 
lysozyme to 1mg/ml immediately before use.
Bimboim-Doly II: 0.2M NaOH, 1? SDS; made fresh. '
Bir/iboi&-Doly III: ,2*5M KAc pH4.8; mix equal volumes of 3M CH^COOK and 
2M CH3COOH, pH should be 4.8.
STET Buffer: 8$ Sucrose, 5? Triton X-100, 50mM EDTA, 50mM Tris-HCl
pH8 .0
Buffered Saline Gelatin (BSG): 0.85? NaCl, 0.03? KH2P0ij, 0.06?
Na2HP0^, 100ug/ml Gelatin.
5? Sucrose BSG: BSG made in the presence of 5? Sucrose.
20? Sucrose BSG: BSG made in the presence of 20? Sucrose.
2.8 Antibiotics. The antibiotic concentrations used throughout for 
both liquid and plate selections were as follows:
Name Selective cono^ Stock sol— Storage temp.(°C)
Ampicillin (Ap) 50ug/ml 5mg/ml (water) +4
Tetracycline (Tet) 10ug/ml* 1mg/ml ( 50? EtOH in water) +4
Chloramphenicol (Cm) 25ug/ml 2.5mg/ml ( EtOH) -20
Kanamycin (Kan) 50ug/ml 5mg/ml (water) +4
Trimethoprim (Tp) 50ug/ml 5mg/ml ( 50? EtOH in water) +4
When required, antibiotic stock solutions were added to molten agar
pre-cooled to 55°C.
*
7ug/ml was employed with pCS210 and pCS211.
25ug/ml was employed when selecting chromosomal Tn5 insertions.
2.9 Indicators. X-gal (5-Bromo-4-chloro-3-indolyl-B-galactoside) was 
used in conjunction with the host strains DS941 and JM101 plus the 
pUC and M13 vectors providing a screen for plasmids with inserts in 
the polylinker region. Clones containing inserts are generally white; 
clones lacking inserts are blue. X-gal was stored at a concentration 
of 20mg/ml in dimethylformamide (DMF) at -20°C and added to L-agar
plates to a final concentration of 2 0ug/ml.
2.10 Growth conditions. Liquid culture for transformation, DNA 
preparations etc. were routinely grown in L-broth, or when Tp 
selection was required in isosensitest broth, at 37°C with vigorous 
shaking. Growth on plates was on L-agar, minimal medium plus 
supplements, or on isosensitest agar for selection on Tp. Antibiotics 
were used as required. Plates contained 25ml of agar solution and 
were incubated at 37°C overnight unless otherwise stated. All 
dilutions were carried out in D&M salts.
Bacterial strains were stored in 50% L-broth, 20% glycerol and 1$ 
peptone at -20°C, and on L-agar slopes ( room temp.). Inocula from 
these stocks were applied to L-agar plates and grown, prior to 
replating on selective plates.
2.11 Preparation of P1 lysates: The donor strain was grown up in L-
broth to late log phase, then the cells harvested by centrifugation ( 
10,000g,5mins). The cells were resuspended in the same volume of fresh 
L-broth, then 100ul of cells mixed with 100ul CaCl2 ( 50mM), 100ul
MgSOjj ( 100mM), and 100ul of a P1 phage dilution sufficient to produce 
an m.o.i of approximately 0.001. The mixture was then vortexed, then 
incubated at 37°C, 25mins, to permit, phage adsorbtion and infection. 
The cells were then added to 3®ls molten soft-agar ( M7°C), then
plated onto a fresh ( undried) L-agar plate (containing 0.5mM CaCl2). 
After overnight incubation ( 37°C), 2.5mls of phage-buffer was added 
to the plate and incubated for 15 mins. The soft agar layer plus phage 
buffer was then harvested and placed in a centrifuge tube. A few drops 
of chloroform were added to the tube, then the mixture vortexed 
thoroughly for 30 secs. This was then allowed to stand for 30 mins ( 
room temp.) before re-vortexing, then spinning out the debris by 
centrifugation ( 12,000g, 10 mins). The resultant supernatant was then 
titred for phage concentration; the method routinely recovering 10^- 
10 °^ p.f.u.ml-1.
2.12 P1 transduction: The recipient strain was grown up to mid-log 
phase in L-broth, then harvested and resuspended in the same volume of 
fresh L-broth. To 100ul of cells was added 100ul CaCl2 ( 50mM), 100ul 
MgSOjj ( 100mM), and sufficient P1 lysate to provide an m.o.i. of
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approximately 0.01. After 20 mins incubation at 37°C, phage infection
was stopped by the addition of 200ul 1M sodium citrate ( filter
sterilised). After theceldition of 500ul of L-broth, the mixture was
incubated at 37°C, 30 mins, to permit expression. Then the cells
plated onto a suitable medium.
2.13 Transformation with plasmid DNA. Plasmids were introduced to 
different strains by genetic transformation. An overnight culture of 
the recipient was diluted 1 in 100 into 20ml L-broth and was grown to 
a density of approximately 10® cells/ml (about 90min - 2 hours). The 
cells were harvested (12000g, 5min, 4°C) and resuspended in 10ml of 
cold 50mM CaCl2. The cells were pelleted again, resuspended in 1ml of 
cold 50mM CaCl2 and kept on ice for at least 15min before use. 200ul 
aliquots of the competent cells were added to the plasmid DNA, mixed 
gently and left on ice for up to 1 hour. The cells were heat shocked 
(2min, 42°C) and returned to the ice for a further 15min. An equal 
volume of L-broth was added and the cells incubated at 3 7°C for 1 hour
to allow expression of the plasmid resistance genes. The cells were
plated out on the appropriate selections. For transformation to 
ampicillin resistance, no expression time was necessary.
2.1A Transfection of JM101 with M13: This followed exactly that
procedure described above ( 2 .1 3), except that after heat-shock the 
cells were incubated on ice for 15 mins, after which 2 0 0ul of fresh,
log phase JH101 culture was added. To this mixture was then added 30ul
of IPTG ( 15mg/ml) and 30ul X-Gal ( H0mg/ml). The cells were then 
mixed, added to 3ml of molten soft-agar ( pre-cooled to ^7°C), and 
then plated onto thoroughly dried plates containing D&M minimal agar ( 
+ B1 and Glucose).
2.15 OV sensitivity test. This technique was used to rapidly confirm 
the recombination status of strains. Stationary phase cultures of the 
strain to be tested and control strains were spotted on to L-agar 
plates at 10“2, 10“  ^and 10“® dilutions. These plates were exposed to 
UV radiation (17.5ergs/sec/M2) for 30 and 60 seconds and incubated 
overnight in the dark. rec+ strains usually grow after 60 seconds 
exposure while recA“ strains show reduced growth after 30 seconds and 
do not grow after 60 seconds exposure. recF“ strains show an inter­
mediate phenotype. Periodically all strains were checked for their
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recombination status.
2.16 Plasmid DNA preparation. Two methods were used to obtain DNA 
from cells. ^
Birnboim and Doly (1979) DNA preparation- Large Scale: 200 ml
cultures of stationary phase cells were harvested by centrifugation 
(12000g, 5min at 4°C). The pellet was resuspended in i|ml of Birmboin- 
Doly I solution and incubated on ice for 5min. 8 ml of Birmboin-Doly 
II solution were added and the solution left on ice for 5min before 
6 ml of cold Birmboin-Doly III solution was added, gently mixed and 
left on ice for a further 5min. The cell debris and most chromosomal 
DNA was removed by centrifugation (32000g, 5min at 4°C) and the 
plasmid DNA precipitated by addition of an equal volume of isopropanol 
followed by centrifugation at 39200g for 15min. This DNA was further 
purified by banding on a CsCl/EtBr gradient. The DNA was resuspended 
in 2.09ml of water and added to 270ul of a 15mg/ml EtBr solution. 5g 
of CsCl were dissolved in 3ml of water and added to the DNA/EtBr 
solution. The gradients were centrifuged in a Beckman Ti70 fixed 
angle rotor at 200,000g for 16 hours at 20°C. Two bands were visible, 
a lower supercoiled plasmid band and an upper chromosomal and relaxed 
plasmid DNA band. The lower band was removed using a Ini syringe and 
the EtBr removed by repeated butanol extractions (using water 
saturated butanol). The salts were removed by dialysis in 2 X 500ml 1 
X TE. The DNA was then ready for use.
Mini DNA preparation using the method of Holmes and Quigley (1981):
1.5ml of an overnight culture containing the plasmid of interest was 
harvested by centrifugation in a 1.5ml eppendorf tube and resuspended 
in 350ul of STET buffer. 25ul of STET buffer containing lysozyme at a 
concentration of 1 0mg/ml was added and the tube vortexed briefly. 
This solution was boiled for JjOsec and centrifuged in an eppendorf 
microfuge for 15min at 4°C. The pellet was discarded using a 
toothpick and 40ul of 3M NaAc and JjOOul of cold isopropanol was added, 
followed by microcentrifugation for 7min which prcipitated the nucleic 
acid. The pellet was washed twice in 70$ ethanol and dried briefly in 
a vacuum drier before being resuspended in 20ul - 50ul 1 X TE. This 
DNA was suitable for digestion and other In vitro manipulations.
27
2.17 Chromosomal DNA preparation. 100ml of stationary phase culture 
was harvested by centrifugation (12000g, 10min, 4°C) and resuspended 
in 3.3ml 25? sucrose. 0.67ml of a 5mg/ml lysozyme solution 4n 0.25M 
Tris-HCl pH8.0 was added and the mixture left on ice for 5min. 1.3ml 
of 0.25M EDTA was added followed by 5.3ml of 2? Sarkosyl (made up in 
50mM Tris-HCl pH8.0 and 50mM EDTA pH8.0). Lysis was allowed to proceed 
for 5min on ice. Treatment of the lysed cells with RNase (final 
concentration 50ug/ml) and then with Proteinase K (final concentration 
50ug/ml) broke down the RNA and proteins. The DNA was purified 
initially by repeated phenol extractions until the interface was 
clear. The addition of 1.5ml of 5M NaCl to every 20ml of solution 
prior to phenol extraction helped clear the interface. Chloroform and 
ether extractions removed any traces of phenol or chloroform. The DNA 
was precipitated using ethanol, washed in 7 0? ethanol and further 
purified by banding in a CsCl/EtBr gradient (see above for this 
procedure).
2.18 Ethanol precipitation of DNA. The DNA solution was made 0.3M in 
NaOAc and 2 volumes of cold ethanol added. After mixing, the DNA was 
precipitated by cooling on ice for up to 1 hour and pelleted by 
centrifugation (27000g, 15min, l|°C for large volumes or 12000g, 15min, 
4°C for small volumes in eppendorf centrifuge tubes). The pellet was 
usually washed in 7 0? ethanol and dried briefly in a vacuum drier.
2.19 Restriction of DNA. Restrictions were usually performed in a 
total volume of 20ul containing between 0.25ug and 1ug of DNA, 2ul of 
10X restriction buffer and 1 unit/ug DNA of enzyme, the volume being 
made up with distilled water. For larger scale restrictions the 
volumes were scaled up accordingly. The reactions were allowed to 
proceed for 1 to 2 hours at the appropriate temperature. Reactions 
were stopped either by the addition of gel loading buffer or by rapid 
heating to 70°C for 5 min followed by rapid cooling on ice.
2.20 Ligation of DNA fragments. The restriction fragments to be 
ligated were mixed such that the insert was in 3 times excess over the 
vector ( 10 times excess for blunt end ligations) and made up to 2 0ul 
by the addition of 2ul 10 X ligation buffer, 2ul 4mM ATP and distilled 
water. T4 DNA ligase was added (0.01 units/ug DNA for ’sticky* end 
ligation and 1 unit/ug DNA for ’Blunt’ end ligation) and the solution
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ligated for 1 hour at room temperature (overnight at 16°C for ’blunt’ 
end ligations). Aliquots of the ligation mix were used to transform 
competent cells. ^
2.21 Calf Intestinal Phosphatase (CIP) treatment. To increase cloning 
efficiency CIP was used to remove the 5'-terminal phosphate groups 
from the linearised vector to prevent recircularisation of the vector. 
This technique is particularly useful if there is no direct selection 
for the insert. CIP works in high, medium or low salt buffers and was 
used at a concentration of 1-2 units/ug DNA. It was added directly to 
the restriction digest for the final 15min of the incubation and was 
heat killed in the manner described for restriction enzymes.
• 2.22 Single colony gel analysis. This technique enables the plasmid
content of a colony to be observed without the purification of plasmid 
DNA. A single colony was patched out (1cm square) and grown 
overnight. The patch was scraped off the plate using a toothpick and 
suspended in 150 - 250ul of single colony gel buffer. The cells were 
left to lyse at room temperature and centrifuged in a microfuge 
(12000g, 4°C) for at least 15min. 30ul of the supernatant were loaded 
onto an agarose gel which did not contain ethidium bromide.
2.23 Rapid whole-cell protein preparation for SDS-PAGE: Take 400ul of
late log phase culture and harvest cells by microfugation ( 20 secs). 
Remove all but 5-10ul of supernatant, then vortex thoroughly to 
generate a thick cell slurry. Add 80ul of Protein loading buffer ( 
with 5$ beta-mercaptoethanol added immediately prior to use). Vortex 
thoroughly, then incubate in a boiling water bath, 5-10 mins. Load 20- 
30ul of sample; the remainder may be stored ( -2 0°C) for future use.
2.24 Gel electrophoresis. Both vertical and horizontal agarose gels 
were used. Vertical gels were used mainly for single colony analysis 
while horizontal agarose gels were used for restriction analysis of 
plasmids and for southern analysis. Unless otherwise stated 1$ 
agarose gels were used.
Horizontal gels. Two types were commonly run.
(1) 100ml gels - 100ml of molten agarose was poured into a 11 X 19cm
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perspex gel former with a 13 space teflon well former. After the gel 
had set, the comb was removed and the gel placed in a horizontal gel 
tank, submerged in E buffer and loaded with 20 - 30ul of sample. Gels 
were usually run overnight at 20V and stained in ethidium bromide 
(0.5ug/ml) for 30mins. The stained DNA was photographed on a 254nM 
wavelength UV transillurainator. Some gels were made up with ethidium 
bromide to a concentration of 0.5ug/ml.
(2) 200ml .gels -■ These gels were made by pouring 200ml of molten agar 
into a 16.5 X 23cm gel former with a 20 space well former. The gels 
were run in E buffer in a gel tank with a buffering capacity of 3 
litres overnight at 20V. The gels were stained with ethidium bromide 
(0.5ug/ml) and visualised on a 25^nM wavelength transilluminator.
Vertical gels: The gel kits held two 16 X 15cm glass plates separated 
by 3mm spacers. After sealing the edges with molten agar the agar was 
precooled to 55°C and poured between the glass plates. The comb (10 
or 15 teeth) was inserted and the gel allowed to set. The top and 
bottom wells were filled with E buffer and the comb removed. Samples 
were loaded and the gel run, generally at 5 V/cm for about 4 hours 
prior to staining in 0.5ug/ml ethidium bromide. The gel was 
photographed on a 254nM wavelength transilluminator.
Vertical gels were used mainly for single colony analysis and the 
interpretation of the DNA band seen followed that of Dugaiczyk e£ ad 
(1975). The fastest migrating and generally most abundant band was 
the supercoiled plasmid monomer. Behind this ran the open cicular 
plasmid band often comigrating with the supercoiled plasmid dimer. 
Open circular dimers and other higher forms ran higher up the gel. 
Plasmid linears could sometimes be detected running between the 
supercoiled monomer and the open circle monomer. Sheared fragments of 
chromosomal DNA ran as a thick band toward the top of the gel. Large 
plasmids like R388 run above the chromosomal band.
Photographing of gels. Ethidium bromide stained gels were viewed on a 
25^nm UV transilluminator and photographed using Polaroid type 67 land 
film or using a Pentax 35mm SLR loaded with Ilford HP5 film. Both 
cameras were fitted with a Kodak Wratten filter No.9.
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2.25 Extraction of DNA from agarose gels using GENECLEAN. After
staining, the gel was placed on a long wave transilluminator (300nM -
/
360nM) and the band of interest excised. The agarose chip was added 
to 2-3 volumes ( usually 800ul) of "Nal" soln’, then heated to 45-55°C 
for a few minutes until the agarose had completely dissolved. 5ul of 
"Glassmilk" suspension was then added, rapidly mixed, then placed on 
ice for 5 mins. Spin ( 5 secs, microfuge), and carefully discard the 
supernatant. Wash pellet three times in ice-cold "New" soln' by adding 
700ul, resuspending the pellet, re-spinning, and discarding the super­
natant. After final wash, take care to remove all traces of New soln*. 
Elute DNA from glass beads bjj^ding 20ul T.E ( pH 8.0), and incubating 
at 50°C for 3 mins. Spin 10 secs to pellet glass beads, then carefully 
remove the supernatant. Re-spin the supernatant to ensure the complete 
removal of all glass beads. The DNA is now suitable for restriction, 
ligation, end-labeling etc.. The compositions of the "Nal", 
"Glassmilk", and "New" solutions are undisclosed.
2.26 Preparation of polypeptides produced from purified minicells.
The plasmid to be examined was transformed into the minicell strain 
DS944. 200ml of L-Broth was inoculated with this transformed strain
and grown upjto stationary phase at 37°C. The minicells were easier to 
purify if the culture was in stationary phase though it did reduce the 
level of incorporation acheived. Partially purified rainicells were 
obtained by low speed centrifugation (5mins, 2000g at room 
temperature) which preferentially pelleted the whole cells. The 
supernatant was carefully decanted and the minicells pelleted (I6000g, 
10min, 4°C) and resuspended in 1ml of BSG. This was loaded onto a 5%- 
20% sucrose BSG gradient, poured using a peristaltic pump and a 
gradient former. The sucrose gradient was centrifuged at I600g for 
30min at 4°C. The minicells form a creamy band in the top third of the 
gradient. These were carefully drawn-off using a pasteur pipette, and 
then harvested by centrifugation (I6000g, 10min, room temperature), 
and resuspended in 0.5ml BSG. The sucrose gradient purification step 
was then repeated. After the second sucrose gradient the minicells 
were harvested and resuspended in about 600ul of M9 minimal media 
supplemented with glucose and vitamin B1. The minicells were split 
into 2 aliquots and IPTG added to one at a final concentration of 
0.1 mM ( to derepress the tac promoter) and incubated with shaking, 
37°C, 20 mins. After incubation 20uCi of 35s-methionine was added and
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the minicells incubated at 37 C with shaking for a further hour.
1.5ml of L-Broth was added and the tubes incubated at 37°C for 30
/
minutes. The minicells were centrifuged at I6000g at room temperature 
for 5min and washed once in phage buffer prior to being lysed with 
about 50ul of protein sample buffer.
2.27 Protein Gel Electrophoresis: The electrophoresis of proteins
followed the procedure of Laemmli (1970). Unless specifically stated 
all SDS-polyacrylamide gels were 10$ running gel with a 4$ stacking 
gel. The gel plates were separated by 0.8mm spacers and the gel was 
pre-sealed using molten 0.6$ agarose in H20. The gels were poured 
according to the table below;
Running Gel Stacking Gel
Acrylamide/Bis (30 ; 0.8) 10ml (10$) 2ml (*1$)
Tris-HCl 11.25ml (1M; pH8.8) 1.9ml (1M; pH6.8)
10$ SDS 0.3ml 0.15ml
TEMED 0.01ml 0.01ml
APS (made fresh; 100mg/ml) 0.15ml 0.15ml
dH20 8.3ml (10$) 10.9ml (4$)
The running gel was poured leaving about 1.5-2.0cm between the top of 
the running gel and the bottom of the comb. Isopropanol was layered 
on top of the running gel to create a sharp interphase. Once the 
running gel had set, the stacking gel was poured after removing the 
isopropanol and washing away any residue with distilled water. The 
comb was pushed into the stacking gel firmly. After the gel had set 
the comb was removed, and running buffer poured into the gel tank 
covering the wells. Residue acrylamide was washed out of the slots 
using running buffer prior to loading the samples. The gel was run 
overnight at about 6mA until the bromophenol blue dye had reached the 
bottom of the gel.
The gel was then either stained with Coomassie to visualise protein 
bands, or prepared for autoradiography as follows; the gel was fixed 
in 30$ methanol/10$ glacial acetic acid for 1 hour before being soaked 
in ENHANCE for a further hour. The EN^HANCE was removed and the gel
soaked in water for a further 30 minutes before being dried in a
/
Biorad vacuum drier at 80°C for at least 1 hour. The dried gel was 
placed against Blue sensitive film (Kodak Xomat S) and kept in the
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dark at -70°C for a variable time (up to 1 month) to allow exposure of 
the film.
/
2.28 Southern hybridisation. Hybridisation of labelled DNA to filter 
bound chromosomal or plasmid borne DNA followed the procedure of 
Southern (1975) as modified by Reed and Mann (1985). Horizontal 
agarose gels were run with the required samples. The gel was 
photographed after ethidium bromide staining. The gel was soaked in
0.25M HC1 for 15 minutes, soaked in 0.4M NaOH for 15 minutes, then 
placed on a glass plate covered by 2 layers of 3MM paper which 
overhung the edges and dipped into a tray containing the transfer 
buffer (0.4M NaOH). Pall Biodyne Nylon membrane cut to the size of 
the gel was pre-soaked in water and placed on top of the gel ensuring 
that no air bubbles were trapped. This was covered by further layers 
of 3MM paper and by paper towels until an 8 cm stack was formed. The 
stack was topped with a glass plate weighed down with a 500ml bottle 
of water. Transfer was allowed to proceed overnight. The nylon 
membrane was briefly washed in 2 X SSC and was then ready for pre­
hybridisation and hybridisation.
Pre-hybridisation was carried out using a solution of 1.5 X SSC, 0.5$ 
Blotto (w/v non fat powdered milk) and M* (w/v) SDS. Heat denatured 
sheared salmon sperm DNA was added at a concentration of 100ug/ml. 
About 1ml per 4cm^ of filter was added, sealed in a plastic bag, and 
gently agitated for 1 hour at 65°C.
Hybridisation was also carried out at 65°C and in the same solution. 
The probe was labelled by nick translation according to Rigby .gt. aJL.
(1977) and denatured by boiling for 5 minutes in 1$ SDS and 1.5 X SSC 
and chilling on ice. The probe was added to the filter by opening up 
the bag and resealing. The solution was mixed by agitation prior to 
incubating with gentle agitation overnight at 65°C.
The filter was washed in wash buffer sucessivily at room temperature, 
42°C, 55°C and 65°C until no, or very few, counts were found in the 
wash buffer. The filter was sealed wet in a plastic bag and 
autoradiographed for a variable length of time depending on the number 
of counts retained on the filter.
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2.29 Nick Translation of DNA. Labelling of plasmid DNA with 32p 
followed the procedure of Rigby e£. jlI (1 977). The nick translation 
reaction was set up according to the following table:
10 X Nick translation Buffer 5ul
DNA 1ug
1ul of 1mM stock 
25uCi (2.5ul)
unlabelled dNTP's 
[ gamma - 32p] dATP 
dH20 up to 44ul
This solution was chilled to 0°C
A 10”  ^dilution of a 1 mg/ml DNase I solution was prepared in ice cold
nick translation buffer and 50$ glycerol (stored at -20°C). 0.5ul of
this solution was added to the nick translation reaction along with 5 
units of E.coli DNA polymerase I. The reaction was incubated at 16°C 
for 1 hour and stopped with 2ul 0.5M EDTA pH8.0.
The unincorporated counts were separated from the labelled probe using 
a spun minicolumn (Maniatis et. al, 1982). Sephadex G-50 was prepared 
in 1 X TE buffer and used to fill a 1ml syringe, one end of which had 
been blocked using siliconised glass wool. The syringe was spun for *1 
minutes at 1500g at 4°C. 100ul of TE was added to the column which
was centrifuged at 1500g for 4 minutes at 4°C. THe nick translation 
reaction was diluted to 100ul with TE and spun through the column in 
the same manner. The void volume was collected in a 1.5ml eppendorf 
tube and contained the incorporated label. The unincorporated counts 
remained in the column.
2.30 DNA sequencing: All DNA sequencing reactions were performed on
single-stranded M13 templates using the di-deoxy chain termination 
technique. All template preparations, solutions and reaction 
conditions were as described in the "M13 Cloning/dideoxy sequencing 
Instruction Manual", published by Bethesda Research Laboratories with 
the following exceptions:
1. Working dideoxynucleotide concentrations:
0.25mM ddATP
0.25mM ddCTP
0.5 mM ddGTP
1.0 mM ddTTP
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2. Final reaction volume was reduced to eliminate wastage.
The primer/template hybridisation mix volume was reduced^to 8ul 
from 12.4ul: composition = 5ul template (1ug)
2ul M13 sequencing primer ( Mng)
1ul 10x polymerase buffer
3. Samples were electrophoresed on 8% polyacrylamide/urea gels as 
described in the BRL manual. When necessary, gels were prepared in 
30$ formamide, this has the advantage of resolving regions of 
extreme secondary structure in the DNA sequence.
2.31 Generation of pBR322::Tn5 derivatives: pBR322::Tn5 derivatives 
were generated by jji vivo transposition of Tn5 from lambda NK^67 into 
pBR322. The procedure for the selection of such events is illustrated 
in figure 2.1; and the structures of two independent isolates pCS80 
and pCS8l are indicated in figure 2.2. For lambda NK*l67 description 
and infection conditions, see chapter 3.
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/DS947 + PBR322
Infect with Lambda NK467
Select for transposition events on 
L-agar plus Ap+Km
Make plasmid DNA from a mixed 
population of Apr Kmr clones
I
Transform DS947 with this plasmid DNA 
selecting for Apr Kmr transformants
V
Screen transformants for Tetr,.to identify 
insertions in the let gene
Restriction map the insertion locus 
using Hindlll and Bglll
?
Two isolates
pCS80 ( 10.2Kb) - Encoding resistance to Ap, Km and Tet 
pCS8l ( 10.2Kb) - Encoding resistance to Ap and Km
FIGURE 2.1 Flow diagram illustrating the procedure used in the
selection of the pBR322::Tn5 derivatives pCS80 & pCS8l.
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Figure 2*2 Structures of the pBR322::Tn5 Derivatives pCS80 & pCS8l
The site of Tn5 insertion in pCS80 ( 2.9Kb), and pCS8l 
( 1Kb), are indicated. The two plasmids are 10.2Kb in 
size; both encode resistance to Ap and Km, whilst pCS80 
also encodes Tetr.
/■
CHAPTER 3
THE ISOLATION OF E. coli xer MUTANTS
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3.1 iHiaopi?moN
The only ColE1 sequence necessary for cer specific
/
recombination, is the 279bp cer site itself ( Sherratt el .ai, 198U). 
This sequence has limited coding potential and is incapable of 
encoding a polypeptide of similar size to known site-specific 
recombination enzymes. This fact led to the suggestion that the cer- 
specific recombinase might be host encoded, at a locus designated xer 
( Summers el al, 1985). The existence of such host functions was first 
demonstrated by Gill Stewart, who isolated two independent mutants 
defective in cer-specific recombination (Xer”). However, whether these 
mutants correspond to one or more complementation groups, and indeed, 
whether either represents a lesion in the recombinase gene itself, was 
undetermined. My first goal was therefore to increase the number of 
independently isolated xer mutants, such that a minimum number of xer 
complementation groups might ultimately be determined. Thus it was 
necessary to optimise both a mutagenesis protocol and an appropriate 
selection procedure.
3-2 CHOICE OF MUTAGEN
Since their relatively recent discovery, transposable elements 
have proven to be extremely useful tools in the field of bacterial 
genetics (For review see Kleckner .et al, 1977). In particular the 
transposon Tn5 has been used extensively in genetic analyses in a 
variety of species, including E. coli (Kleckner jet aJL, 1977; Berg & 
Berg, 1983). Tn5 is a composite transposon comprising two terminal 
1535bp IS50 elements (IS50L and IS50R), flanking a 2.7Kb.p central 
portion (Fig. 3.1; Auerswald .et al, 1981; Beck jet al, 1982; Mazodier 
et M i  1/985) - The central portion of Tn5 encodes the Neomycin phospho­
transferase II (NPTII) gene whose expression confers resistance to the 
aminoglycoside antibiotics neomycin and kanamycin. In addition, two 
other genes confer resistance to CL990 ( a member of the bleomycin 
family of antibiotics), and to streptomycin respectively. However the 
streptomycin resistance gene is cryptic in JL. coli (Berg et al, 1982; 
Berg & Berg, 1983; Mazodier jet al, 1985). Some of the properties of 
transposable elements as mutagens are listed below, with particular 
reference to Tn5.
1. Tn5 is ranked amongst those transposable elements with the lowest 
insertional specificities (Kleckner jet al, 1977). It inserts into many 
different locations around the coli chromosome ( Shaw & Berg,
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Figure 3.1 Diagrammatic Representation of Tn5
1979), and into a many different sites within particular genes (Miller 
.al, 1980; De Bruijn .et al, 1983). Nonetheless, Tn5 does exhibit a 
bias towards insertion in certain target sites, so-called "Hotspots”. 
However, of those hotspots studied in detail, no target site consensus 
sequence is apparent. In the case of two such hotspots in the 
plasmid pBR322, short stretches of sequence with limited homology to 
IS50 ends are present in close proximity. It has been suggested that 
these homologous sequences in the target DNA may play some role in 
promoting insertions in the nearby hotspot (Berg & Berg, 1983; De 
Bruijn & Lupski, 1983).
2: Insertion of a transposable element into a gene usually results in
the complete inactivation of that gene, such mutations being generally 
non-leaky and stable. Reversion of lacZ::Tn5 insertion mutants occurs 
at frequencies of approximately 10"^  per generation (Berg, 1977), 
such reversion being the result of a transposase-independent excision 
event ( Egner & Berg, 1981). Secondary transposition (transposase 
dependent) of the Tn5 element, giving rise to two chromosomal copies, 
can occur at frequencies of up to 0.1-156 (Berg, 1977). Clearly this 
phenomenon can complicate the interpretation of subsequent results. 
The frequency of secondary IS50 transpositions is less readily
measured, but is of reduced significance.
3. Tn5 insertions into multigenic operons usually exert highly polar 
effects on downstream genes, such polarity being independent of the 
relative orientation of Tn5 insertion. Indeed such polarity- has been 
exploited in determining the genetic organisation of a number of 
operons, for example, the complex nif gene cluster of jC*. pneumoniae ( 
Merrick et ad, 1980). In a minority of cases reported, Tn5 insertion 
does not exert a strict polar suppression of downstream genes ( Berg 
et al. 1980, De Bruijn ejt al, 1983). Some heterogeneity in polar
affects is not at all unexpected.
4. Transposon mutagenesis results in the introduction of a novel
physical and genetic marker at the insertion locus. This has a number 
of very considerable advantages over classically induced genetic 
lesions, for example;
a) Insertion of the NPTII gene permits the pre-selection of a
randomly rautagenised population prior to screening for a desired
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mutant. This can considerably reduce the number of clones which 
have to be screened. ^
b) The inserted transposon sequence, with its resistance 
determinants, provide markers which facilitate both physical and 
genetic linkage analyses. One can also exploit the 100$ linkage 
between a mutant allele and its inserted copy of Tn5 in the process 
of strain construction, a process which can be extended to the co­
transduction of neighbouring alleles (Kleckner e£ ^ 1, 1977). 
c) An insertion locus of interest can be readily cloned by virtue of 
its linkage to a selectable transposon marker.
5.' Finally, the use of Tn5 as a mutagen is aided by the availability 
of highly engineered, transposon delivery vectors. These vectors can 
greatly increase the ease and efficiency with which mutant populations 
are generated.
3.2.2 LAMBDA NK467 as a Tn5 Delivery vector
Ideally, one would like to introduce a selectable transposable 
element on a "suicide vector", that is, one which fails to replicate 
in the host strain, such that when subsequently selecting for a 
transposon marker, one recovers clones arising predominantly from 
transposition events. The vector lambda NK467 satisfies this 
criterion. This vector, a derivative of phage lambda, was constructed 
by N. Kleckner, and is reviewed in detail by De Bruijn & Lupski 
(1983). The phage genotype is as follows; delta b221, rex::Tn5. 
C)am29> JPam80. The b221 deletion removes the attP site along with the 
phage int and xis genes ( Davidson & Szybalski, 1971). This phage is 
therefore unable to efficiently integrate into the host genome. The jQ 
an £ genes are both essential for vegetative phage replication, 
therefore lambda NK467 can propagate only in an amber suppressing 
strain. Consequently when this phage infects any lambdas, Su° 
strain, it is unable to replicate or integrate. Thus the vast majority 
of Kmr clones which arise upon selection, must be the result of Tn5 
transposition events.
3.3.1 Selection of xer mutants
My selection of xer mutants was based on the same principle as 
previously described ( chapter one); that is, the transformation of 
mutant populations with a 2-cer pseudodimeric plasmid, the resolution 
of which results in the loss of a selectable marker. However the
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plasmid employed previously for this purpose, pKS44l (Fig 1.6), 
resulted in a surprisingly leaky selection. It was observed that 
transformation of pKS441 into a wildtype host gave risye to 
transformants which were resistant to both ampicillin and 
chloramphenicol. However, when plasmid DNA from such transformants was 
analysed by agarose gel electrophoresis, the parental form (pKS44D 
was undetectable with only its resolution product, p442, being 
present (G. Stewart, and my own observations (data not shown)). 
Therefore it is clear that when using pKS44l, chloramphenicol 
resistance ( Cmr), does not correlate well with the Xer phenotype. In 
order to explain the persistent chloramphenicol resistance observed, 
one is forced to conclude that the cat gene is being replicated, 
albeit perhaps at some low level. The maintenance of the cat gene on a 
replicon might come about in a number of ways, for example;
a) A low level of undetected pKS44l may still be present in the cells. 
This could represent either plasmid which is yet to be resolved, or 
indeed, which is unresolvable. Alternatively it may represent a 
steady state concentration of pKS44l arising from the cer mediated 
fusion of p442 and p443.
b)Conversely, p443 may be replicated by becoming integrated, 
perhaps transiently, into the host’s chromosome.
c) Finally, the small circular form, p443t may be capable of a low 
level of autonomous replication.
Each of these possible expla nations implies that the cat gene dosage 
would be considerably reduced, and that the Cmr phenotype presumably 
depends upon high levels of expression from the few remaining copies 
of cat. I therefore decided to investigate the potential of an 
alternative test plasmid, pKS455, which is identical to pKS441, except 
that it carries a promoterless copy of the cat gene from pACYC184 
(Fig. 3.2). We presume that expression of cat in this construct is 
dependent on transcription known to emanate from within the cer site ( 
D. Summers, pers. comm.). With a reduced level of cat gene 
transcription one might expect that phenotypic expression of 
chloramphenicol resistance might require high gene dosage. Table 3.1 
illustrates the results obtained when pKS455 is transformed into 
either an Xer” strain (CSX10), or into a wildtype strain DS947. The 
observation that CSX10 transformed with pKS455 is unable to grow under 
chloramphenicol selection immediately after transformation, but is 
able to do so after a period of growth, may be explained in terms of
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Figure 3,2 Diagrammatic representation of the Xer-Dependent 
Resolution of the 2-cer reporter plasmid pKSU55
TABLE 3.1 Transformation of DS947 or CSX10 With pKS455
STRAIN
DS947
ti
CSX 10
Antibiotic
Selection
Ap
Cm
Ap
Cm
i
Transformants.ml of 
Transformation Mix
3 x 103 
0
1 x 10n 
0
Percentage of clones 
which grow when replica 
plated onto Cm
<0.04
100
Strains DS947 and CSX10 were made competent as described in 
materials and methods, after which they were transformed
with pKS455, and equal aliquots plated onto L-agar plus
1 1either Ap ( 50 mg.l ), or Cm ( 30mg.l” '). After overnight
incubation at 37°C, colonies were counted and the number of 
transformants per ml calculated. The Apr colonies from each 
transformation were then replica-plated onto L-agar plus Cm 
( 30mg.ml“"'), incubated overnight ( 37°C), then the
proportion of growing colonies scored.
TABLE 3.2 Frequency of Tn5 Transposition From lambda NK467
p.f.u. of Total N- of Frequency of Transposition 
Strain NK467 Kmr clones per p.f.u. of NK467
DS947 2 x 109 2 .2 x 105 1.1 x 10"n
n n n
gene dosage. It seems unlikely that significant plasmid DNA 
replication will take place until a transformed cell has recovered, 
and re-initiated its cell cycle. It may then take a number of 
generations before the plasmid copy number is such that the low level 
of cat gene expression is sufficient to confer a Cmr phenotype.
Clearly pKS^55 produces a more reliable relationship between Cmr 
and the Xer phenotype of a transformed strain; provided that strain is 
permitted a short period of growth prior to selection. Accordingly, 
this plasmid became the centrepiece of my mutant isolation strategy. A 
flow diagram depicting this strategy is shown in Figure 3.3.
3.3.2. GENERATION OF MUTANT POPULATIONS
Large populations of £. coli::Tn5 insertion mutants were generated 
as follows: To approximately 1x10^ stationary phase cells, of either 
CSH26 or DS947, were added 2 x 1 0 ^  plaque forming units (p.f.u.) of 
lambda NK467. The resultant culture was incubated statically for two 
hours, to permit expression of Kmr. The total number of viable Krar 
clones generated within this population was then determined by plating 
small aliquots onto L-agar+ Km. The frequency of transposition is then 
expressed as the number of Kmr clones recovered per infectious phage 
particle added (Table 3.2). The results shown in Table 3.2 were highly 
reproducible, indicating that large populations ( 2 x 1 0 ^ )  of independent 
Tn5 insertion mutants can be generated with ease. A mutant population 
of this size could, in principle, saturate the E. coli chromosome with
an insertion every 15bp or so.
In order that the mutagenised population could then be transformed
with pKS455, it had to be amplified. This was done by inoculating the
entire primary population (1011 cells of which 2x105 are Kmr mutants) 
into 100mls of L-broth plus Km, then growing this culture overnight. 
From this culture a 0.5ml inoculum (approximately 2 . 5 x 10  ^ Kmr cells) 
was subcultured and made competent for transformation. The final 
number of Kmr cells present in the transformation protocol was 
determined to be approximately 2.5x10^ ®. This population represents 
the progeny from an initial inoculum of 2x10^ independent mutants. If 
one assumes that each mutant clone is fairly represented, then each 
mutant will be present as approximately 1 x 1 0 ^  siblings. Is this 
sufficient to ensure the transformation of at least one sibling of 
y each?
In order to answer this question I calculated the proportion of
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Infect with Lambda NK467
' f
Select and amplify a population of Tn5 
insertion mutants by growth in L-broth plus Km
Make Kmr population competent and 
transform with pKS455
Select Apr transformants on 
L-agar plus Ap+Km
V
Replica-plate onto L-agar plus Cm+Km
V
Pick Cmr clones and screen for plasmid 
content by single-colony gel
Accept only one Xer~ mutant 
from each population
Nine independent Xer~ mutants 
( CSX1 & CSX4-CSX11)
FIGURE 3.3 Flow diagram illustrating the mutant isolation strategy
cells made competent by my standard protocol (see Materials and 
Methods). This was determined by transforming a small aliquot (0.1ml) 
of competent cells with an excess of plasmid (pKS455) DNA,/then 
plating those cells onto selective and non-selective media to 
determine the relative viable counts (Table 3.3). The slightly better 
results obtained with CSH26 over DS947 correlates with the generally 
fitter phenotype of the former. Using this information one can 
calculate that when transforming a population comprising 2x10^ mutant 
clones, each present as 1x10^ siblings, then one can hope to transform 
45 siblings of each mutant clone. This calculation is based on two 
major assumptions:
1. That all viable Tn5 insertion mutants are of equal fitness, thus 
maintaining an even representation within the population throughout 
growth.
2. That each mutant clone can be transformed with an efficiency 
equal to that of the parental strain.
Whilst these assumptions are patently untenable, the calculations 
based upon them nontheless provide a useful guide to the scale of the 
experiment. I should add that one could circumvent the requirement for 
population amplification after mutagenesis by introducing the 2-cer 
test cartridge via either sex factor mating, or phage infection, both 
of these routes of genetic transfer being capable of achieving 
extremely high efficiencies. Such a system would be of great advantage 
in screening for any Xer“ mutants which exhibit a significant 
reduction in fitness. As indicated in Fig. 3.3, the transformed 
populations were then plated onto L-agar+Km+Ap, followed by replica 
plating onto L-agar +km+Ap+Cm to select for Cmr mutants. The 
proportions of Cmr clones recovered from DS947 and from two 
independent DS947::Tn5 populations are shown in table 3.4.
3-4.1 CHABACTEBISATIOW OF Cmr HOTAHTS
As a consequence of the selection procedure, one would expect to 
recover two major classes of Cmr mutants:
1. Chromosomal Xer mutants
2. Plasmid mutants (including both cer mutants and plasmid 
rearrangements).
In order to distinguish between these possibilities, plasmid DNA was 
recovered from Cmr clones then retransformed into the parental (Xer+) 
strain. In those cases where the recovered plasmid was resolved,
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TABLE 3-3 Percentage of Cells Made Competent
Strain
Viable Count Prior 
to Transfonnation 
(c.f.u. ml”^)
N- of Apr- 
Transformants
of Input Cells 
Transformed
CSH26
DS947
5.4 x 1CP
4.8 x 109
3 .8  x 106
2 .0  x 106
0.07
0.04
TABLE 3-4 Proportion of Crar Clones Isolated After Transfonnation 
of a Population of DS947::Tn5 Mutants With pKS455
of Apr N— of Apr Cmr Frequency of
Population clones clones Cmr clones
DS947::Tn5 *1 3.4 x 104 14 4.1 x 10"4
DS947::Tn5 #2 3 .0 x 104 20 6.7 x 10” 24
DS947 2.1 x 104 4 1.9 x 10"4
DS947::Jn5 *1 and *2 represent two independently mutagenised 
populations of DS947.
giving rise to Cms transformants carrying only p456, it was assumed to 
have come from a bona fide xer mutant; by way of examples, the results 
of such analyses are presented for four mutants identified (/CSX3, 
CSX4, CSX5, & CSX11; Fig.3.4). This definition will have precluded any 
xer mutants which so affect the 2-cer substrate as to render it 
unresolvable. Using this criterion I have isolated a total of nine 
independent xer mutants, each from quite seperate populations of Tn5 
insertion mutants (Table 3.5).
3.4.2 COTRANSDUCTION ££ J M  S&Z LESION liXffl IBS.
In order to determine whether or not any of the newly isolated 
xer mutants were caused by transposon insertion, I carried out a 
series of P1 transduction analyses. If an xer mutation is the direct 
result of a Tn5 insertion, then one would expect to observe a high 
degree of linkage between the xer mutation and the Tn5 NPTII gene. 
Whilst in principle the two ought to display 100$ linkage, secondary 
transposition events can result in apparently reduced linkage.
Generalised transducing lysates were prepared by growing P1kc on 
various independent mutants ( Lennox, 1955). Transductions were 
performed as described in Materials and Methods, with Tn5 trans- 
ductants being selected by their resistance to Km. These Kmr 
transductants were then transformed with the 2-cer reporter plasmid 
pCS202 ( see Fig. 3.6). Transformants were selected on chloramphenicol 
(the pCS202 maintenance marker), then screened for their resistance to 
tetracycline (the pCS202 deletion marker). Plasmid DNA was also 
recovered from these transformants and analysed by agarose gel 
electrophoresis (Fig. 3.7). Those transductants which, when trans­
formed with pCS202, were Tetr and carried a plasmid comigrating with 
PCS202 were scored as being Xer“. Those which were Tets and carried a 
plasmid comigrating with the pCS202 deletion derivative, pCS203 ( see 
Fig. 3.6), were scored as being Xer+. The frequency of cotransduction 
of Xer~ with Kmr for several independent mutants was calculated in 
this way (Table 3.6). From the results in table 3.6, one can conclude 
that there is a copy of Tn5 tightly linked with each xer lesion 
tested. In the case of the xerA3 allele, the data strongly suggest 
that this lesion is a direct result of transposon insertion into the 
xerA gene. Insufficient datacw^ available to make a strong case for 
causal insertion in the xerB2f xerB3. xerBM and xerAB alleles. The 85$ 
cotransduction observed between Tn5 and xerB1 might reflect transposon
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Figure 3.4 The recovery of plasald DMA froo xer mutants and its 
subsequent resolution in a wild-type strain. Mini-prep’s of plasmid 
DNA were prepared from CSX3, CSX4, CSX5 & CSX11; all of which were 
found to contain various multimeric forms of pKS455. (a) CSX3, lane 1; 
CSX4, lane 2; p456 marker, lane3; pKS455 marker, lane 4; CSX5, lane 5; 
CSX11, lane 6. However, after transformation of these DNA prep’s ( 
PCSX3, pCSX4, pCSX5 & pCSX11) Into DS947, plasmid DNA was again 
recovered and found to contain the resolution product p456. (b) pCSX3, 
lane 1; pCSX4, lane 2; p456 marker, lane 3; pKS455 marker, lane 4;
pCSX5, lane 5; pCSX11, lane 6.
cer
PstIPstI
pCS202 - 7. 7Kb
\  dv ori
Figure 3.6 Structure of the 2-cer reporter plasnid pCS202: pCS202 was 
constructed by cloning the 2.7Kb cer-tet-cer "cartridge” as a PstI 
fragment (from pCS201) into the unique PstI site in the vector pCB101. 
pCS202 encodes resistance to both Cm and Tet when maintained in an 
Xer“ host. However, Xer-dependent resolution of pCS202 deletes the tet 
gene to produce pCS203 ( 5.3Kb; encoding resistance to Cm).
1 2 3 4 5 6 7 8 9 10 11 12 13
Figure 3.7 Co-transduction of the xerA^ allele with Tn5. Using a P1- 
lysate from CSX1, Kmr was transduced into DS903. Ten independent 
transductants were transformed with pCS202, then plasmid DNA recovered 
and analysed on a single colony gel; these ten clones are shown in 
lanes 1-6 and 10-13 (incl.). Markers are p£S202, lane 7;pCS203, lanes 8 
+ 9.
TABLE 3.5 Derivation and Nomenclature of Xer” Mutants
Parental Mutagenised Xer” Mutant Mutant
strain Population Strain Name Allele
CSH26 CSH26::Tn5 *3 CSX1 xerA3
D S W DS947::Tn5 *1 CSX4 xerB1
n ii  ii  #2 CSX 5 xerB2
tt it »i *3 CSX6 xerB3
it it it CSX7 xerB4
it i i  n *3 CSX 8 xerBS
tt i i  .1 # 6 CSX9 XbrB6
it i i  it CSX 10 xerB7
it »  i i  * 8 CSX 11 xerA5
The strains listed above are the original isolates
independent mutant; the original lab-names for each, pl.us 
all their subsequent derivatives are listed in Appendix I.
TABLE 3.6 Frequencies of Co-transduction of Xer” with Krar
Pike Lysate 
of Strain
xer
Lesion
N- of Kmr 
Transductants
of Xer”/Kmr Co-transduction 
Co-transductants frequency
CSX1 x e r  A3 20 20 1.0
it q xerB1 26 22 0.85
" 5 xerB2 2 2 1.0
7 xerB4 1 1 1.0
»• 8 xerBS 3 3 1 .0
i. n xerAB 1 1 1 .0
insertion at a locus tightly linked to a spontaneous xerB lesion. If 
this were the case, the genetic distance between the two loci would 
have to be less than 0.5 mins (Taylor & Trotter, 1 967); the maximum 
distance between loci which can be cotransduced by phage P1 being 
approximately 1.8 mins (Miller, 1972). Alternatively, xerB1 might be 
the genuine result of Tn5 insertion, but the degree of linkage 
observed may have been reduced by a low level of secondary 
transposition events. Subsequent data, derived from the cloning of 
both the xerB and xerB1 alleles, provides compelling evidence that 
this xer lesion does carry an inserted Tn5. It seems likely that 
secondary transpositions will only have a significant affect on the 
co-transduction frequency when they have occurred in the donor 
population prior to making the transducing lysate. Indeed, I have 
since made a fresh lysate from CSX1 which co-transduces Xer” with Kmr 
at a frequency of only 50%, This clearly illustrates the major 
disadvantage of this type of mutagenesis.
3.4.3 £AN fiPlE.1 COMPLEMENT THE RECOMBINATION DEFICENCY JR XSZ MUTANTS?
The 279bp cer site represents the only ColE1 sequence necessary, 
in an Xer+ host, to promote multimer resolution and enhance plasmid 
stability (Summers & Sherratt, 1984, & D.K. Summers, pers. comm.). 
However, previous attempts to identify any plasmid encoded recombinase 
may have been thwarted by the existence of complementing chromosomal 
functions. If so, one might expect ColE1, in turn, to complement xer 
mutations. This has not been observed. Wildtype ColE1 has been shown 
to multimerise in an xerA3 strain, CSX1, whereas it is predominantly 
monomeric in the isogenic parent CSH26. Furthermore, ColEI is rapidly 
lost from CSX1, but is stably maintaind in CSH26 ( Stewart, 1986). 
This latter observation also demonstrates that xer functions play a
role in ColEI stability, thus corroborating the observed correlation
o
between mor|merisation and plasmid stability (Summers & Sherratt, 
1984).
The observation that ColEI is rapidly lost from an Xer” strain is 
an intriguing one. It had previously been assumed that ColEI might 
exert a positive selection on its own maintenance within a population, 
via colicin E1 production. Colicin production is a lethal event, but 
is normally initiated in only a small fraction of the population, a 
situation somewhat analagous to phage bursts within a lysogenic 
population ( Durkacz et. .&!, 1974). A level of colicin is thus built
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up, within the environment, which is lethal to non-immune cells. ColEI 
encodes reciprocal colicin immunity, and so ColE1+ cells are presumed 
to have a selective advantage within the population. The ^ rapid 
appearence of plasmid-free segregants within an Xer” population might 
suggest that colicin production, in itself, cannot serve to stably 
maintain ColEI. The possibility exists that all such segregants are in 
fact colicin E1 resistant mutants. Such resistant strains can arise as 
a result of mutation of the cell surface receptor for colicin. The 
sensitivity of our plasmid free segregants to colicin E1 has not been 
determined. Furthermore, I must add that the level of colicin 
production from an Xer”, ColE1+ host has not been determined. It is 
possible that significantly reduced levels of colicin are produced by 
an Xer” population, either as a direct consequence of reduced cea gene 
expression or perhaps indirectly as a result of the rapid loss of 
ColEI from the population.
3.4.4. flXHEB PHENOIIF.es -QE IsxT STRAINS
ColEI has a number of close relatives, identified by DNA 
sequence homology, and overall genome organisation. These include 
ColK, pMB1, ColA, and CloDF13. The CloDF13 crl site, and the ColK ckr 
site, have been shown to be functionally analagous to cer. promoting 
both monomerisation and increased stability (Hakkaart ei al, 1984, 
Summers et. .al, 1 985). The crl and ckr sites exhibit considerable 
sequence homology to cer. centered around a 150bp "core" of maximal 
homology. This core homology is maintained by sites in both pMB1 and 
ColA whose recombinational properties have yet to be investigated (See 
Fig. 1.2). The sequence homology led us to ask whether or hot the ColK 
and CloDF13 sites also depend upon host xer functions. Evidence 
suggests that indeed they do. It has been shown that crl and ckr 
multimers are not recombined in either xerA or xerB mutants (G. 
Stewart, 1986; D. Summers, pers. comm.). Furthermore, crl and ckr 
plasmid derivatives which exhibit very stable phenotypes in wildtype 
strains, are highly unstable in the xerB mutant DSX1 ( Stewart, 1986).
No other phenotype of xer mutants has yet been observed. They 
exhibit indistinguishable growth rates from their isogenic parents ( 
Stewart, 1986), and appear quite normal with respect to colony and 
cellular morphology.
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3.5 DISCUSSION M B  CONCLUSIONS
Previous evidence has demonstrated that the 279bp cer site is the 
only ColEI sequence required to facilitate multimer resolution. This 
monomerisation activity is correlated with, and indeed indistinguish­
able from, the role of cer as a plasmid stability determinant. There 
is to date, no direct evidence for any trans acting products of the 
cer locus. Nontheless it seems highly probable that cer is tran­
scribed, at least in part, in vivo. It has been suggested that 
transcription of the crl locus is essential to its function as a 
recombination site ( Hakkaart et al, 198*0. Whether this represents a 
requirement for transription per se. or the need, for a functional crl- 
encoded RNA or peptide, is unclear. A role for transcription in the 
stimulation of recombination at the H0T1 site in the cerevisiae 
. rRNA gene cluster has recently been reported by Voekel-Meiman et al 
(1987).
The existence of an E. coli K12 chromosomal function, essential to 
cer site-specific recombination, was first demonstrated by Gill 
Stewart, who isolated two spontaneous xerB mutants DSX1 and DSX2. 
Using a similar selection principle, but with a more reliable system, 
I have isolated a further nine independent xer mutants. Of these nine 
xer mutations, six have been tested for their genetic linkage to the 
transposable element, Tn5. In all six cases a high degree of linkage 
was observed ( via P1 cotransduction), indicating that in each case a 
copy of Tn5 is inserted at, or very near, the mutant xer locus. These 
closely linked , perhaps causal, Tn5 insertions can now be exploited 
in a number of ways.
1.In the process of strain construction, these insertions have 
proven useful in the transduction of mutant xer alleles into a 
variety of genetic backgrounds (Appendix 1).
2. They also provide a route by which one can readily clone the mutant 
xer loci, via their linkage to a selectable Tn5 marker. The cloned 
chromosomal sequences then provide important information regarding 
the structure of the xer locus. Furthermore, the cloned xer 
sequence can be used as a probe to identify clones, within 
libraries, which carry a wild type copy of that gene. This approach 
to the cloning of wild type genes, is invaluable in the absence of 
a geneticselection for the wild type clone.
3. In principle, these insertions also provide a very useful means 
with which to map the xer lesions on the E. coli chromosome. This,
*16
however, proved to be extremely problematic. The mapping of xer 
genes is discussed in Chapter 4.
These mutants provide a base from which to launch a detailed 
investigation of host genes, and gene products involved in cer 
specific recombination. I decided to concentrate on this analysis, 
rather than continue isolating more mutants. Clearly the 11 idependent 
mutants isolated to date do not represent a large enough sample, to 
give us confidence that all xer complementation groups are 
represented. Therefore an important extension to this work would be a 
more rigorous mutant isolation programme; this would ideally include 
the use of alternative mutagens. Furthermore, the development of a 
strategy capable of detecting conditionally lethal xer mutants is 
crucial if we are to identify xer genes whose products are essential 
to host viability.
All xer mutants isolated to date have been selected by virtue of 
their ability to maintain a 2-cer plasmid in its multi-cer. state. 
Whilst we interpret this as being indicative of the loss of the 
resolution activity, there is an alternative explaination. It is 
plausible that cer-specific resolution is unaffected in our mutants, 
but that the reverse reaction, that of cer mediated fusion, is 
enhanced. Such fusions could be catalysed by either a site-specific, 
or homologous, recombination mechanism. One might then argue that the 
xer functions identified, are in fact merely negative regulators of 
the fusion pathway. This possibility is seriously undermined by the 
observation that cer-mediated fusions are infact inhibited in an Xer" 
strain. It has been shown that two co-existing cer’4' plasmids (which 
carry no sequence homology outwith cer). will fuse in vivo, forming a 
"cointegrate" structure, present at only very low levels. Cointegrate 
formation occurs independently of RecA, but is dependent on XerA, with 
no fusions being detected in an XerA" strain ( Summers, pers. comm.). 
It would therefore appear probable that both the fusion, and 
resolution reactions are debilitated by the same xer lesion.
Finally, it is interesting to note that we have observed no 
phenotype of xer mutants other than those associated with episomal 
site-specific recombination and concomitant plasmid stability. Indeed, 
the xer functions are, apparently, the host's contribution to the
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major stability determinant of ColEI and its relatives. It seems 
probable that these functions perform some other role in coli. the 
exposition of which may shed considerable light on the nsfture and 
evolutionary origin of the cer/xer interaction.
CHAPTER 4
CLONING THE xerA GENE
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4.1 INTRODUCTION
In order to carry out a detailed investigation, of the xer genes 
identified by our mutant selection procedure, it was decided to clone 
them in plasmid vectors. Initially no positive selection was 
available for the Xer+ phenotype, therefore the availability of an 
xerA::Tn5 insertion mutant, xerA3, was central to the cloning 
strategy. This strategy involved firstly the cloning of the mutant 
xerA? allele, exploiting its linkage to the nptll gene of Tn5. 
Restriction information derived from the cloned chromosomal DNA 
flanking this insertion locus was then used to facilitate the cloning 
of the wildtype xerA gene.
4.2.1 CLONING THE xerA? MUTANT ALLELE FROM CSX1
It has been shown that the xerA? allele from strain CSX1 exhibits 
100/S linkage to Tn5 in P1 transductional mapping ( Table 3.6). Hence, 
this particular xer lesion must have Tn5 inserted either in, or very 
near, the xerA gene. Therefore by cloning out the Tn5 element plus 
flanking chromosomal DNA, one can expect to recover either the 
disrupted xerA gene sequence, or chromosomal DNA from a locus tightly 
linked to xerA.
To this end, chromosomal DNA made from CSX1 was cut to completion 
with the restriction endonuclease EcoRI. for which there are no 
recognition sites within Tn5. The resultant digest was ligated to 
PBR322 vector DNA which had previously been cut with EcoRI and 5’- 
dephosphorylated with CIP. The resultant ligation mix was transformed 
into the Reck" strain DS902, and Apr, Kmr transformants selected on L- 
agar containing the.appropriate antibiotics. In this way the 19.4Kb 
plasmid, pCS300, was isolated.
4.3 RESTRICTION MAPPING JQF PCS300
The restriction map of pCS300 ( Fig. 4.1) was derived via a 
relatively standard approach. Various restriction digests of pCS300, 
were size fractionated by gel electrophoresis through either agarose 
or polyacrylamide gels, different percentages of each gel matrix being 
employed, where appropriate, to provide optimal resolution of 
fragments in different size ranges ( Maniatis jet al, 1982). The 
electrophoretic mobilities of all restriction fragments were measured 
by hand, as were those of marker fragments of known molecular weights; 
routinely lambda cl857, or pBR322 ( Daniels et al, 1983» Sutcliffe,
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1979). These mobilities were entered into the computer program 
ZGELFIT ( A.C. Boyd, pers. comm.), together with the molecular weights 
of each standard fragment. This program then calculates the 
approximate molecular weight of each unknown fragment, by comparing 
its mobility to the spectrum of mobilities of standard fragments, 
according to the algorithm of Dugglesby, Kinns, & Rood (1981). This 
assumes that for each DNA fragment , the electrophoretic mobility is 
inversely proportional to the molecular weight. This particular 
algorithm has been shown, to be superior to methods which plot 
mobility versus log[molecular weight] (Boyd, 1982). Computer 
calculations of molecular weights were only accepted for fragments 
whose mobilities lay within the spectrum of standards available on 
each gel. Furthermore, the standard deviation between observed and 
expected molecular weights of the marker fragments (i.e. ZGELFIT 
output vs. ZGELFIT input) were calculated. This provides an estimate 
of the range within which, the relationship between molecular weight 
and moblilty is reliable for any given gel; only those unknowns whose 
sizes lay within this range were accepted.
The data generated in this way were used to assemble, on paper, 
the restriction map of pCS300 shown in figure 4.1. The logical 
construction of this map was greatly aided by the presence in the 
plasmid of two large stretches of known DNA sequence, namely pBR322 
and Tn5 ( complete restriction maps of these known sequences were 
generated using the automatic string search facility of the computer 
program ZSEARCH ( Boyd. A.C. pers. comm.)). In cases where this 
information proved insufficient for the ordering of sites, various 
double restriction digests were also employed. Only a representative 
sample of those gels generated in the course of this restriction 
mapping are shown (Figs. 4.2, 4.3, & 4.4). The restriction endo­
nucleases employed are listed in Table 4.1, together with a breakdown 
of the number of cuts each is observed to make in the various 
components of pCS300 ( i.e. in pBR322, Tn5, or in the chromosomal 
DNA).
The restriction map of pCS300 indicates that it is approximately
19.4 Kb in size, comprising 4.3Kb of pBR322 DNA plus an insert of 
approximately 15.0Kb. This insert represents approximately 9.2Kb of E. 
coli chromosomal DNA punctuated by a centrally located copy of Tn5 
(5.8Kb). This restriction .map provides valuable information regarding 
the structure of the insertion locus.
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Figure M.1 The Restriction Map of pCS300
The presence of a n/u between enzymes labels indicates 
that the two enzymes cut at the same site. The presence of a 
between labels indicates that the enzymes cut at very closely linked 
sites and cannot be resolved on the map-scale shown: note that the
order of the Kpnl and Pstl sites at 4500bp has not been resolved.
Note the presence of a hyper-sensitive EcoRI site at 13.9Kb. For a 
linear map of the pCS300 insert, see Fig. 4.9.
Table 4.1 The number of Recognition Sites Identified in pCS300 
for Various Restriction Endonucleases
N— of Cuts Predicted N— of Sites in-
Enzyme in pCS300 pBR322 Tn5 Chromosomal
Accl 5 2 2 1
BamHI 3 1 1 1
Bglll 2 0 2 0
Clal 2 1 0 1
EcoRI 2 1 0 2S
Hindlll 4 1 2 1
Hpal 6 0 2 5
Kpnl 1 0 0 1
Notl 2 0 2 0
Pstl 8 1 4 3
Sail • 2 1 1 0
Smal 1 0 1 0
SphI 4 1 1 2
Sstll 6 0 4 2
Xbal 0 0 0 0
Xhol 4 0 3 1
The 2 EcoRI sites represent the boundaries between the 
vector sequences and the cloned insert.
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Figure 4.2 Restriction analysis of pCS300.
Lane Sample Lane Sample
1 Lambda/Hindlll 8 Lambda/Hindlll
2 pCS300/HindIII 9 oCS300/BaraHI/BglII
3 pCS3 0 0/Hind 111 /Mil I 10 pCS300/BamHI
4 pCS^QO/EcoRI/Bglll 11 PCS300/BamHI/EcoRI
5 n o n 12 pCS300/SmaI
6 pCS300/£giH 13 pCS300/SaII
7 pCS300/£££RI
Samples were run on a 0.8£ agarose gel. Note the presence of two very
prominent EcoRI partial restriction products in lane 7 ( 2.5 and 12.6
Kb) and lane 11 ( 2.5 and 5.8kb). These are the result of a hyper- 
£
sensitive EcoRI site located at co-ordinate 13•9Kb ( see Fig. 4.1). 
This site has been only slightly restricted in the EcoRI/Bglll digests 
( lanes 3 & 4) since extreme precautions were taken to limit the
amount of EcoRI employed.
1 2 3 4 5 6 7 8 9
—1652 bp
Figure 4.3 Restriction analysis of pCS300
Lane Sample Lane Sample
1 pCS300/XhoI 6 PCS300/Pstl
2 pCS300/ClaI 7 pCS300/BamHI/Pstl
3 pCS300/XhoI/ClaI 8 pCS300/PamHI
4 pBR322/DdeI 9 Lambda/Hindlll
5 PCS300/EcoRI/Pstl
Digests run on a 1$ agarose gel.
Figure 4.4 High resolution restriction analysis of pCS300
Lane Sample Lane Sample
1 pCS300/£amHI 6 Lambda/HintfHI
2 pCS300/Clal 7 dCS300/EcqRI
3 pCS^OO/BamHI/Clal 8 pCS300/£££Ri/Hindiii
i\ pBR322/£&uA 9 pcs300/Hindin
5 pBR322/MeI 10 pCS300/£i^I/HindIII
Digests run on a 3.5? polyacrylamide gel. The sizes of marker 
bands are given in base pairs.
4.4 DOES THE INSERT CLONED IN PCS300 CORRESPOND TO THE xerA? ALLELE?
Despite the fact that P1 transduction data has identified a single 
Tn5 insertion, in CSX1, inextricably linked to the xerA? allele, we 
cannot simply conclude that it is this locus which has been cloned in 
pCSSOO. It is inevitable that secondary transpositions will occur ( 
Berg, 1977), giving rise to alternative Tn5 insertion loci in ( at 
least initially), a small proportion of the population. It is 
plausible that the primary insertion locus is on an EcoRI fragment 
which is less readily cloned than one such secondary insertion locus; 
this might be simply due to the very large size of the fragment, or 
perhaps as a consequence of one, or more, of the genes that it carries 
being detrimental to host viability when present in multicopy. In this 
event, the sequence cloned in pCS300 might have proven to be a time 
consuming ”Red herring”. In order to obviate this possibility, I 
compared the flanking restriction patterns of the cloned Tn5 in 
PCS300, with those of the primary insertion, in situ, in the chromo­
somes of CSX1, and its xerA? transduced derivatives, CSX3 and CSX14.
This was achieved by cutting pCS300 and chromosomal DNA ( made from
CSX1, CSX3, and CSX14) with either SphI or BamHI: both BamHI and SphI 
cut once within Tn5 (at positions 3056 and 2084 respectively, Fig. 
1.1), therefore each unique insertion will yield two highly 
characteristic Tn5 containing fragments. These digests were resolved 
on 0.7/6 agarose gels, then Southern blotted onto nylon membrane
filters. The blots were then probed with radiolabelled Tn5 sequences
generated by the nick-translation of pCS80; this plasmid is a 
pBR322::Tn5 derivative generated in. vivo by transposition from lambda 
NK467 into pBR322, the procedure for selecting such events, and the 
structure of two pBR322::Tn5 isolates ( pCS80 & pCS8D are shown in 
Figs 2.1 and 2.2 respectively).
On digestion with SphI , pCS300 gives rise to four fragments, A, 
B, C, and D, of approximately 6.3, 4.8, 4.0, and 4.0 Kb respectively 
(Fig. 4.6). Whilst all four fragments will hybridise to pCS80 
sequences, clearly fragments C and D will co-migrate and therefore 
appear as a single band; note that only fragments B and C would be 
expected from a chromosomal digest of this same Tn5 insertion locus in 
situ. SphI digestion of CSX1, CSX3 and CSX14 chromosomal DNA 
generates, in each case, only two discrete SphI fragments indicative 
of the presence of a single major copy of Tn5. The two fragments 
detected in these chromosomal digests are approximately 4.8 and 4.0 Kb
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respectively. They co-migrate with fragments B and C from the 
pCS300/SphI digest, and are therefore indistinguishable from the 
restriction pattern predicted for the in situ chromosomal digestion of 
the Tn5-insertion locus which has been cloned in pCS300 ( Fig. *1.7).
A similar analysis of BamHI restriction digests corroborates the 
SphI results. Upon digestion with BamHI. pCS300 yields three 
restriction fragments Af, B‘, and C’ of 12.3, 5.4 and 1.7Kb
respectively (Fig. 4.6). As shown in figure 4.8, all three of these 
fragments hybridise to pCS80 DNA used as a probe ( the relatively weak 
signal from fragment C! reflects the small amount of pBR322 sequence 
that it carries). As shown in figure 4.6, the insert cloned in pCS300 
carries a BamHI site in the right hand arm of the flanking DNA, but it 
does not include the nearest chromosomal BamHI site to the left hand 
side of the insertion. From this one can predict that BamHI digestion 
of chromosomal DNA containing the corresponding Tn5 insertion _in situ, 
will generate two fragments, one of 5.4Kb and the other of greater 
than or equal to 8.5Kb. The blot shown in figure 4.8 confirms that all 
three mutants contain a single copy of Tn5 (generating two bands which 
hybridise to the pCS80 probe), and that all three strains share the 
same major insertion locus. The sizes of the two bands generated are 
5.4Kb and >12.3Kb. These compare with the predicted sizes, based on 
the pCS300 map, of 5.4 Kb and >8.5Kb.
From the combined SphI and BamHI restriction data presented, one 
can conclude that all three mutant strains, CSX1 and its two xerA3 
transduction derivatives, CSX3 and CSX14, all carry a single major 
primary copy of Tn5. Furthermore, that in all three strains, that Tn5 
copy is present in an identical location which thus identifies it as 
the transposon genetically linked to the xerA3 allele. Finally, the 
SphI and' BamHI restriction map of the insertion locus cloned in 
pCS300, is entirely consistent with that insert being the xerA3 linked 
locus from strain CSX1.
I should stress that the chromosomal bands hybridising to pCS80 
sequences are assumed to be due to homology to Tn5, as opposed to the 
PBR322 portion of pCS80. The justification being that each strain is 
Kmr, and so must surely carry Tn5 sequences, however none of the 
strains contain episomal plasmid DNA. Indeed, whilst CSX1 had been 
cured of pKS455 ( by a passive non-selective growth period), the 
transductants CSX3 and CSX14 had never been transformed with any 
plasmid whatsoever. Obviously had any signals been detected from the
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Figure 4.7 Sphl-restricted chromosomal DNA from CSX1, CSX3, & CSX14, 
probed with nick-translated pCS80. The photograph presented above is 
a composite of two autoradiograms of different exposure times.
Lane Sample
1 pCS300/SphI
2  n rt
3 CSXl/SDhl
4 CSXVSDhl
5 CSX14/SphI
1 2  3 4
Figure 4.8 BamHI-restricted chromosomal DNA from CSX1, CSX3, A CSX14, 
probed with nick-translated pCS80 As in the case of Fig 4.7, the
photograph shown above is a composite of two autoradiograms of 
different exposure times.
Lane Sample
1 CSX1/BamHI
2 CSXVBamHI
3 CSX14/BamHI
4 pCS300/BamHI
control Tn5” strain, or multiple signals from the Tn5+ strains, then 
the blots would have been re-probed with labelled pBR322 DNA.
4.5 CLONING THE WILD-TYPE xerA GENE
The cloned xerA3 allele in pCS300 could have been used as a probe 
for.homologous sequences in a genebank prepared from a wild-type E. 
coli strain ( for example, in colony or plaque hybridisations). 
However, since 5.2Kb of chromosomal DMA to the left of the Tn5 
insertion, plus 4.0Kb to the right, had been cloned with the mutant 
locus, it seemed likely that the entire xerA gene sequence would be 
present within the cloned EcoRI fragment; we therefore adopted a 
simpler, though less direct, approach to the cloning of the wild-type 
xerA gene.
Having cloned and restriction mapped the mutant xerA3 allele, we 
deduced the restriction map of the wild-type locus by simply deleting 
Tn5 from the pCS300 map ( this assumes that no significant 
rearrangements have taken place at the target locus during, or after, 
Tn5 insertion). Thus by cloning size-selected restriction fragments 
from digests of wild-type chromosomal DNA, we aimed to create a "mini-
i
genebank", greatly enriched for the specific sequence of interest. We 
chose to target in this way the predicted 8.45Kb EcoRI/Hindlll 
fragment, which runs from the Hindlll site 3.15Kb to the right of Tn5 
in pCS300, to the EcoRI site 5.2Kb to its left ( Fig. 4.1). This 
particular fragment has the advantage over the predicted 9.2Kb EcoRI 
fragment, of having heterologous ends, thus potentially enhancing the 
cloning efficiency.
Chromosomal DNA was prepared from strain DS902 (Xer+), carrying 
F’4315 ( Bachmann, B., pers. comm.). This F’ ( carrying approximately 
mins. 89-91) was initially believed to complement the xerA3 mutation, 
thus by inference, was thought to carry the xerA gene ( Stewart, 
1986). DNA was made from this strain in the belief that it was diploid 
for xerA. thus further enriching for the desired clone. However, 
subsequent attempts to repeat F'4315 complementation of xerA3 have 
failed ( M. Burke and D. Sherratt, pers. comm.). The reasons for this 
anomaly are unclear, but might reflect the notorious instability of 
Hfr4315 and its derived F*. It should be added that the mapping of 
both the xerA3 and xerA5 mutations has proven to be problematic in 
many other respects, a phenomenon to be discussed more fully later.
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DNA prepared from DS902 + F’4315 was cut to completion with EcoRI 
and Hindlll. The resultant double digest was size fractionated by 
electrophoresis through a 0.4$ agarose ( low melting temperature 
grade) gel. DNA fragments in the 7-13Kb size range were recovered from 
the gel matrix, and ligated to the vector pAT223, also cut with EcoRI 
and Hindlll. The resultant ligation mix was then transformed into 
DS941, and Apr transformants selected. The plasmid pAT223 is an 
expression vector similar to pKK223 ( Brosius, .et al. 1981) but based 
on pAT153 and encoding resistance to ampicillin ( Boyd, A. C., pers. 
comm.; Twigg and Sherratt, 1 980). Recombinant clones recovered were 
screened for their insert size by single colony gel analysis. Clones 
with inserts of approximately 8.5Kb were then tested for their ability 
to complement the xerA3 mutation in CSX3. This was done by transform­
ing each test plasmid into CSX3 carrying the reporter plasmid pCS202. 
Since pAT223 and pCS202 are based on compatible replicons, with 
independently selectable resistance markers, transformants carrying 
both plasmids can be readily recovered by selecting on L-agar plus 
ApfCm. Transformants were then either restreaked onto the same medium, 
and grown overnight prior to plasmid DNA recovery, or where stated, 
plasmid DNA was recovered from ’’pooled transformants”, (i.e. 30-50 
colonies scraped off the primary transformation plate). Plasmid DNA 
from such transformants was analysed, on single colony gels, to 
determine whether pCS202 persisted in its 2-cer form, or had been 
resolved to its deletion derivative, pCS203. In this way Gill Stewart 
isolated pGS30, a plasmid which functionally complements pCS202 
resolution in a xerA3 background ( see Fig 4.10, section 4.6). This 
plasmid also effects complementation in a RecA", XerA" strain 
(DSX360), therefore can be said to complement xer A3 in trans ( 
Stewart, 1986). The restriction mapping of pGS30 revealed that it 
carries an EcoRI/Hindlll insert of approximately 8.45Kb. Furthermore, 
the restriction map of this insert corresponds closely ( for all 
enzymes tested), with that predicted from the flanking DNA cloned in 
pCS300 ( Fig 4.9); using the same assay system, pCS300 does not 
complement pCS202 resolution in CSX3 ( data not shown). Therefore we 
conclude that we have cloned the wild-type equivalent (presumably from 
DS902), of part of the sequence present in pCS300, and that this wild 
type sequence includes a functional xerA gene.
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4.6 DETERMINING THE MINIMUM PGS30 SEQUENCE WHICH COMPLEMENTS xerA^
It seemed probable that the xerA gene might be smaller than 
8.45Kb, therefore Gill Stewart generated a number of pGS30 subclones, 
and tested each for xerA^ complementation. The three SphI fragments 
from pGS30 were cloned into the SphI site in pBR322. Of these three 
subclones only pGS36 ( carrying the 3.1Kb SphI fragment from the 
centre of the pGS30 insert) proved capable of complementing a xerA.3 
mutant. In addition the 0.93Kb SphI/Accl fragment from pGS36 was 
cloned into pUC19 ( Yanisch-Perron e_t al., 1985) to generate pGS38 ( 
Stewart, 1986; See Fig 4.9). The subclone pGS38 was found to partially 
complement resolution of pCS202 to pCS203 in CSX3; that is to say, 
that on single colony gel analysis of plasmid DNA recovered from a 
test strain, pGS38 is observed together with both pCS202 and pCS203. A 
gel illustrating the relative abilities of pGS30, pGS36, and pGS38 to 
complement pCS202 resolution in CSX3 is shown in figure 4.10. The gel 
shows that pGS30 and pGS36 both efficiently complement the Xer" pheno­
type of CSX3, as evidenced by the absence of any detectable levels of 
pCS202, coupled with the appearence of pCS203. On the other hand pGS38 
complements partially, whilst the control plasmid pC%1~Q does not 
complement at all. From these data, one can conclude that the 3-1Kb 
SphI fragment, present in pGS36, contains sufficient sequence 
information to encode an xerA gene product capable of efficiently 
complementing the xerA3 mutation.' The partial complementation by pGS38 
was initially interpreted as indicative of the deletion of some pGS36 
sequences, which are required for efficient complementation. However, 
data to be presented shortly suggests this interpretation to be false.
This type of gel assay for complementing activity has been used 
extensively, with pCS202 and with analagous reporter plasmids, 
throughout this thesis. In order to limit the number of similar gels 
presented in the thesis, I will in general refer only to the results 
of such assays. The results of such "gel assays" for Xer 
complementation will be expressed in three qualitative terms:
1. "Positive" or "efficient" complementation; i.e. No pCS202 
detectable, but its resolution product plus the complementing ( test) 
plasmid being clearly visible. Thus pGS30 and pGS36 are described as 
efficiently complementing pCS202 resolution in CSX1 ( Fig. 4.10).
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Figure 4.9 Linear Restriction Map of the pCS300 Insert, Indicating
the Extent of the Wild-Type Sequences Present in a Number 
of Plasmid Sub-Clones.
The site of Tn5 insertion in xerA3 is indicated at 5.1Kb 
on the pCS300 map. The restriction map of the pGS30 insert is 
indistinguishable from that of the chromosomal sequences present in 
pCS300.
Figure 4.10 Complementation of pCS202 resolution in CSX3 by pGS30, 
pGS36 and pGS38.
Lane Sample Lane Sample
1 PGS30 5 CSX3/PCS202 + pGS30
2 PGS36 6 " " + pGS36
3 PGS38 7 » » + pGS38
4 pCS20 8 " " + pCS20
9 PCS202
10 PCS203
"CSX3/pCS202 + pGS30n, indicates that strain CSX3 was transformed 
first with pCS202, and then subsequently with pGS30. Plasmid pCS20 was 
used as a negative control and represents pUC8 carrying an 850bp 
insert ( specifically the rom gene of ColEI).
2. A "Negative" result indicates the absence of any detectable 
reporter-plasmid resolution product, with only the 2-cer form plus 
the test plasmid being visible. This is the case with pCb^.0 ( Fig. 
4.10)
3. "Partial Complementation" (+/-) is used to describe the situation 
observed in pGS38 complementation tests ( Fig. 4.10). In this case 
both resolved and unresolved forms of the reporter plasmid are 
present, plus of course the complementing plasmid.
4-6.2 THE PARTIAL COMPLEMENTATION PHENOTYPE OF OGS38
The partial complementation phenotype of pGS38 was intriguing, 
especially since sequence data for the 0.93Kb Sphl/AccI fragment, 
inferred that the entire xerA gene was likely to be present in pGS38 ( 
Chapter 6). Therefore the complementation characteristics of pGS38 
were investigated further. The samples run on the gel shown in figure 
4.10 are derived from pooled transformants. It was therefore necessary 
to investigate the clonal phenotype of individual transformants to 
ascertain whether or not single clones also exhibit mixed phenotypes 
with respect to pCS202/pCS203. Individual clones were streaked out 
onto L-agar plus Ap+Cm and incubated overnight before analysis of 
their plasmid content on single colony gels. By repeated sub-culturing 
of each clone, the persistence of the mixed phenotype was also 
determined. After the first overnight subculture (approximately 30 
doublings), of 14 individual transformants of CSX3 carrying pCS202 
plus pGS38, 13 out of 1 4 clones contained both pCS202 and pCS203 in 
roughly equivalent amounts. In one case out of 14, no pCS202 was 
apparent, only pGS38 and pCS203. After one further sub-culture the 
pattern was quite different; 13 out of 14 clones now contained pCS203 
plus pGS38, but no detectable pCS202 ( by ethidium bromide staining). 
In only one case out of 14 did the mixed phenotype persist. These 
results indicate that the "partial complementation" phenotype is a 
genuinely clonal one, and not an artefact of having made plasmid DNA 
from a mixture of transformants. The gradual elimination of pCS202 in 
each clone ostensibly suggests that there is a slow rate of resolution 
ongoing in these strains; one which takes on average between 30-60 
generations to resolve all available pCS202 into its derivative 
pCS203. .However, one must be very cautious in interpreting such 
resolution data in quantitative terms since pCS202 and pCS203 are
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mutually incompatible; whilst this in itself imposes a serious 
complication on any "kinetic” analysis, there would be an additional 
complication should one form have some unknown replication and/or 
segregational advantage over the other. The problem posed by 
incompatibility can be explained as follows: Consider a CSX3 cell 
carrying pGS38, pCS202 and pCS203. Since pGS38 is compatible with both 
pCS202 and pCS203» then it can be assumed, for the moment, to be 
inherited by all progeny. However, since pCS202 and pCS203 are 
incompatible, then at cell division progeny will arise, at some 
indeterminate frequency, which have received either pCS202 or pCS203» 
whilst the remainder of the progeny will have received both. This 
provides an alternative route via which pCS202~/pCS203+ clones can 
arise, independent of Xer activity. Conversely, any CSX3 (pGS38) 
segregants which receive only pCS202, would be capable of re­
establishing a mixed phenotype. It is interesting to note that no 
clones were detected (in the limited sample of 14), which carried only 
pGS38+pCS202. Such clones would have been expected to appear if 
complementation with pGS38 resulted in a transient period of Xer 
activity, followed by its complete shutdown.
It is plausible that the observed mixed phenotype is the result of 
gross segregational instability of pGS38. In this scenario, after 
transformation of CSX3+pGS38 with pCS202, the incoming plasmid 
replicates prior to its resolution into pCS203. If PGS38 is extremely 
unstable, then during cell division a segregant might arise which 
carries pCS202 (+/- pCS203), but no pGS38. Although such a segregant 
would be phenotypically Aps, it would be very likely to survive and 
grow, within the protective body of a predominantly Apr colony ( due 
to the depletion of the local Ap concentration as a consequence of 
beta-lactamase activity). Such Aps clones would of course be Xer”, and 
might be the entire source of pCS202 in plasmid preps. Whilst within a 
single colony this phenomenon might occur to some degree, it cannot 
explain the persistence of the mixed phenotype after streaking to 
single colonies, since each founder cell must have carried pGS38. 
The partial complementation phenotype of the pGS38/pCS202 plasmid 
combination was found to be independent of the order in which the two 
starting plasmids are transformed into CSX3. In other words, CSX3 
carrying pGS38 then transformed with pCS202, behaves indistinguishably 
from CSX3 carrying pCS202 then transformed with pGS38, both with 
respect to the appearance, and persistence of the mixed plasmid
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phenotype ( data not shown).
4.6.3 EFFICIENT COMPLEMENTATION OF xerA^ BY PCS34Q
It should be stressed that pGS36 and pGS38 differ not only in the 
size of the chromosomal fragment that they carry, but also in that 
they are based on different vectors, pBR322 and pUC19 respectively. 
Whilst these two vectors are closely related, they have very different 
copy numbers; pUC19 being present at approximately 90 copies per 
chromosome equivalent, compared to 40 copies for pBR322 ( Jones, 1985; 
Timmis, 1981). I have found that when the equivalent insert to that 
present in pGS38, is provided on a lower copy number plasmid, pCS349, 
then highly efficient xerA complementation is observed. Plasmid pCS349 
was constructed as follows; the equivalent to the 0.93Kb SphI/AccI 
fragment from pGS36 was cut out of mCS320 as an EcoRI/Hindlll fragment 
( mCS320 is an M13 mp19 derivative containing the 0.93Kb fragment from 
pGS36 cloned into the polylinker region for the purposes of DNA
..sequence determination (see Chapter 6)). The EcoRI/Hindlll fragment
IIfrom mCS320 was ligated to the EcoRI/Hindlll restricted vector,
li
upCB19B, to generate pCS349 ( See Fig 4.11). Vectors pCBl8B and 19B are 
improved lambda dv derivatives of the plasmid pCB101 ( Boyd & 
Sherratt, 1986); they lack a number of restriction sites present in 
their predecessor, pCB101, thus rendering more of the polylinker sites 
unique ( including EcoRI and Hindlll). Both vectors encode Cmr, and 
they represent a ’’matched pair”, differing only by the orientation of 
their poly-linkers with respect to the lac promoter and lacZ’ 
sequence; pCBl8B carrying the mpl8 version ( as found in pUCl8), and 
pCB19B carrying the mp19 version ( Boyd A.C., pers. comm.; Yanisch- 
Perron et al, 1985). Plasmid pCS349 was tested for its ability to 
complement pCS210 resolution in strain CSX11 ( xerA5). The reporter 
plasmid pCS202 could not be used with pCS349 since both are based on 
lambda dv replicons, and so are mutually incompatible. The reporter 
plasmid pCS210 offers compatibility with pCS349 ( since the former is 
based on the p15A replicon), plus an independently selectable marker, 
i.e. Tetr for pCS210 and Cmr for pCS349. Furthermore, the deletion 
marker of pCS210 is the E. coli lacZ gene, enabling resolution to be 
monitored indirectly via LacZ activity on X-gal plates ( See Fig 
4.12). Strain CSX11 was used since it is chromosomally deleted for the 
lac operon ( being delta lac/pro), therefore the LacZ activity of this 
strain is solely dependent on that encoded by pCS210. Complementation
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Figure 4.11 Structure of the xerA minimal-clone pCS349
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Figure 4.12 Structure of the 2-cer reporter plasnid pCS210: pCS210 
carries a 3.6Kb cer-lacZ-cer "cartridge" inserted into the unique 
EcoRI site in the vector PACYC184. The resultant plasmid encodes beta- 
galactosidase plus resistance to Tet when maintained in an Xer” host; 
however, Xer-dependent resolution of pCS210 deletes the lacZ gene to 
generate pCS211 ( 4.3Kb; encoding resistance to Tet).
tests were performed following the same principle as before, where 
CSX11 carrying pCS210 was transformed with various test plasmids, 
after which the transformants were plated out onto DM minimal medium, 
containing casamino acids ( 12), glucose ( 0.22), X-gal ( 25mg.l”1), 
tetracycline (7mg.l~^ ), and a suitable antibiotic for the selection of 
cells containing the test plasmid. After overnight incubation, 
transformant colonies were scored for their colony phenotype with 
respect to the blue/white colour test, and in most cases, plasmid DNA 
from pooled transformants was analysed on single colony gels. Using 
this assay system I tested plasmids pGS36, pGS38, pCS349 plus the 
vector controls pUC19 and pCB19B, and found that pGS36 and pCS349 both 
complement pCS210 resolution efficiently, whereas pGS38 exhibits a 
similar partial complementation phenotype to that observed in previous 
experiments; pUC19 and pCB19B do not complement at all ( Table 4.2; 
Fig. 4.13)- Colour photographs of the primary transformation plates 
from pCB19B, pCS349 and pGS38 complementation tests are shown in 
figure 4.14. The colony colours listed in table 4.2 correlate very 
well with the observed plasmid content of each strain tested. In the 
cases of pGS36 and pCS349, the white colonies reflect the absence of 
any detectable pCS210 in the pooled transformants ( Fig 4.13, tracks 6 
and 8). Note that in tracks 5 and 7 some dimeric pCS211 is present 
which does not appear in the pCS211 control track ( Fig 4.13 track 4). 
The two major forms present in track 4 migrating above the monomer 
supercoiled pCS211, are presumed to be linear monomer and open circle 
monomer forms; this is supported by comparing the relative migration 
rates of each form in track 4 (pCS211) and track 1 (pCB19B). In the 
plasmid DNA isolated from the pCB19B and pUC19 complementation tests ( 
tracks 5 + 7), no monomeric pCS210 or pCS211 are present. There is, 
however, a band in both cases which comigrates with pCS210 trimer. As 
can be seen in the CsCl purified pCS210 DNA sample, such 
multimerisation of pCS210 in an Xer“ strain is common. On pooling 
plasmid DNA from the blue and white colonies which appeared in the 
pGS38 complementation, both pCS210 and pCS211 were apparent in single 
colony gels in similar ratios to those previously observed with 
pCS202:pCS203 ( data not shown). When the primary transformant 
colonies are re-streaked onto fresh medium, pGS36 and pGS349 
transformants re-streak as purely white clones, whereas pUC19 and 
pCB19B transformants re-streak as exclusively blue clones. In the case 
of pGS38, both the blue and pale blue transformant colonies ( Fig.
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Table 4.2 Complementation Tests in CSX11 + pCS210 With Various
xerA Sub-Clones
Test Colony Phenotype XerA
Strain Plasmid on X-Gal Complementatioi
CSX11+pCS210 pGS36 White +
it pGS38 Blues, Pale Blues +/-
and Whites
it pCS349 White +
tt pUC19 Blue -
u pCB19B Blue -
Complementation was scored as either Efficient (+), Partial (+/-), 
or Negative (-).
The ratio of Blues: Pale Blues: Whites being approx. 20:60:20. 
Note that all Blues and Pale Blues re-streak to give rise to 
exclusively white colonies.
Figure 4.13 
and pGS36.
Lane
1
2
3
4
Complementation of pCS210 resolution in CSX11 by
Sample Lane Sample
pCB19B 
PCS349 
pCS210 
pCS211
CSX11/pCS210 + pCB19B 
" " + PCS349
" " + pUC>*^
" " + pGS36
PCS349
b. c.
Figure 4.14 Complementation of pCS210 resolution in CSX11 by pCS349 
and pGS38 as assayed by the pCS210 colony-colour test.
(a) CSX11/pCS210 + pGS38; (b) CSX11/pCS210 + pCS3*49; (c) CSX11/pCS210 
+ pUC8. The negative control for complementation was pUCfH) I should 
stress that the CSX11 + pUCl3 gives rise to white colonies in the 
absence of pCS210.
4.14), re-streak to give predominantly white colonies ( indicative of 
the resolution of pCS210 to pCS211). A few pale blue secondary 
colonies do arise, but these too restreak as exclusively whites in the 
next sub-culture ( white colonies from the pGS38 complementation 
restreak as whites).
The pCS210 resolution assay in a delta lac/pro background provides 
a colour test which accurately reflects the pCS210/pCS211 status of a 
clone. Therefore in a number of future complementation tests, the 
colour test has been deemed sufficient evidence as to the Xer 
phenotype of a strain; where stated, such npCS210 resolution colour 
tests" have also been confirmed by "pCS210 gel assays" in which the 
clones plasmid content was directly visualised.
From these complementation assays there is now conflicting data as 
to the efficacy of the 0.93Kb Sphl/AccI fragment in xerA complement­
ation. The pCS349 data infers that this fragment does indeed contain 
the entire xerA gene, an inference corroborated by DNA sequence 
analysis of this region ( Chapter 6). The question is therefore raised 
as to whether the mixed phenotype observed in pGS38 complementation is 
a consequence of poor complementation per se, or is infact the result 
of some inhibitory influence of pGS38 on Xer activity. In order to 
test for any such inhibitory role, the effects of pGS38 on the Xer 
phenotype of wild-type hosts was determined.
4.7.1 INHIBITION OF JCS2Q2 BBSQLDHQH IN PS902 BY PGS38
The partial complementation observed for pGS38, relative to pCS349 
(carrying the same cloned chromosomal sequence), seems to iwjjVvj that 
either pGS38 is not efficiently expressing xerA ( perhaps as a result 
of mutation), or that the presence of pGS38 has a direct inhibitory 
affect on Xer dependent pCS202 resolution. To test this latter 
possibility, DS902 was transformed with pGS38, then DS902 (pGS38) was 
transformed with pCS202 to determine the Xer phenotype. DS902 is Xer+ 
in a pCS202 resolution assay; after transformation with pCS202, single 
colony gel analysis of plasmid DNA recovered from pooled Cmr 
transformants reveals that only pCS203 is present ( data not shown). A 
single DS902 (pGS38) clone was transformed with pCS202, selecting the 
desired transformants on L-agar +Ap+Cm. Five independent transformants 
were then subcultured overnight, prior to being analysed on a single 
colony gel (Fig. 4.15). In this case, significant levels of pCS202 
persist, indicative of an inhibitory effect of pGS38 on the Xer
61
1 2 3 4 5 6 7 8
PIIII
ill
•-* -i 1
'I
Figure 4.15 Inhibition of pCS202 resolution in DS902 by pGS38
Lane Sample
1 PGS38
2 PCS202
3 PCS203
4-8 DS902/pGS38 + pCS202
5 independent isolates.
activity of DS902. That the cloned xerA gene does not exert a similar 
effect on DS902 when cloned on a lower copy number vector was 
demonstrated using the plasmid pCS350. This plasmid is based on a 
derivative of pCB101, namely pGS301; pGS301 is 5.8Kb, and encodes 
resistance to tetracycline. Plasmid pGS301 has a unique PvuII site, 
into which was cloned the EcoRI/Hindlll xerA fragment from mCS320, 
after blunting the 5*-protruding ends by f,Filling-inn with Klenow in 
the presence of all A dNTPs. The resultant plasmid, pCS350 ( 6.75Kb), 
is therefore in the lambda dv compatibility group, encodes Tetr, and 
carries the E. coli xerA gene. This plasmid was constructed for the 
purpose of complementing the resolution of the reporter plasmid, 
PKS455, in XerA” strains and was found to do so ( data not shown). 
DS902 with or without pCS350, was transformed with pKS455f and pooled 
transformants were analysed on single colony gels. DS902 was found to 
efficiently resolve pKS455 into its deletion derivative, p456, 
irrespective of the presence or absence of pCS350 ( data not shown). 
Therefore, one can conclude that the presence of plasmid-borne copies 
of the xerA gene does not in itself exert an inhibitory influence on 
DS902 Xer activity; the phenomenon seems to be peculiar to the high 
copy plasmid pGS38.
4.7.2 EFFECTS OF PGS38 AND pBAD ON Xer ACTIVITY OF DSQ41
The next major question to be investigated was whether or not 
the inhibitory influence of pGS38 was specific to the presence of the 
xerA insert, and not just a feature of the vector. To this end DS941 
(laclq). was transformed with either pGS38 or the vector pBAD. Clearly 
the ideal control would have been pUC19> however, pBAD is very similar 
to pUC19 in size, copy number, and sequence; the major difference 
being that pBAD carries the tac promoter- rrnB terminator cartridge of 
PAT223, as opposed to the lac promoter and LajcZ’ sequence of pUC19 ( 
A.C Boyd pers. comm.). DS941 carrying either pGS38 or pBAD, was then 
transformed with pCS202, and transformants selected on L-agar plus 
Ap+Cm. Single colony gel analysis of subcultured transformants showed 
that no inhibition of pCS202 resolution was apparent by either pBAD or 
pGS38 ( Fig. 4.16). It seemed possible that the observed difference 
between pGS38 inhibition in DS902 and DS941 might reflect the laclq 
status of the latter; the lacl  ^mutation increases the level of lac 
repressor 10 fold over the wild-tvpe lacl gene ( Muller-Hill et al. 
1968). DS941 is thus capable of more effective repression of multicopy
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Figure 4.16 Effects of pBAD and pGS38 on pCS202 resolution in DS941 
when grown in the absence of IPTG. Five independent clones of 
DS941/pBAD + pCS202 were analysed (lanes 1-5), together with 5 clones 
of DS941/pGS38 + pCS202 ( lanes 10-14). Markers: pBAD, lane 6; pCS202, 
lane 7; pCS203, lane 8 ; pGS38, lane 9.
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Figure 4.17 Effects pBAD and pGS38 on the resolution of pCS202 in 
DS941 when grown under IPTG-induced conditions. As in figure 4.16, 
five independent clones of DS941/pBAD + pCS202 were analysed ( lanes
1-5), as were 5 clone of DS94l/pGS38 + pCS202 ( lanes 9-13). Markers: 
pBAD, lane 6; pCS202+pCS203 mixture, lane J; pGS38, lane 8.
lac promoters in pGS38, than is DS902 (l a d ) ( this contention is 
supported by observations made on the expression of cloned genes; this 
laboratory) . Therefore, assuming that overexpression of the xerA gene 
from the lac promoter in pGS38 was essential to the inhibition of Xer 
activity, I repeated the DS941 experiment in the presence of the 
gratuitous lac inducer IPTG. DS941 containing either pBAD or pGS38, 
was grown up for transformation in the presence of IPTG (20rag.l“ )^. 
After transformation with pCS202, transformants were selected on L- 
agar plus Ap+Cm+IPTG. Surprisingly, single colony gel analysis of 
subcultured clones revealed that both pGS38 and pBAD produced a 
significant inhibitory effect on the resolution of pCS202 ( Fig. 
4.17). Previous experiments with DS941 and the reporter plasmid pCS208 
suggest that the DS941 Xer activity is not inhibited by IPTG per se ( 
Chapter 3).
These results, summarised in table 4.3, appear to indicate that 
the presence of a high copy number plasmid does not, in itself, 
inhibit Xer activity, but that the affect requires the induction of a 
strong plasmid promoter, irrespective of the gene being driven from 
that promoter. The need to induce pGS38 with IPTG in order to observe 
inhibition in DS941 is not inconsistent with the observed inhibitory 
effects, during complementation tests, in other strains in the absence 
of IPTG; the reason being that the strains employed in pGS38 
complementation tests, were all either laclf or delta lac/pro: 
therefore none would have been able to effectively repress pGS38 ( 
c.f. DS902). Obviously, to determine whether or not "partial 
complementation" and "Xer+ inhibition” are one and the same 
phenomenon, one would like to test pGS38 complementation in an XerA", 
laclQ strain in the presence and absence of IPTG. For this purpose, a 
suitable strain could be constructed by transduction of the xerA3 
allele into DS941.
4.8 DOES THE CLONED xerA GENE COMPLEMENT ANY OTHER xer MUTANTS?
The 0.93Kb Sphl/AccI fragment appears to carry all the sequence 
necessary for the complementation of the xerA~3 and xerA5 mutants. 
Therefore this subclone was tested for its ability to complement the 
remaining nine independently isolated mutants ( xerBI-xerBQ). 
Complementation tests were performed as described previously, and 
involved the test and reporter plasmid pairings of either 
pGS38+pCS202, or pCS350+pKS455; in no case was complementation
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Table 4.3 Summary of Plasmid Inhibition Results
Resident IPTG
Strain Plasmid Induction
DS902 pGS38
" pCS350
DS941 pGS38 +
if ii _
" pBAD +
11 11 _
Reporter Plasmid 
Resolution
Inhibited
Efficient
Inhibited
Efficient
Inhibited
Efficient
observed ( data not shown). Furthermore, the larger wild-type clone, 
pGS30, has been tested for its ability to complement pCS202 resolution 
in various xerB mutants ( including xerB1. B2, B4, B5, B8, and B9), 
and as before no complementation was observed ( G. Stewart, 1986). 
Therefore it seems clear that the xerB mutations cannot be 
complemented by the cloned xerA gene, and that the (intact) xerB gene 
is not present within the pGS30 insert ( later evidence will confirm 
this conclusion).
4.<i CHROMOSOMAL MAP POSITION M . TH£ xerA LOCOS
As already intimated, the attempts to map the xerA locus using 
conventional ( "recombinational") techniques, have proven to be 
problematic; with different experiments yielding quite different 
results ( Stewart, 1986; D. Sherratt & M. Burke, pers. comm.). The 
reasons for these inconsistencies remains unclear, but might reflect 
some biological function of XerA ( or a closely linked gene), e.g. in 
the recombination processes involved during Hfr crosses etc..
A completely novel, indirect route for mapping a gene's position 
on the Ei. coli chromosome has recently been made possible by the 
publication of the complete restriction map of the K-12 chromosome for 
the restriction endonucleases Hindlll. BamHI. EcoRI. EcoRV. Bgll. 
KpnI. Pstl & PvuII ( Kohara .et. aJL, 1 987). Obviously, one can 
scrutinise the chromosomal map for close-fits to the restriction 
pattern of a cloned gene. The only match identified to the restriction 
pattern surrounding xerA ( derived from pCS300 & pGS30), is found at 
3^55Kb on the Kohara e_t aJL map, equivalent to 70.5 mins on the 
conventional JE*. coli K-.12 linkage map ( Fig. M.19)* The close 
corespondence between the two restriction maps makes it seem highly 
likely that xerA does indeed map to 70.5 mins; in order to confirm 
this conclusion two of Kohara's clones from this region have been 
requested, and will be tested for the presence of the xerA gene. Only 
two other genes have currently been mapped within this immediate 
vicinity, those being argR. ( 70.5; regulatory gene), and mdh ( 70.U; 
malate dehydrogenase: Bachmann, 1983)• According to the Kohara jet al 
map, both argR and mdh should be present in pCS300 ( and perhaps in 
pGS30), however neither function has previously been implicated in a 
recombination system.
70-3-70-5 mins.
xerA Locus
P H£ R
5-9 6*4 69 7-6 8-1 9-3 Kb
P K
PP
■f'
B H R
i i i
59 6-3 68 7-7 8 5 9-2 Kb
Figure 4.20 Comparison Between the Restriction Map of the xerA 
Locus and that of the 70.4 min. Region on the coli 
K-12 Linkage Map.
Code: B= BamHI E= EcoRI
H= Hindlll K= Kml
P= PstI
4. t# DISCUSSION AND CONCLUSIONS
The Tn5 insertion tightly linked to the xerA3 allele in CSX1, has 
been cloned as an EcoRI fragment, together with 9.2Kb of flanking 
chromosomal DNA, in the plasmid pCS300. The restriction map of this 
plasmid was determined, and used to confirm that the cloned locus does 
indeed correspond to xerA3.
Using restriction data derived from pCS300, the wild-type xerA 
gene was cloned as an 8.45Kb EcoRI/Hindlll fragment into the vector 
PAT223, the resultant clone being identified by virtue of its 
complementation of pCS202 resolution in CSX3. The complementing 
function has been narrowed down to a 0.93Kb Sphl/AccI fragment, which 
complements two out of the 11 independent mutants isolated; the mutant 
alleles in question were thus designated xerA3 and xerA5. This minimal 
clone fails to complement any of the remaining nine mutants, all of 
which have since been shown to belong to a single complementation 
group, xerB. The larger clone, pGS30, was found to be unable to 
complement any of the six xerB mutants tested, indicating that a 
functional xerB gene is not present. The DNA sequence of the 0.93Kb 
Sphl/AccI fragment has been determined ( see chapter 6).
An inhibitory affect on pCS202 resolution by the transcriptional 
induction of the multi-copy plasmid, pBAD, was uncovered. In DS9^1» 
the presence of pBAD reduces the apparent rate of resolution of 
incoming pCS202, but does so only in the presence of IPTG. No such 
affect is apparent in the absence of IPTG. A similar IPTG-dependent 
affect has been demonstrated for pGS38, however my data cannot exclude 
the possibility that an overexpressed xerA gene may play a 
contributory role in this case. The nature of the observed inhibitory 
affect of induced pBAD on Xer-dependent resolution of pCS202 is 
intriguing. It seems likely that the induction of strong promoters on 
such high copy plasmids, will exert considerable stress on the 
transcriptional/translational apparatus of the cell; but how such a 
"stress" might affect Xer activity is unclear. Possible causes might 
include the induction of a "stress" response ( such as the "heat 
shock" response ( for a recent review see Lindquist, 1986)); one of 
the direct, or indirect, effects of which being a reduction in 
apparent Xer activity. It is possible that total Xer activity in 
"pCS202 resolution inhibited" strains may not be reduced, but that Xer 
factors ( and/or co-factors), may be sequestered to perform other 
activities in the cell, thereby diminishing the rate of the only Xer
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reaction that we can monitor. It is interesting to speculate that the 
reduction in cer-specific recombination during "transcriptional 
stress" might reflect the potential involvement of transcription of 
the cer locus in promoting recombination ( see Chapter 1). If this 
were so, then the sequestration of transcriptional factors by 
multiple, induced lac or tac promoters, might exert a competitive 
inhibition on recombination at cer sites. Other less exciting 
possibilities might include a "stress" related reduction in the 
expression of xerB and/or any other unidentified xer gene(s). It seems 
unlikely that the induction of pBAD has a deleterious affect on gene 
expression in general, since the growth rate of induced pBAD- 
containing DS9^1 is indistinguishable from that of an uninduced 
culture. However, I should add that the presence of an additional 
plasmid, namely pCS202, might further stress a pBAD induced cell; the 
growth rates of DS941+pBAI>4-pCS202 have not been measured.
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CHAPTER 5
CLONING THE XerB GENE
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5.1 INTRODUCTION
The xerA gene was cloned by exploiting an xerA-linked Tn5 
insertion. The same route was available for the cloning of xerB via 
the Tn5 insertion mutant xerB1. However, the reporter plasmid pCS210 ( 
described in chapter 4), offers an alternative approach to the 
cloning of xer genes by providing a reliable colony colour test for a 
strain’s Xer phenotype ( via the deletion of the lacZ gene). This 
plasmid therefore provides a means with which to rapidly screen an E. 
coli genebank for complementation of an Xer“ mutant. The archetypal 
’’XerB”” mutant used in the screening was CSX4, carrying the Tn5-linked 
lesion. xerB1. Direct screening for xerBI complementation obviates the 
requirement for first cloning the xerB! allele in order to target the 
wild-type sequence. Nonetheless xerBI was cloned and ultimately 
provided useful information as to the structure of the xerB locus and 
the nature of the xerBI lesion.
5.2 CLONING THE XerBI ALLELE FROM CSX4
The Tn5 element in the chromosome of CSX*! was found to be present 
on very lar ;ge (>30KB) EcoRI. Clal, and SstI restriction fragments via 
Southern blot analyses ( data not shown). Such large fragments could 
not be readily cloned into a plasmid vector ( although of course 
suitable lambda vectors are available). Therefore it was decided to 
clone flanking DNA to only one side of the transposon insertion. The 
restriction enzyme BamHI cuts once in Tn5 ( at position 3056bp), thus 
generating two Tn5 fragments, one of which carries the intact NPTII 
gene. In a southern blot of BamHI-restricted CSXM DNA, two fragments 
were detected which hybridised to labelled pCS80 sequences. The two 
fragments were sized relative to size standards which also hybridise 
to pCS80 ( namely pCS300/BamHI and pCS300/EcoRI). The calculated sizes 
of the two CSXVBamHI fragments being approximately 5.2Kb and 3.6Kb 
respectively ( data not shown). Since BamHI cuts Tn5 into two 
portions of 3056bp and 2762bp respectively, then one can calculate 
that in order to produce two chromosomal fragments of 5.2 and 3.6 Kb, 
the transposon must have inserted into a 3Kb BamHI fragment, and must 
be situated either 0.6Kb or 0.8Kb from one end.
BamHI-restricted CSX4 DNA was ligated to BamHI/CIP treated pBR322, 
transformed into DS902, and transformants selected on L-agar +Ap*Km. 
In this way the plasmid pXB1 was isolated. Strain DS902 carrying pXB1 
was found to be resistant to Ap and Km, but is sensitive to Tet,
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consistent with the inactivation of the pBR322 tet gene by an insert 
in the BamHI site.
5-2.2 RESTRICTION MAPPING OF PXB1
Plasmid pXB1 was restriction mapped using the same approach 
described in detail in section 4.2.2, "Restriction mapping of pCS300". 
Again a sample of those gels used to generate pXB1 restriction data 
are shown ( Figs. 5.1, 5.2, 5.3); determination of the order of the
three closely spaced Hindlll sites, and the three closely spaced AccI 
sites, required the sizing of small fragments, from various single and 
double digests, on polyacrylamide gels ( c.f. Figs. 5.2 & 5.3). The 
restriction map of pXB1, plus a list of all the restriction endo­
nucleases tested for restriction of pXB1, is presented in figure 5.4. 
The restriction map of pXB1 reveals that the plasmid carries a a 5.2Kb 
BamHI fragment inserted at the BamHI site of pBR322; the size of 
this insert is identical to one of the two Tn5-containing fragments 
observed in the Southern analysis of CSX4/BamHI DNA discussed above. 
Thus it seems likely that the insert in pXB1 does indeed represent 
part of the major Tn5 insertion locus of CSX4. This 5.2 Kb insert 
comprises 3056bp from the left end of Tn5, plus approx. 2.1Kb of 
flanking chromosomal DNA. Whilst this represents the flanking DNA to 
only one side of the insertion, it nonetheless provides important 
information with regards to the structure of the xerBI locus; 
information which ultimately demonstrated that the xerBI lesion is 
indeed the result of a Tn5 insertion into the xerB structural gene.
5.3 CLONING THE WILD-TYPE XerB GENE
The strategy for cloning xerB involved screening an Ej_ coli K12
library for complementation of reporter-plasmid resolution in CSX4.
The cosmid library employed was a generous gift from Derek Blake, ( 
University of Oxford). The library was generated from the canonical E. 
coli strain, OP-Phi, by Sau3A partial digestion and phosphatase 
treatment of genomic DNA. The partial digestion products were size- 
fractionated on a sucrose gradient, ligated to BamHI-restricted cosmid 
vector DNA, pDVcos, and then packaged, in vitro, into infective phage 
particles ( Derek Blake, pers. comm.). The cosmid vector pDVcos is a 
5Kb derivative of pTCF ( Grosveld et al., 1982); its other salient 
features are that it is based on the pMB1 replicon, encodes resistance
to Ap, has a unique BamHI site, and carries two tandemly arranged
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1 2 3 l* 5 6 7 8 9 10 11 12 13 14 15 16
Figure 5.1 Restriction analysis of pXB1
Lane Sample Lane Sample
1 pXB1/uncut 9 pXB1/AccI
2 pXB1/£coRI 10 " /Xhol
3 " /Sstll 11 " /Hpal
4 " /Hindlll 12 Lambda/EcoRI
5 " /Clal 13 pXBI/Sall
6 Lambda/HindITT 14 " /£stl
7 pXB1/FstI 15 " /Smal
8 n /SphI 16 " /PvuII
Digests were run on a 1 £ agarose gel. The sizes of marker bands are
given in Kb.
1 2 3 4 5 6 7 8 9 10 11 12
Figure 5.2 High resolution restriction analysis of pXB1
Lane Sample Lane Sample
1 dXB1/SphI 7 PBR322/Alul
2 " ZSPhl/Sall 8 pXB1/AccI/HindHI
3 pBR322/MeI 9 " /Hindlll/Sall
4 pXBI/Sphl/AccI 10 pBR322/HhaI
5 " /Sail 11 pXB1/Hindlll
6 " /AcqI 12 " /Hindlll/Sohl
Digests were run on a 5? polyacrylamide gel. The sizes of bands are
given in base pairs,
Figure 5.3 High resolution restriction analysis of pXB1
Lane Sample Lane Sample
1 pBR322/M£l 6 pXBI /Accl/Hlndlll
2 pXB1/£fifcI 7 PBR322/Hhal
3 " /S&hl/As&I 8 pXB1/Hindlll/SphI
4 PBR322/Alul 9 " /Hindlll
5 pXB1/AccI
Digests were run on an Q% polyacrylamide gel. The sizes of fragme
are given in base pairs.
N— of Cuts Predicted N— of Sites in-
Enzyme in pXB1 pBR322 Tn5 Chromosomal
AccI 6 2 1 3
BamHI 2 1 1 1
Bglll 2 0 1 1
Clal 1 1 0 0
EcoRI 1 1 0 o
Hind.II I 5 1 1 3
Hpal 3 0 1 2
PstI 4 1 3 0
Sail 3 1 1 1
Smal 1 0 1 0
Mil 3 1 1 1
SstI 1 0 0 1
Sstll 1 0 1 0
Xhol 2 0 2 0
*Note that only the left-hand end of Tn5 is present in pXB1 ( 1-3056bp). 
The 2 BamHI sites in pXB1 correspond to the vector/insert 
boundaries.
8500
Hindlll
8000
Accl / Sail 
I PvuII 
X/ 1000
8000,
PvuII
Aool
PvuII
CL
pXBl 5Kb m
7000
3000
Hpal
8000 Ball I
Sail / Accl
SphI 7 ^ 7 ^  
BamHI If 
Sail / Accl I 
Hindi 11 Hpal
SphI Accl
5000 I 
Accl 
Hindi II
Hindlll
Figure 5.4 Restriction Map of pXB1
Note that only those enzymes which have sites within the 
cloned chromosomal sequence have been represented. For a tabular 
sumnary of all enzymes tested with pXB1 see figure 5.4b.
copies of the lambda cos site ( Derek Blake, pers. comm.). A cosmid- 
based library offers the considerable advantage that large genomic 
fragments ( H0-50Kb) may be cloned, thus reducing the total number of 
individual clones required to yield fair representation of the entire 
genome. Efficient lambda packaging requires that the cos ends be 
separated by approx. 37-52Kb (i.e. 78-105? of the size of the lambda
genome) ( Feiss & Becker, 1983; Hurray, 1983). Therefore, when using a 
5Kb cosmid vector, the process of encapsidation selects for insert 
sizes of approx. 30-45Kb.
The pMB1 replicon of p D V c o s  renders this cosmid compatible with the 
pCS210, therefore I proceeded to screen the cosmid library for XerB+
clones, by testing for the deletion of lacZ from pCS210 on X-Gal
plates: Obviously any XerB complementing cosmid which also encodes
the EL coli lacZ gene would produce a "Biologically false negative" in 
the 210-colour test, and so may go undetected. Clearly this 
possibility could be averted by making a library from a LacZ” Xer+ E. 
coli strain. Despite this potential problem, the library was screened 
as follows; CSX^ (pCS210) was grown to saturation, shaking at 37°C, in 
20mls L-broth + Tet (7mg.l“ )^ + 0.2? maltose. The culture was
harvested by centrifugation ( 6000g, 2 mins.), and resuspended in
10mls 20mM Tris-HCl, pH 7.5, 10mM MgCl2. Ten microlitres of packaged 
phage suspension was then added to 0.2ml of these cells and this 
mixture incubated at 37°C for 30 minutes. After this phage adsorbtion 
and infection phase, 0.2ml L-broth was added, and incubation continued 
at 37°C for a further 30 minutes to permit expression of the cosmid 
bla gene. The total transfection mix was then plated onto H plates of 
”210 medium" + Ampicillin ( "210 medium" comprising, DM minimal medium 
plus casamino acids ( 1?), glucose ( 0.2?), X-Gal ( 25mg.l” )^, and
tetracycline ( 7mg.l~^)). After two days incubation at 37°C, the
colonies were counted and scored for their blue/white colour. A total 
of 582 colonies were recovered of which one was white, the remaining 
581 varying in colour from pale to dark blue. The single white clone 
(BH), plus 20 pale blues, were restreaked onto 210 medium + Ap, and 
incubated for two days at 37°C; clone B4 maintained its white pheno­
type, whilst the 20 pale blue clones gave rise to both pale and dark 
blues. Therefore, in one case out of 582 there had been a complete 
loss of LacZ activity, whilst maintaining resistance to tetracycline. 
A STET Mini-prep of plasmid DNA was made from clone B4, analysed on 
agarose gels, and found to contain a high molecular weight species
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(cosmid pB4), plus a plasmid co-migrating with pCS211 ( the pCS210 
deletion derivative) ( data not shown). The cosmid pB4 was clonally
purified by transformation of this STET DNA, into DS902 under
conditions of dilute DNA concentration. Transformants were selected on 
L-agar+ Ap, then screened for co-transformation with pCS211 by
patching out onto L-agar +Ap, or L-agar+ Ap+Tet. Two out of four
transformants tested were Apr, Tets and a large scale plasmid DNA 
prep’ was made from each; the two isolates of this cosmid clone were 
labelled pB4 and pBM*. The abilities of pB4 and pB4* to complement the 
xerB.1 lesion were then re-tested by transformation into CSX^ J ( 
pCS202), selecting transformants on L-agar+Ap+Cm. STET DNA prepared
from pooled transformants was run on a 0.85$ agarose gel, and was 
found to contain a cosmid species plus pCS203, with no pCS202
apparent; identical results were obtained with both pB4 and pB4* ( Fig 
5.6a). Therefore one can conclude that pBH does indeed complement the 
xerB1 lesion, indicating that either the xerB gene, or a suppressor 
has been cloned. The cosmid pB4 has also been found to complement
pCS202 resolution in strains DSX1 ( xerB8), DSX2 ( xerBQ)f CSX20 ( 
xerB2). CSX21 ( xerB4) and CSX22 ( xerB5); however, it fails to 
complement CSX3 ( xerA3) in the same assay ( Fig. 5.6b), and likewise 
it fails to complement CSX11 ( xerA5) in a 210 colony-colour assay, 
indicating that a functional xerA gene is not present on the same pB4 
cosmid insert.
5.3 TARGETING pB4 SEQUENCES FOR SPBCLONING via HOMOLOGY TO pXB1
Restriction mapping of pB4 was not undertaken due to its large 
size, crudely estimated from various digests to be approximately *l5Kb 
( see Fig. 5.7a). Clearly the restriction pattern of pB4 is' quite 
complex, therefore I decided to "Home-in" on the xerB locus by 
exploiting the flanking DNA cloned in pXB1. I could not predict the 
sizes of wild type restriction fragments from the map of pXB1, since 
only one flank of the insertion locus is present. However, by probing 
Southern blotted pB4 digests with nick-translated pXB1, then those 
cosmid fragments bearing the equivalent locus could be detected. 
Obviously, since p D V c o s  is derived from pBR322, then cosmid vector 
sequences will also be detected by the pXB1 probe. One way to 
differentiate any genomic signals from vector signals is to run 
analogous restrictions of chromosomal DNA alongside the pB4 digests. 
The chromosomal DNA should, in theory, only hybridise to the genomic
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Figure 5.6 pB4 complementation tests in CSX3 and CSX4. Panel (A) 
Illustrates the successful complementation of pCS202 resolution in 
strain CSX4 by both pB4 and pB4': CSX4/pCS202 + pB4 , lane 1; 
CSX4/pCS202 + pB4', lane 2; pCS202, lane 3; pCS203, lane 4. Panel (B) 
illustrates that neither cosmid complements the Xer“ phenotype of 
CSX3: pCS202 + pCS203 mixture, lane 1; CSX3/pCS202 + pB4, lane 2; 
CSX3/PCS202 + pB4’, lane 3; CSX3/pCS202, lane 4.
sequences from pXB1; this assumption being supported by the previous 
failure to detect any specific hybridisation of pCS80 to blots of wild 
type chromosomal DMA ( see Fig. 4.7, section 4.4). Any pB4 restriction 
fragments detected which are identical in size to bands detected in
the analagous chromosomal digest are therefore very likely to
represent genomic fragments from around the xerB locus. Such fragments 
could then be preferentially sub-cloned and tested for XerB
complementation. To this end pB4 and DS947 chromosomal DNA were each 
restricted with Sail. Hindlll. PstIT SphI, Sstll. or Xhol. The digests 
were then run on a 0.7# agarose gel which was stained and photographed 
prior to Southern blotting onto Nylon membrane ( Fig. 5.7a). The
following samples were run as molecular weight size markers; plasmid 
pCS80 linearised with EcoRI ( 10.2Kb), pCS300 linearised with Smal ( 
19.5Kb), and pCS300 cut with EcoRI ( 15.1Kb and 4.3Kb plus the 12.6Kb 
and 2.5Kb partials). All of these bands, with the exception of the 
2.5Kb pCS300/EcoRI partial, should yield signals when probed with pXB1 
by virtue of their hybridising to pBR322 and/or Tn5 sequences. As 
additional markers, a lambda cl857/HindIII digest was also run on the 
gel. The blot was then probed with a mixture of nick-translated pXB1 
plus nick-translated lambda DNA ( in a ratio of 9:1 respectively); all 
procedures were as stated in materials and methods. This somewhat 
cavalier approach to the probing of a filter ( i.e. labelled pBR322;, 
Tn5, lambda, and xerB1 sequences) could have been tempered by 
subsequently reprobing the same filter ( stripped of initial label) 
with labelled pCS80 + lambda, thus enabling true genomic signals to be 
identified by negative inference. This was deemed unnecessary since 
pB4 fragments "Targeted” in this way were rapidly subcloned and shown 
to complement xerB1 mutants. The autoradiogram generated from this 
pXB1/lambda probed blot is quite complex ( Fig. 5.7b), however it is 
clear that only Hindlll and SphI generate small genomic fragments 
with ( stong) homology to pXB1, therefore these two restrictions will 
be considered in detail, with reference to any predictions made from 
the restriction map of pXB1 ( see Fig. 5.4):
Hindlll: The three genomic Hindlll sites in pXB1 predict
hybridisation to four DSQ47/HindIII fragments, one of 120bp, one of 
460bp and two boundary fragments of unknown sizes. One of these latter 
two bands is expected to yield the strongest signal due to its 1.4Kb 
of homology with pXB1. It is this strong band which must carry at
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least part of the wild type xerB locus. In practice this strong signal 
was found to originate from a 1.9Kb fragment ( Fig 5.7b, lane 12), 
with the predicted 460bp fragment also visible. The predicted 120bp 
fragment would have run off the bottom of the gel, but may have been 
barely detectable in any case. The fourth fragment is expected to 
produce a signal of 40? the intensity of that of the 460bp band ( due 
to its 208bp homology to pXB1) and consequently is not clearly 
visible. A candidate band of approximately 8Kb can be seen on the
original autoradiogram. The salient points regarding the pB4/HindIII 
digest are that the 1.9Kb, and 460bp genomic fragments appear to be 
present. The 1.9Kb fragment was therefore subcloned and tested for
XerB complementation. It is interesting to note that there is no 
signal from an 8Kb fragment. Therefore, if the 8Kb band in the DS9^7 
digest is real, then this would indicate that the xerB locus is 
situated within 10ICb ( 8+2) of the end of the pB4 insert.
SphI; One SphI site in the genomic sequence of pXB1 predicts that two 
DS947 fragments should be detected. The position of the site predicts 
one strong, and one weak signal, with the strong signal emanating from 
the fragment encompassing the Tn5 insertion site in xerB1. In fact 
four signals were observed whose approximate sizes are 2.7» 2.8, 5.5
and 6.6 Kb respectively ( Fig. 8, lane 14). The major signal is 
clearly from the 2.8Kb fragment, therefore it is this fragment which 
was targeted for subcloning from pB4. The two larger bands are faint 
and are presumed to be partial digestion products. The pB4/SphI
digest clearly produces a strong signal from a 2.8Kb fragment, however 
whether or not the 2.7Kb fragment is present is unclear.
Significantly, PB4/Sphl generates the same two faint bands ( 5.5 and 
6.6Kb) as observed in the DS947 digest; that these two pB4 fragments 
are partial digestion products is clear from the original gel 
photograph (Fig. 5.7a, lane 5).
The remaining enzymes tested all generated a high molecular weight 
chromosomal band exhibiting strong homology to PXB1. However, notice 
that Sstll digestion also generates a small chromosomal restriction 
fragment ( 4 Kb) which yields a relatively weak signal; this band also
appears in the pB4 digest. The appearence of two bands in the chromo­
somal digest cannot be easily interpreted since there are no Sstll
sites within the chromosomal sequences present in pXB1 ( see Fig.
5.4b); it may indicate the presence of a second chromosomal locus with
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Figure 5-7 Southern hybridisation of parallel restrictions of cosaid 
PB4 and DS947 chromosomal DNA, probed for hoaology to pXB1.
Panel A) Ethidium bromide stained gel photographed prior to blotting..
Lane Sample Lane Sample
1 Lambda/Kindlll 10 pCS80/EcoRI
2 pB4/SalI 11 DSQ47/SalI
3 " /Hindlll 12 M /Hindlll
4 " /PstI 13 " /PstI
5 " /SPhi 14 n /SPhi
6 " /Sstll 15 n /Sstll
7 " /Xhol 16 " /Xhol
8 pCS30Q/SmaI
9 pCS300/EcoRI
1 2 3 4  5 6 7  8 9 10 11 12131415 16
Fig. 5.7 Panel B) Southern blot probed with nick-translated pXB1 plus 
nick-translated lambda DNA. Notice that the photograph is again a 
composite of two seperate autoradiograms exposed for different periods 
of time.
homology to xerB. however further work would be necessary to confirm 
this.
In summary, the combined Hindlll and SphI data strongly suggest 
that the genomic sequence present in pXB1 is also present in pB4. The 
DS947 data suggests that the wild type sequence encompassing the site 
at which Tn5 is inserted in xerB1. is borne on a 2.8Kb SphI 
restriction fragment, or a 1.9Kb Hindlll restriction fragment. Both of 
these fragments appear to be present in pB4, therefore both were sub­
cloned into plasmid vectors and tested for XerB complementation. In 
addition a 3Kb fragment identified in pB4/BamHI digests was also sub­
cloned ( pB4/BamHI digestion generates only three fragments of approx­
imately 24, 18 and 3 Kb respectively; data not shown). This small 
BamHI fragment is of special interest since previous blotting data had 
indicated that the xerB1-linked copy of Tn5 , is inserted into a 3Kb 
BamHI fragment in the chromosome of DS947 ( see section 5.2).
5.3.2 ISOLATION OF XerB4- SPBCLONES FROM pB4
Having identified certain small pB4 restriction fragments which 
are likely to carry at least part of the xerB gene, I set about 
subcloning them, but in order to guard against erroneous prejudice I 
proceeded as follows: pB4 was cut with either BamHI or SphI. treated 
with CIP, then these digests ligated to either BamHI-restrieted 
pCS100, or Sphl-restricted pUCl8 as appropriate: the vector pCS100 was 
constructed by cloning the rom gene from ColE1, as a 309bp Hpall 
fragment, into the Marl site of pUC8. Both ligations were then 
screened for XerB+ clones by transformation into CSX4 (pCS210), 
followed by plating out onto 210-medium + Ap. Obviously, any clones 
which effect complementation should be readily identifiable by their 
white colony colour. Of four white clones recovered from the 
BamHI/pCS100 ligation, all were found to contain two plasmid species; 
one comigrating with pCS211, and the other being approximately 6Kb in 
size. The "targeted" 3Kb BamHI fragment from pB4, when cloned into 
pCS100 (3Kb), would of course generate a plasmid of 6Kb. The 6Kb 
plasmid from one such clone was designated pCS110, and was clonally 
purified from the reporter plasmid by transformation of STET DNA into 
DS902, selecting for Apr transformants and screening for Tets clones. 
The structure of pCS110 was then determined by digestion with BamHI. 
SphI \ . and v?ith Hindlll and EcoRI. The restriction map of the 
3Kb BamHI insert from pCS110, plus its orientation relative to the
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pCS100 polylinker, are shown later in Fig 5.15.
With regards to the SphI subcloning, from a total of seven white 
clones analysed, all appeared identical with respect to their plasmid 
content, comprising pCS211 plus a second species of approximately 5.5 
Kb. The 5.5Kb plasmid from one such clone was designated pCS1-11, and 
was clonally purified as described for pCS110. The restriction map of 
pCS111 has been determined for various enzymes including SphI. BamHI. 
Hindlll. Sail etc. ( See Fig. 5.15). Both pCS110 and pCS111 were then 
re-tested to confirm their XerB+ status; in the standard CSX4 (pCS210) 
colony colour assay, both scored as XerB+, whereas pUCl8, pCS100, and 
pAT153 all fail to complement.
5.3.3 DEFINING THE MINIMUM COMPLEMENTING SEQUENCE
From restriction analyses of pCS110 and pCS111, it appears that 
their inserts overlap considerably ( see Fig. 5.15), and that both 
contain the 1.9Kb Hindlll fragment originally targeted for subcloning 
in section 5.3.1 ( b). Therefore this Hindlll fragment was sub-cloned 
from pCS111 as follows; Hindlll-res trie ted pCS111 was run on a 0.8$ 
gel, and the 1.9Kb fragment recovered from the gel as described in 
materials and methods. The purified fragment was then ligated to 
Hindlll restricted pUCl8, and this ligation was transformed into DS9^1 
( lacZ delta M15), and then plated out onto L-agar+ Ap, X-Gal, and 
IPTG (the use of X-Gal in this case being to screen for pUCl8 clones 
with inserts which disrupt their lacZ1 coding sequence; such 
disruption generally resulting in a failure to complement the 
chromosomal lacZ delta M15 mutation leading to a phenotypically LacZ"1 
clone). A number of Apr, LacZ” clones were screened for size by single 
colony gels, then their insert size and orientation confirmed by 
restriction with Hindlll. Accl. and by Hindlll/AccI double digestion. 
In this way pCS112 was isolated ( See Figs. 5.11 and 5.15). This 
plasmid was also found to complement pCS210 resolution in CSX4 
according to the 210-colony colour test. At this point I initiated the 
DNA sequence analysis of this 1.9Kb Hindlll fragment ( see chapter 7), 
rather than attempting to further reduce the complementing function 
"Blind”. The resultant DNA sequence predicted a number of useful 
restriction sites, which I confirmed empirically, then exploited for 
the generation of various pCS112 sub-clones which were then tested for 
complementation in CSX4. The strategies employed to construct each 
subclone are detailed explicitly in Figs. 5.11, 5.12, and 5.13. The
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Figure 5.11 Construction of pCS130, pCS131 and pCS132 by Deletion of 
sequences from pCS112
The Kpnl and HincII deletions were achieved by 
restriction followed by re-ligation at low DNA concentrations. The 
Accl deletion required "Filling-in" of non-compatible Accl ends with 
Klenow + dNTPs; the resultant blunt-ends were then ligated to generate 
PCS130.
pCS130 carries thel687bp Hindlll/Acc fragment from pCS112 
PCS131 " " 1467bp Hindlll/Kpnl " » "
pCS132 " " 1070bp Hindlll/HincII ” ” "
EcoRI
Hindlll
EcoRI
Hindlll
bla
DIGEST WITH EcoRI/Hindlll
I
LIGATE TO pCB18B (EcoRI/HindK)
HindHt EcoRI
pC S120 
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cat
cat
Figure 5.12 Construction of pCS120 and pCS121
pCS120 carries the I641bp EcoRI/Hindlll fragment from 
pCS112, whilst ,pCS121 contains the 27^bp fragment.
Mlul
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HindlllHindi
EcoRI
mCS112 
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I
Mlul
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I
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I
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Hind IE(HincII)
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A
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Figure 5.13 Construction of pCS124 and pCS125
mCS112 is an M13mp19 derivative containing the 1.9Kb 
Hindlll fragment from pCS111 cloned into the polylinker for the 
purpose of DNA sequence determination. There is a single Mlul site in 
mCS112 situated 829bp from the RIGHT-HAND Hindlll site. The sub-clone 
pCS124 contains the 829bp fragment, whilst pCS125 carries the 1092bp 
Hindlll/Mlul fragment.
subclones pCS120, pCS121, pCS124, pCS125, pCS130, pCS131, and pCS132 
were each tested for complementation of pCS210 resolution in CSX*J via 
a colony-colour test assay. The results of these complementation tests 
are summarised in Table 5.1; in each case the Xer phenotype conferred 
by each sub-clone has been confirmed in a pCS202 gel resolution assay 
( data not shown). The results clearly show that pCS110, 111, 112 and 
pCS130 all complement in CSX4, but that the remaining sub-clones do 
not. It is very important to note here that the observed efficiency 
of pCS112 and pCS130 complementation depends upon the medium onto 
which the test-plasmid transformation is plated; on L-agar+Ap+Tet 
partial complementation is observed in pooled transformants, but on DM 
minimal agar + Glucose, Casamino acids, Ap + Tet efficient 
complementation is observed, this phenomenon will be discussed 
shortly. Unless otherwise stated, all future complementation tests 
were plated onto a DM/Casamino acids medium. The results of this 
complementation analysis are summarised in figure 5.15. The minimum 
sequence identified as retaining the complementing function is the 
I687bp Hindlll/Accl fragment in pCS130. Furthermore the data suggests 
that the functional xerB locus must extend beyond the EcoRI site at 
one end, and beyond the Kpnl site at the other; i.e. it must be a 
minimum of 1l8?bp in size. The correspondence between the pXB1 
restriction map and those of pCS111, and pCS112 ( Fig. 5.15) confirms 
that the complementing function cloned is, by definition, the xerB 
gene as opposed to a suppressor allele. I should add that all of these 
complementation tests were performed in a RecA+ background therefore 
one cannot state unequivocally that complementation is effected in 
trans. Obviously recombination between the chromosomal and plasmid 
borne sequences can occur, such recombination could regenerate a 
functional xerB gene even when both chromosomal and plasmid copies are 
defective. Whilst homologous recombination does proceed in CSX4, it 
does so at low efficiences due to its RecF~, RecE“ status. Further­
more, given the relative position of the Tn5 insertion in xerBI ( see 
pXB1), one would expect recombination to be almost as efficient at 
regenerating an xerB gene from either pCS120 and/or pCS131 as it is 
from pCS130. This is patently not the case, therefore it seems 
reasonable to conclude that pCS130 complementation in CSX4 is not 
dependent on recombination with the xerBI locus, and thus is likely to 
be effected in trans by a functionally intact xerB locus.
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Figure 5.15 Complementation of xerBI by Various Sub-Clones
Each sub-clone was tested for complementation of pCS210 
resolution in CSX4: indicates complementation whereas a
indicates failure to complement. The complete insert is shown in each 
case, with the exception of pXB1 where only a portion of the Tn5 
sequence is represented. Only those restriction-sites which have been 
confirmed empirically are shown:
ENZYME CODE: A= Accl H= Hindlll N= Narl
B= BamHI Hp= Hoal P= PvuII
Bg= Belli K= Kpnl S= Sall/AccI*
E= EcoRI M= Mlul Sphl= SphI
Note that the extent of the xerB coding sequence ( identified by DNA 
sequence analysis- see Chapter 7) is indicated by a broad-hatched 
arrow. The sizes of the inserts in pCS110, 111, 112, 130 & 131 are 
as indicated.
FOR INFORMATION ONLY: Tne relative orientations of each insert with
respect to the vector’s polylinker ( and plac) was determined for 
pCS110 & pCS111. In the case of pCS110 the vector’s lac promoter 
drives transription rightward through the insert as shown above, i.e. 
from Sail to SphI. The opposite is true in pCS111, with plac initiated 
transription running from right to left ( i.e. from BamHI to EcoRI).
Table 5.1 Complementation of xerBI by Various Plasmid Sub-clones
Test 
CSX 4 •
Strain Test Plasmid Colony Phenotype Xer Phenotype 
h pCS210 PCS110 White +
"111 i i +
" 112 i i +
" 120 Blue -
" 121 i i -
" 124 it -
" 125 i i -
" 130 White +
it  1 3 1 Blue -
" 132 i i -
5.4 DOES THE MINIMUM xerB CLONE COMPLEMENT ANY OTHER xer MUTANTS. ?
The cloned xer A gene was found to complement two out of the 11 
mutants isolated, thus consigning nine mutants to a nnon-XerAn group. 
The cosmid pB4 complements the Xer~ phenotypes of the six members of 
this group against which it has been tested. This indicates either 
that all of these mutants are XerB*", or that pB4 carries a number of 
other-xer genes. In order to help distinguish between these 
possibilities, it was necessary to test the minimum xerB+ sequence 
against all of the other mutants. Ideally the I687bp Hindlll/Accl 
fragment should have been used, however, at the time of the analysis 
this had not yet been identified thus it was the 1921bp Hindlll 
fragment which was tested. The complementation assay was the standard 
transformation of pCS112 into a mutant strain carrying pCS202, 
followed by agarose gel analysis to determine the status of the 
reporter plasmid. All nine nnon-XerA” mutants were tested in this way, 
and in each case, efficient complementation was observed ( Fig. 5.16). 
It would therefore appear likely that all the xer genes identified by 
our mutant isolation programme have now been cloned.
5.5 MAPPING THE xerB LOCUS ON THE E. coli K12 LINKAGE MAP
A long term goal in a number of laboratories is to develop a 
characterised library of the E^ coli K12 genome; i.e. a set of 
restriction mapped, overlapping clones which represent the entire 
chromosome. Such a library should^us to !,home-inn on a map location 
and thus rapidly clone a gene whose map position is known. Conversely, 
one should be able to match cloned genes to within the library, and 
thus determine a very accurate map position for the cloned locus. Dr. 
Knott in Oxford is currently developing a characterised cosmid 
library, and generously agreed to attempt to match pB4 to the clones 
characterised to date. The procedure involves sizing all cosmid 
restriction fragments generated by Hinfl digestion, then feeding this 
"HinfI fingerprint” into a computer program which searches for 
comparable restriction spectra amongst a database of clones. 
Fortunately, the search for pB4 like sequences proved successful, 
with pB4 mapping to a region from which eight contiguous cosmid clones 
had been characterised; indeed pB4 served to join two smaller 
contiguous sequences ( contigs), to form Contig 48 ( Fig. 5.17). Dr. 
Knott had previously found that cosmids 157/1 and 296/57 both 
hybridised to a synthetic oligonucleotide prepared against the pyrB
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Figure 5.16 Complementation of Independent Xer" Mutants by pCS112
Mutant Allele
Strain Designation'
CSX4 xerBI
1 5 B2
1 6 B3
" 7 B4
" 8 B5
" 9 B6
" 10 £.7
DSX1 B8
DSX2 £9
CSX3 A3
CSX11 A5
pCS112 
Complementation
+
+
+
+
+
+
+
+
Complementation was scored in a pCS202 gel resolution assay.
467/ 52
_____ 296/57
 15 7/1_____
266/45
________ B4_ _ _ _ _ _ _ _
_____ 296/24_____
_ ___ _ _ 377/36______
_____  177/40_ _ _ _ _ _ _
377/24
Figure 5.17 Overlapping Cosmid Inserts Corresponding to Contig 48
BamHI Hindlll Kpnl EcoRI Hindlll BamHI
96-5 mins. 1-------------- 1------- 1------------ 1------ 1 1 3-1 Kb
BamHI Hindlll Kpnl EcoRI Hindlll BamHI
XerB Locus 1----------- 1------ 1- - - - - - - - - - - - - - - - - 1--- 1---- 1 3-0 Kb
Figures.18 Comparison Between the Restriction Map of the Cloned
xerB Locus With That of the 96.5min Region of the K-12 
Chromosome.
In addition note that there are no PstI sites in either 
fragment.
gene sequence. The pyrB locus ( encoding aspartate carbamoyl- 
transferase) has been mapped to 96.5 mins ( see Bachmann, 1983)? thus 
contig 48 had been tentatively assigned to this region of the E*. coli 
K12 linkage map. Dr. Knott kindly supplied me with her clones from 
contig 48 which I proceeded to test for the presence of the xerB. 
pyrB. and argl genes by means of genetic complementation. I failed to 
recover cosmid 266/45 from the material received, however, as will 
become clear, this particular clone would probably yield redundant 
information. Cosmids were tested for xerB by complementation of pCS210 
resolution in CSX4, as assayed by the 210 colour test. The results 
indicate that only pB4 and 157/1 encode a functional xerB gene, the 
remaining six cosmids all fail to complement CSX4 ( Table 5.2). Each 
cosmid was then tested for its abiliy to complement the uracil 
requirement of a pyrB mutant strain. In addition I tested each clone 
for the presence of the argl gene, whose map position is estimated as 
96.6mins ( Bachmann, 1983). The argl gene encodes ornithine carbamoyl 
transferase, as does its duplicate gene argJF ( 7 mins.), therefore I 
tested for each cosmid's ability to complement the arginine 
requirement of an argl. argF double mutant. Strain NGX2 is pyrB. argl. 
and argF. and is therefore a suitable host strain for both 
complementation tests. NGX2 was transformed independently with each of 
the eight cosmids, or with pBR322 as a control, transformants were 
then selected on DM minimal agar plus Glucose, casamino acids, uracil 
and Ap. Eight colonies from each transformation were patched out 
sequentially onto three media composed of DM minimal agar h- glucose 
and Ap, plus the following supplements;
1) Proline, Leucine, Arginine, and Uracil ( "Ura+Arg" medium)
2) Proline, Leucine, and Arginine ( "Arg” medium)
3) Proline, Leucine, and Uracil ( "Ura” medium)
The plates were then incubated at 37°C for two days before being 
scored for the presence or absence of growth. The results are 
summarised in table 5.3 from which it seems clear that pB4, 157/1 and 
296/57 all complement both the uracil and arginine requirements of 
NGX2, and thus would appear very likely to carry the pyrB and argl 
genes. Of the remaining 5 cosmids tested, 3 can be said to complement 
neither requirement, those being 377/24, 177M0, and 467/52. No
conclusions can be drawn with regards to 296/24, or 377/36. The
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Table 5.2 Complementation of xerBI by Various Cosmids from Contig 48
Test Strain Cosmid Colony Phenotype XerB Phenotype
CSX4 + pCS210 P377/24 Blue _
u p177/40 it -
It P377/36 t! -
II P296/24 I I -
I I pB4 White +
I I p157/1 White +
It P296/57 Blue -
II P467/52 Blue -
II pBR322 Blue -
Table 5.3 Complementation of Arginine and Uracil Prototrophy in NGX2
by Cosmids from Contig 48
Strain
NGX2
Growth on DM minimal + supplements
Strain
Phenotype
Cosmid Ura+Arg Ur a Arg PyrB Argl
P377/24 + _ — _ _
P177/40 + - - - -
P377/36 - - - N.D N.D
P296/2H - - - N.D N.D
pBH + + + + +
P157/1 + + + + +
P296/57 + + + + +
P467/52 + - - - -
pBR322 + - - - -
NGX2 was transformed with each cosmid, selecting Apr clones on DM 
minimal, Cas-amino acids + Ap. Several colonies were then patched onto 
each test medium. The failure of P377/36 and p296/24 transformants to 
grow on even Ura+Arg medium seems to reflect the genetic instability 
of these cosmids since neither strain would re-grow when patched onto 
DM, Cas-amino acids + Ap, but would grow in the absence of Ap; ( N.D.= 
Not Determined).
Table 5.*t Cosmid Genotypes Established by Genetic Complementation
Cosmid Established Genotype
PB4 xerB. pyrB. argl
pi57/1 xerB. pyrB. argl
P296/57 pyr.B, argl
✓
established genotypes of each cosmid from contig 48 are summarised in 
table 5.4. These genotypes would suggest that the overlaps between 
"cosmid fingerprints" shown in figure 5.17 are misleading, since 
296/57 and pB4 do not apear to overlap at all, and yet both express 
PyrB and Argl. Such errors from the fingerprints may arise as a result 
of HinfI-fragment truncation by cosmid vector sequences; thus two 
inserts may share considerable overlap at their ends, but this might 
not be obvious if their terminal fragments have been truncated to 
different lengths. Obviously this method of fingerprinting can only 
detect overlaps which share at least one intact Hinfl fragment, 
however, in practice multiple common-fragments are required to assign 
an overlap.
The genetic data strongly suggests that xerB must be located in 
very close proximity to pyrB and argl. a very conservative estimate 
would be to within 0.5 mins, or 15-25Kb. However, from this data we 
cannot distinguish the order of genes on the linkage map, save to say 
that it must be either xerB-pyrB-argl or pyrB-argl-xerB: therefore I 
concluded that xerB maps to between 96-97 minutes on the K-12 linkage 
map.
This work had been completed at the time of publication of the 
restriction map of the E. coli K-12 chromosome ( see chapter 4). If 
one searches this map for restriction "fingerprints" compatible with 
that of the xerB locus, then the only convincing match is found at 
4560Kb, equivalent to 96.5 mins on the K-12 linkage map ( Fig 5.18). 
This comparison confirms the genetically established map position, and 
thus highlights the potential of the Kohara map in the prediction of 
chromosomal map positions from simple restriction data.
5.6 DISCUSSION AND CONCLUSIONS
The xerB gene has been cloned, and defined genetically to within a 
1.69Kb Hindlll/Accl fragment. The slightly larger 1.92Kb Hindlll 
fragment cloned in pCS112 has been found to complement all nine 
mutants in the "non-XerA" complementation group. On the assumption 
that this fragment encodes a single xer gene ( an assumption supported 
by sequence data, chapter 7), all nine of these mutants have been 
assigned to the xerB complementation group, and designated alleles 
xerBI-xerB9 ( Appendix 1). However, as will be discussed in chapter 7> 
I cannot, at this stage, formally preclude the existence of other 
small xer genes within this fragment. Had more time been available,
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then all those sub-clones listed in figure 5.15, would also have beer- 
tested for their abilities to complement xerB2-xerBQ. Comparisons of 
the restriction maps of the cloned xerB and xerBI alleles, coupled 
with the xerBI complementation data ( Fig. 5.15), makes it quite clear 
that the Tn5 insertion in strain CSX4 is within the functional xerB 
locus.
An apparent inconsistency exists between the inhibitory affects on 
Xer activity observed with pGS38 and pBAD ( chapter 4), compared with 
the highly efficient complementation effected by pCS112. However, as 
alluded to earlier, complete resolution of pCS202 to pCS203 is 
observed only when pooled transformants of CSX4 ( pCS202) + pCS112 are 
taken off DM minimal agar, whereas a partial resolution phenotype is 
observed when L-agar cultures are used. The 210 colony colour test is 
affected in a similar fashion; i.e. pCS112 transformants grow as 
uniform white colonies on 210-mediura ( DM minimal based), but grow as 
mixed blues and whites on L-agar based medium, the basis of this 
medium affect would seem unlikely to also cause "partial 
complementation" with pGS38, since in this case mixed blues and whites 
are observed regardless of the medium employed. Whilst these 
complementation tests are fraught with the possibility that clonal 
segregation of test and reporter plasmid may lead to a mixed 
phenotype, it seems irrefutable that pBAD and pGS38 can exert an 
inhibitory affect on the cer-specific recombination in x%7ild type 
strains. Clearly one would now wish to re-test these inhibitory 
affects on minimal medium, and also to test for any inhibitory affects 
of pCS112 in a wild type strain which are not apparent in the 
complementation assay. If such tests do not resolve the anomaly, then 
one might investigate other possible explainstions for the difference. 
These might include:
1) That pCS112 exerts less "Stress" on its host than either pBAD or 
pGS38, perhaps as a simple consequence of the plasmid construction, or 
perhaps as a result of the function(s) it expresses.
2) Increased levels of XerB protein, resulting from high gene dosage, 
might act to suppress the inhibitory influence of the vector; the 
simplest route for which would be if vector-inhibition is effected via 
a reduction in host xerB gene expression. In order to test this 
hypothesis, one might supply the cloned xerB gene on a plasmid
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compatible with pEAD, then test for their combined affect in a wild 
type host. Some of these experiments may help to unravel this 
intriguing phenomenon.
Finally, the XerB gene has been mapped to 96.5 mins. on the E. 
coli K12 linkage map. The interval between 96-97 mins. contains only 
eight previously identified loci, none of which are obviously 
associated with a DNA recombination function; they are fdp ( Fructose 
diphosphatase, 96.0 mins), corB ( Mg++ transport system I, 96.4 mins), 
pvrB and pyrl ( aspartate carbamoyl transferase catalytic and 
regulatory subunits respectively, 96.5 mins), argl ( 96.6 mins), sbaA 
( regultion of serine and branched chain amino acid metabolism, 96.7 
mins), valS ( 96.8 mins), and leuX ( leucine tRNA, 97.0 mins) ( 
Bachmann, 1983).
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CHAPTER 6
SEQUENCE OF THE xerA GENE
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6.1 INTRODUCTION
The xerA gene has been delineated genetically to within a 0.93Kb 
SphI/AccI fragment, the determination of whose DNA sequence was 
considered a priority for several reasons:
1. The xerA sequence may be compared against sequence databases, 
chiefly to ascertain whether or not the locus has been sequenced 
previously having been identified via some other host function.
2. The DNA sequence can be used to predict the precise structural 
organisation of the xerA gene, plus the primary structure of its 
polypeptide product ( assuming that the gene product is indeed a 
protein).
3. The DNA and inferred protein sequences may then be searched 
for sequence "motifs” associated with particular functions; e.g. 
for the presence of a ”cer-like” site in the DNA, or for a "Helix- 
Turn-Helix” DNA binding motif in the polypeptide, or for 
similarities to other known recombinases etc..
6.2 SEQUENCING STRATEGY
The sequencing strategy centered upon the generation and cloning 
of a series of nested deletions which enabled the ordered, and thus 
rapid generation of contiguous sequence data. The approach employed 
was that of Henikoff (1985), which exploits two very useful features 
of E_*. coli Exonuclease III ( ExoIII):
1. Processive digestion of DNA ends at a uniform rate.
2. The 3 T—5 * exonucleolytic activity of ExoIII is dependent on a 
"recessed” 3*-0H end, i.e. one which is part of a duplex. It 
therefore fails to initiate exonucleolytic degradation at a 
DNA end with a 4bp 3* protrusion.
Thus if a DNA duplex is digested with two different restriction 
enzymes such that it has a "protected” 3’ protrusion at one end, and a 
"susceptible" 5’ protrusion at the other, then subsequent ExoIII 
digestion will proceed in a uni-directional fashion. The importance of 
this is that a vector with a cloned insert can be subjected to ExoIII 
deletion in such a way as to delete into the inserted sequence whilst 
protecting the vector, thus deleted molecules may be cloned after 
simple re-circularisation. By performing an ExoIII deletion time- 
course, stopping samples at specific intervals, then a series of 
nested deletions are generated; the technique is illustrated in a flow 
diagram in figure 6.1. Obviously this approach has the considerable 
advantage of enabling a given strand to be sequenced in a defined
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Figure 6.1 Flow Diagram Illustrating the ExoIII-Deletion Technique
order, thus the complete single strand sequence can be determined in a
highly efficient manner. In order to obtain the second strand
sequence, one may clone the same fragment in the opposite orientation 
with respect to the ’’Primer hybridisation site”, then begin deleting
inwards from the alternative end. In addition to their use as
sequencing templates, deletions generated in this fashion may be 
employed to further delineate the cloned function via complementation 
tests.
One strand of the XerA sequence was determined using ExoIII 
deletion derivatives of the wild type Sphl/AccI fragment as templates, 
whilst the second strand was determined from deletion derivatives of 
the xerA3::Tn5 insertion locus originally cloned in pCS300; this had 
the advantage of precisely defining the Tn5 insertion sequence. The 
two substrates used for ExoIII deletion were raCS320 ( wild type; Fig. 
6.2), and mCS301 ( xerA3: Fig.6.2). In addition two specific subclones 
were required to complete the xerA3 strand, those being mCS304 ( Fig. 
6.3a) and mCS305 ( Fig. 6.3b). The deletion protocol employed was as 
published by Henikoff ( 1985), the sole modification being that ExoIII 
digestions were performed at 30°C, as opposed to 37°C; this lower 
reaction temperature was found to result in a more uniform deletion of 
the available substrate. The rate was calibrated by a deletion time- 
course on an Sstl/BamHI-restricted mCS320 substrate, followed by S1 
digestion, after which samples were run on an agarose gel, and the 
mode fragment size for each time point calculated from the electro­
phoretic mobility of the major band ( Fig. 6.4). In this way the 
deletion rate was calibrated to between 130-150bp.min“  ^ per 
susceptible end at 30°C. Therefore in order to generate suitable 
overlaps for the purposes of accurate sequence determination, time- 
points were taken at 2 min intervals. After S1 digestion, end-repair, 
and re-ligation, the ligation mix was transfected into JM101 (
Yanisch-Perron et al, 1985) then plated out as described in materials 
and methods. The phage plaques recovered were picked and resuspended 
in 0.5ml 2YT medium for long term storage at 4°C. Individual clones 
were grown up, by infecting 2.5ml of faintly turbid JM101 with 50 
microlitres of stored phage, followed by incubation with vigorous 
shaking at 37°C overnight. From these cultures a 1.5ml aliquot was 
microfuged, 5 mins., and the whole-cell pellet seperated from the 
phage containing supernatant. Replicative form DNA (RF DNA) was 
recovered from the cell pellet via the STET procedure, then linearised 
by restriction with Hindlll and sized on 0.7* agarose gels. Clones
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Figure 6.2 Construction of mCS320 and mCS301
Only those polylinker sites of some significance are 
shown, other polylinker sites present are indicated by a period (.).
mCS30^
B.
mCS305
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1003 bp
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primer
Figure 6.3 Construction of mCS304 and mCS305
Figure 6.4 ExoIII deletion time-course of mCS320. Time-points were 
taken at 2 minute intervals as described in the text, then sized by 
agarose gel electrophoresis. Loading order: Tq ( time zero), Lane 2; 
T2 ( 2 minute time-point), lane 3; , lane 4; Tg, lane 5; Tg, lane 6;
Size markers: M13mp19 linearised with HincII, lane 7; Lambda/Hindlll 
lanes 1 + 8.
with probable overlapping deletions were identified, and then single­
stranded DNA ( s.s DNA) was recovered from the appropriate culture 
supernatant (as described in materials and methods), for use as 
template in the di-deoxy chain termination sequencing procedure of 
Sanger et al. (1977). In total, four deletion derivatives of raCS320 
were sequenced (plus of course raCS320 itself), those being mCS320 
A 2 1 , A ? ? , A25 and A M .  These five clones provided 924bp of
contiguous sequence running from the AccI site to the SphI site ( 5’-
3M.
Exonuclease III deletions of mCS301 were performed in an identical 
fashion, except that the substrate DMA was initially restricted with 
PstI and Xhol to provide protected and susceptible ends respectively. 
Suitable clones were again size- selected prior to sequencing; the 
sequenced clones being mCS301 A213, A 4 7 ,  A 4 8 ,  A 4 9 ,  A 8 2 ,  A 8 6 ,
plus mCS304 and mCS305. The raCS304 and 305 sequences run ( 5f-3') from 
the equivalent of the SphI site in pCS300 into the left end of Tn5, 
whereas the remaining sequences all run, out of the right end of Tn5, 
towards the AccI site. All sequencing reactions and associated gels 
were performed and run as described in materials and methods. All 
autoradiograms were interpreted by eye, and the sequence read on at 
least two seperate occaisions. The sequence was then entered into 
computer files using the sequence assembler/editor program ZALIGN ( 
Boyd, A. C., pers. comm.). Each sequence was entered twice into two 
independent files, then those files cross-compared to eliminate 
"input-errors”. Finally, each computer file was double-checked against 
a final proof-reading of the autoradiograms. The derivation of the 
XerA sequence is shown in tabular form ( including the database file 
names; Table 6.1). The complete 926bp annotated sequence ( including 
the intact AccI site not available from mCS320) is presented in figure 
6.6.
6.2.2 DETERMINATION OF THE xerA3::Tn5 BOUNDARY SEQUENCE
The sequences of the right- and left-hand boundaries between the 
Tn5 element and the xerA gene were sequenced in clones mCS305 and 
mCS301 A213 respectively. The boundaries were identified by aligning 
the sequences to the outside ends of IS50R and IS50L ( Krebs & 
Reznikoff, 19 8 6; Fig. 6.7). Note that transposition of Tn5 creates a 
9bp "Target duplication” at the site of insertion; that is to say that 
9bp of target DNA are replicated during insertion of the element such 
that the replicated copies flank the transposon in direct repeat (
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Table 6.1 XERA112 Sequence Derivation
Plus Strand
Clone
mCS304
mCS305
mCS301A213
tt 49
It 48
tt 47
ft 86
tl 82
Minus Strand
Clone
mCS320 
raCS320A22 
n 21
it  2 5
ft 2|H
File-Name
XerA112 
Co-ordinates
Length of 
Sub-sequence Gel(s)
*C.MCS304 
*C.MCS305 
*C.MCS301213 
ft 4 9
" 48
" 47
" 86 
" 82
1-319
198-319
292-409
322-558
484-621
592-828
695-827
807-943
319
121
117
237
138
237
133
137
4,12
7
6
5,4
5
5
2
2
XerA112 Length of
File-Name Co-ordinates Sub-sequence Gel(s)
*C.MCS320 926-671 255 7,10
*C.MCS32022 750-425 305 8,9
" 21 619-221 398 8,9
" 25 558-208 350 8,9
" 44 280-1 280 10,11
Figure 6.6 Annotated XERA112 Sequence
P1
sPhI -35 A-box
> GCATGCCGTGACGCAGGCATGTTTCTCAATAACGAAATTTGATAAAATCCCGCTCTTTCA
< CGTACGGCACTGCGTCCGTACAAAGAGTTATTGCTTTAAACTATTTTAGGGCGAGAAAGT
10 20 30 40 50 60
r) . C bOX
-10 B-box -35 p2 d D
> taacattatttcagcc^tcttcIgggctgactgttocataaaaattcatctgtatgcac
< ATTGTAATAAAGTCGGAAGAAGTCCCGACTGACAAACGTATTTTTAAGTAGACATACGTG■
70 80 90 100 110 120
X e rA
MetArgSerSerAlaLysGlnGluGlu
> AATAATGTTGTATCAACCACCATATCGGGTGACTTATGCGAAGCTCGGCTAAGCAAGAAG
< TTATTACAACATAGTTGGTGGTATAGCCCACTGAATACGCTTCGAGCCGATTCGTTCTTC
130 140 150 160 170 180
LeuValLysAlaPheLysAlaLeuLeuLysGluGluLysPheSerSerGlnGlyGluIle
> AACTAGTTAAAGCATTTAAAGCATTACTTAAAGAAGAGAAATTTAGCTCCCAGGGCGAAA
< TTGATCAATTTCGTAAATTTCGTAATGAATTTCTTCTCTTTAAATCGAGGGTCCCGCTTT
190 200 210 220 230 240
ValAlaAlaLeuGlnGluGlnGlyPheAspAsnlleAsnGlnSerLysValSerArgMet
> TCGTCGCCGCGTTGCAGGAGCAAGGCTTTGACAATATTAATCAGTCTAAAGTCTCGCGGA
< AGCAGCGGCGCAACGTCCTCGTTCCGAAACTGTTATAATTAGTCAGATTTCAGAGCGCCT
250 260 270 280 290 300
LeuThrLysPheGlyAlaValArgThrArgAsnAlaLysMetGluMetYalTyrCysLeu
> TGTTGACCAAGTTTGGTGCTGTACGTACACGCAATGCCAAAATGGAAATGGTTTACTGCC
< ACAACTGGTTCAAACCACGACATGCATGTGCGTTACGGTTTTACCTTTACCAAATGACGG
310 320 330 340 350 360
ProAlaGluLeuGlyValProThrThrSerSerProLeuLysAsnLeuValLeuAspIle
> TGCCAGCTGAACTGGGTGTACCAACCACCTCCAGTCCATTGAAGAATCTGGTGCTGGATA
< ACGGTCGACTTGACCCACATGGTTGGTGGAGGTCAGGTAACTTCTTAGACCACGACCTAT
370 380 390 400 410 420
AspTyrAsnAspAlaValValVallleHisThrSerProGlyAlaAlaGlnLeuIleAla
> TCGACTACAACGATGCAGTTGTCGTGATTCATACCAGCCCTGG.CGCGGCGCAGTTAATTG
< AGCTGATGTTGCTACGTCAACAGCACTAAGTATGGTCGGGACCGCGCCGCGTCAATTAAC
430 440 450 460 470 480
Fig. 6.6 cont.
ArgLeuLeuAspSerLeuGlyLysAlaGluGlylleLeuGlyThrlleAlaGlyAspAsp
> CTCGCCTGCTGGACTCACTGGGCAAAGCAGAAGGTATTCTGGGCACCATCGCTGGCGATG
< GAGCGGACGACCTGAGTGACCCGTTTCGTCTTCCATAAGACCCGTGGTAGCGACCGCTAC
490 500 510 520 530 540
ThrllePheThrThrProAlaAsnGlyPheThrValLysAspLeuTyrGluAlalleLeu
> ACACCATCTTTACCACCCCTGCTAACGGTTTCACAGTCAAAGACCTGTACGAAGCGATTT
< TGTGGTAGAAATGGTGGGGACGATTGCCAAAGTGTCAGTTTCTGGACATGCTTCGCTAAA
550 560 570 580 590 600
GluLeuPheAspGlnGluLeu*** ^
> TAGAGCTGTTCGACCAGGAGCTTTAATCTCTGCCCCGTCGTTTCTGACGGCGGGGAAAAT
< ATCTCGACAAGCTGGTCCTCGAAATTAGAGACGGGGCAGCAAAGACTGCCGCCCCTTTTA
610 620 630 640 650 660
> GTTGCTTATCCCTCTCAACCCCCTGCTTTCCCCTGCGATTAATTTAACGAATAGTGCGTT
< CAACGAATAGGGAGAGTTGGGGGACGAAAGGGGACGCTAATTAAATTGCTTATCACGCAA
670 680 690 700 710 720
> TTACTGCGACATGTCATTCACACAATGAATACATAAGGTAAAAAAAGCACATTATGCAAA
< AATGACGCTGTACAGTAAGTGTGTTACTTATGTATTCCATTTTTTTCGTGTAATACGTTT
730 740 750 760 770 780
> ATTCATTATCTAATTGAAAAAACTAGAATTAACGATAAATAACCGTATTTTTAATTCTTT
< TAAGTAATAGATTAACTTTTTTGATCTTAATTGCTATTTATTGGCATAAAAATTAAGAAA
790 800 810 820 830 840
> TTTGTTATTAAAATTCACATTTTTAACACTTAGTATCAACTGAAACAGTTAGCGCGGTAT
< AAACAATAATTTTAAGTGTAAAAATTGTGAATCATAGTTGACTTTGTCAATCGCGCCATA
850 860 870 880 890 900
AccI
> TAATTAGCTCAATAATTAGTGTATAC 
< ATTAATCGAGTTATTAATCACATATG 
910 920 926
a).
Tn5REV
mCS305
1 10 20 30 
CTGACTCTTATACACAAGTAGCGTCCTGAA
11. i!.;11! > I j I! 111! I! < I!I j! j!!
AGTCTCGCGGATGTTGACCAAGTTTGGTGCCTGACTCTTATACACAAGTAGCGTCCTGAA 
290 300 310 319 3’
b).
30 20 10 1 
Tn5 : TTCAGGACGCTACTTGTGTATAAGAGTCAG
i i i i i i i 1 1 i i i i  1 1 1 1 i i  11 i i ii i i 11 i
i i i i i i i i i i i i m i i i i i  i i i i i i i i i i i
mCS301 A213 : TTCAGGACGCTACTTGTGTATAAGAGTCAGGTTTGGTGCTGTACGTACACGCAATGCCAA 
5’ 311 320 330 340
Figure 6.7 Alignment of Tn5 Ends With the mCS305 and mCS301A213
Sequences
The top strand numbering refers to the Tn5 sequences, 
where 'oase-pair 1 corresponds to the first base of the transposon. The 
bottom strand numbering refers to the XERA112 sequence co-ordinates as 
shown if figure 6.6. The 9 base-pair duplication is highlighted in 
bold-type. Note that in the case of rnCS305 a total of 66bp of Tn5 
sequence was determined, whereas in mCS30lA213 208bp of the inserted 
transposon sequence was determined. The derived Tn5 sequence was found 
to be identical to that published by Xrebs &. Reznikoff ( 1986).
Schaller, 1978). In this case the duplicated sequence is clearly 5’- 
GTTTGGTGC-3’, corresponding to base pairs 311-319 in Fig. 6.6. When 
one excises the Tn5 sequence, "in coraputero", by splicing the two 
direct repeats such that only one copy remains, then the xerA3 derived 
sequence is the perfect complement of that derived from mCS320.
6.3 DNA SEQUENCE ANALYSIS
An astonishing wealth of DNA sequence information has been 
generated in recent years, the availability of which has allowed 
sequence comparisons of regions of DNA with known biological 
functions, e.g. protein coding sequences (PCSs), promoters, ribosome 
binding sites etc.. Comparative studies of this sort have uncovered 
"consensus sequences” and other sequence "motifs” correlated with 
genes as a whole, and with specific associated functions. Armed with 
information of this nature one can then analyse novel sequence data 
and distinguish probable protein coding genes from intergenic non­
coding DNA. The features associated with coli genes upon which I 
shall focus are;
SEQUENCE MOTIF PROGRAM
1. Open Reading Frames (ORFs). HYPOTHETICAL
2. Gene Content:
a. Periodicity in base composition ZFICK -
b. Codon bias CODONPREFERENCE
3. Transcriptional initiation sites. ZPROM
4. Translational initiation sites. ZPERTRON
5. Transcriptional termination sites. TERMINATOR
Before proceeding with a discussion of computer assisted sequence 
analysis it is pertinent to define the terms "Window" and "Weight 
Matrix". A "Window" is a fixed length of sequence, e.g. 200bp, within 
which a statistical calculation is performed. The window is then 
shifted along the sequence by some small increment, e.g. 3bp, after 
which the calculation is repeated, re-considering the bulk of the 
previous window in the light of the new increment. Clearly this 
approach has powerful applications in the identification of 
statistical trends within a sequence.
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A "Weight matrix" is employed when one is searching for a sequence 
which is similar to a given consensus sequence. The consensus sequence 
is, by definition, derived from a number of similar sequences, and 
therefore is not in itself a useful comparative tool since it gives no 
appreciation of the relative importance of each residue within the 
sequence; however, a weight matrix can offer such discrimination. The 
typical matrix is a 2-dimensional array of values and sequence, with a 
column number equal to the consensus sequence length, and a row number 
equal to the number of possible residues to be found in the sequence ( 
e.g. 4 rows in DNA weight matrices). The "weighted" matrix is then 
constructed empirically by scoring the frequencies with which any 
given residue occurs at each position within the sequence. In general, 
programs employing such matrices compare a sequence window against the 
matrix, calculate a score for each window, then print out those scores 
above a user defined threshold. Obviously the reliability of the 
weight matrix, plus the definition of a realistic threshold value are 
the keynotes to this type of analysis.
6.3.2 OPEN READING FRAMES
An open reading frame (ORF) is classically defined as the series 
of "sense" codons between two in-frame "non-sense" codons (i.e. UAA, 
UGA, or UAG). However, only those ORFs which include an in-frame 
initiation ( or "start") codon may be considered as potential protein- 
coding genes. The AUG start codon initiates translation in 91$ of 300 
characterised EL_ coli proteins, whereas GUG initiates in 8$ of cases; 
Two natural JEU. coli proteins are initiated by the UUG codon, whereas 
there is a single example of AUU initiation ( Gold jet al, 1984; 
Stormo, 1986). The identification of potential Protein Coding 
Sequences (PCSs) by the identification of ORFs has been further 
complicated by studies on the EL coli rf2 gene, whose protein product 
(Release Factor 2), is only expressed when the translating ribosome 
commits a frame-shifting "error" ( Craigen & Caskey, 1986).
The program HYPOTHETICAL displays ORFs in a schematic fashion 
illustrating all "hypothetical" genes which are initiated by either an 
AUG or GUG codon and which extend beyond a defined minimum length: a
minimum "Gene" length of 50 codons was chosen on the grounds that most 
E. coli protein-coding genes are longer than 50 codons, whilst most 
fortuitous ORFs are less than 50. A total of four potential genes were 
identified in this way, of which only three are wholly contained 
within XERA112, the fourth spanning the SphI site ( Fig. 6.8). Of the
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1 116 232 347 463 579 695 810 926
 !-------- !--------!--------!--------!--------!--------!------- !
ORFD
ORFA
+ >
ORFB
<----------------- h
ORFC
<-------------- h
START PREDICTED
ORF CODON CO-ORDINATES STRAND CODONS MOLECULAR WEIGHT (KDa)
A AUG 156-623 + 156 17.3
B AUG 452-207 - 82 9.0
C GUG 498-289 - 70 7.7
D - *-169 + 56*
Figure 6.8 HYPOTHETICAL genes identified in the XERA112 sequence.
three intact ORFs ( A, B, and C), all three would be disrupted by the 
Tn5 insertion in xerA3 ( 310bp). It is important to note that minicell 
analyses have demonstrated that the plasmid pGS38 encodes an insert 
specific polypeptide of apparent molecular weight equal to l6.5KDa ( 
Stewart, 1 986); from figure 6.8 it is evident that only ORF-A could 
encode such a polypeptide, the predicted molecular weight being 
17.2KDa. It therefore seems highly probable that ORF-A represents a 
genuine PCS ( PCS-A) which is expressed in vivo, since this gene is 
disrupted in the xerA3 mutant then it represents a very strong 
candidate for the xerA gene itself. Having identified several ORFs in 
the XERA112 sequence I attempted to distinguish bona fide PCSs, 
including PCS-A, from fortuitous ORFs using the computer programs 
ZFICK and CODONPREFERENCE.
6.3.3 ZFICK ANALYSIS
An objective statistical analysis of coding and non-coding DMA 
sequence has revealed that the base usage pattern of coding sequence 
has a characteristic periodicity, arising as a consequence of the fact 
that any given base ( i.e A, C, G, or T) is most often found in the 
same codon position ( i.e. 1s ,^ 2nc*, or 3rc*)j there is no such period­
icity in non-coding sequence ( Fickett, 1982). The TESTCODE algorithm 
statistically assesses periodicity within a 200bp sequence window, a 
"Testcode Indicator" ( T.I.) value is then assigned to the window 
centrepoint, then the calculation window is shifted by 3 bp. The T.I. 
value gives a measure of periodicity within the sequence, from which 
its "Probability of coding" may be inferred. The threshold values 
listed below were determined empirically by comparing the T.I. values 
of coding and non-coding sequences. Using these thresholds TESTCODE 
was applied to independent test data, and found to make erroneous 
"Coding" predictions in only 3% of all 200bp windows tested. Erroneous 
"Non-coding" predictions were 6$, whilst "No Opinion" was expressed 
for 18$ of coding sequences ( Fickett, 1982).
T.I. VALUE PROBABILITY OF CODING PREDICTION
< 0.74 < 0.29 Non-Coding
0.74 - 0.95 0.40 - 0.77 No Opinion
> 0.95 > 0.92 Coding
The program ZFICK uses the TESTCODE algorithm and plots the T.I. 
values graphically ( Boyd. A.C., pers. comm.). ZFICK analyses of the
TESTCODE. (+) STRAND
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Figure 6.9 ZFICK Analysis of the XERA112 Plus Strand
Below the TESTCODE output there is diagrammatic 
representation of the three reading frames running from left to right. 
Code: HZ = ATG codon; _j_ = GTG codon; HZ = Non-sense codon.
TESTCODE. (-) STRAND
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Figure 6.10 ZFICK Analysis of the XERA112 Minus Strand
Note that the reading frames on the Minus strand output 
run from right to left.
XERA112 plus strand sequence t rig. o.y;, reveais consiaerauie 
correspondence between PCS-A and a region of predicted coding 
sequence. It should be noted that a "tailing-off" towards the end of a 
PCS is expected due to the randomising affect of adjacent non-coding 
sequence as the analysis window spans the PCS boundaries. With this in 
mind it should be obvious that a small PCS is likely to yield a 
relatively poor TESTCODE ( this is-true for the 189t>p ColE1 rom gene; 
data not shown). Since TESTCODE is detecting a periodic signature 
within a sequence, then the two complementary DNA strands are expected 
to yield very similar ZFICK plots as can be seen by comparing Figs.
6.9 and 6.10. This reflects a major limitation of ZFICK, this being 
that whilst it can identify a coding region, it does not differentiate 
between frames v/ithin that region. Therefore, whilst ZFICK supports 
PCS-A, we must also consider ORFs B and C as potential genes. One way 
to statistically compare the contents of each frame independently is 
to examine the codon bias, this was done using the CODONPREFERENCE 
program.
6-3-ft CODONPREFERENCE ANALYSIS
Due to the degeneracy of the genetic code, most amino acids are 
specified by more than one codon ( synonomous codons). The analysis of 
codon usage patterns within known PCSs has revealed that synonomous 
codons are not used at equal frequencies, their relative frequencies 
being dependent on both the gene and the organism. In E*. coli the 
observed codon bias strongly correlates with the relative abundance of 
the cognisant tRNAs ( Ikemura, 1981a; 1982). Highly expressed E. coli 
genes ( e.g. for the ribosomal protein RpoC, or outer membrane protein 
OmpA) almost exclusively use those codons which are recognised by the 
most abundant tRNAs; a phenomenon believed to reflect their 
requirement for efficient translation ( Post jet a_l, 1979; Post & 
Nomura, 1980; Ikemura, 1981b; Grosjean & Fiers, 1982). On the other 
hand, genes whose protein products are expressed at low levels (e.g. 
Lac repressor, or DnaG), tend to use synonomous codons in rough 
proportion to the abundance of the corresponding tRNA, thus resulting 
in a smaller codon preference ( Grantham et al, 1980). In striking 
contrast, non-coding regions of coli DNA exhibit no pronounced 
preference for any tri-nucleotide sequences ( Gribskov et al, 1984). 
The CODONPREFERENCE program determines a "Codonpreference statistic" 
(CPS) for windows of 25 codons and in all three reading frames. The CP 
statistic is based on the lik&iirhood that any given codon will be
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found in either coding or non-coding sequence, as defined by an 
empirically determined "Codon frequency table" ( C-ribskov et al. 1984; 
Grantham et .al, 1981). In practice the CODONPREFERENCE algorithm 
performs weli in the detection of genes which are either highly or 
moderately expressed ( producing a CPS of between 1.0 - 2.0), but less 
well against poorly expressed genes ( e.g. dnaG scores a CPS of 
between 0.5 - 1.0). The average CPS expected from random sequence is
0.45, but this varies with base composition. The program plots the CPS 
value against the sequence for all three frames in the strand under 
analysis; superimposed upon each plot are all those ORFs identified by 
HYPOTHETICAL as potential genes. Reading frames in both the plus and 
minus strand outputs run from left to right, thus the minus strand 
numbering does not directly compare to the plus strand. In addition 
the plots include the positions of all "rare" codons ( i.e. those 
whose usage represents 5% or less of the usage of synonomous codons), 
it has been noted that there is paucity of rare codons in most genes ( 
noticeable even in weakly expressed ones), whereas they are common in 
non-coding sequence ( Gribskov et al, 1984).
CODONPREFERENCE plots of the XERA112 sequence are presented in 
Figs. 6.11 and 6.12. From consideration of both plots it is clear that 
PCS-A exhibits considerable codon bias, although it is interesting to 
note that a shorter ORF, ORF-A*, would exhibit a higher mean CPS than 
does PCS-A. However ORF-A* would only encode a polypeptide of 
approximately 12KDa, much smaller than that observed in mini-cells. 
Therefore one is forced to conclude that the N-terminal 1/3rd of PCS-A 
has a more restricted codon choice than does the remainder of the
coding sequence, this might reflect other selection pressures exerted
ft
on this part of the sequence e.g. the need to maitain a specific 
nucleotide sequence in this region. Alternatively, the poor codon 
usage might serve to limit the rate of translation of PCS-A. Open 
reading frame D exhibits a CPS value typical of random sequence, and 
on this basis is unlikely to represent a protein coding gene. On the 
other hand ORFs B and C coincide with regions of above average codon 
preference; it should be noted however, that both of these ORFs are 
wholly internal to PCS-A and that 0RF-B is "in-phase" with PCS-A ( Two 
reading frames may be described as in-phase when they are encoded on 
opposite strands by the same codon triplets). Furthermore the codon 
preference plot for PCS-A and 0RF-B are in fact mirror images of one 
another ( Figs. 6.11, 6.12). The phenomenon of bias codon usage on one 
strand being mirrored in-phase on the complementary strand has been
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Steinberger, 1984). The expla. nation for this appears to lie in the 
’choice" of codons which JLs. coli prefers. Of the 22 preferred codons ( 
de Boer, 1986), 10 can be split into two groups of complementary 
pairs, the consequence of which being that when one of these 10 codons 
appears on one DNA strand, its compleraetary preferred codon appears in 
phase on the other strand: e.g.
Lys 
51 CUG 3’
3T GAC 5’
Gin
The evolution of a preference for complementary codons is apparent, 
and yet the selection pressure for this is less so; it might reflect 
an exploitation of certain "optimal" codon-anticodon interaction 
energies ( Grosjean & Fiers, 1982), or alternatively it might be a 
consequence of a requirement to optimise double stranded coding 
capacity. Therefore, whilst this analysis clearly supports the 
contention that ORF-A corresponds to a protein coding sequence, ORFs 
B, and C are less readily assigned; they both exhibit poorer codon 
bias than PCS-A, but this might simply reflect their relative levels 
of expression.
6.3.5 TRANSLATIONAL INITIATION SITES: ZPERTRON ANALYSIS
An initiation codon (i.e. AUG, GUG, or more rarely UUG or AUU), 
is not in itself sufficient to promote efficient initiation of 
translation, thus inferring that additional sequence(s) are required. 
However a consensus sequence for translational initiation sites ( 
often called "Ribosome binding sites" (RBSs)), has remained elusive, 
with only the central "U" of the initiation codon being absolutely 
conserved in all known translational starts ( Stormo jet al, 1982). One 
relatively common feature of ribosome binding sites is the presence of 
a short region of three or more purine nucleotides, located 51 to the 
start codon, which is complementary to part of the 3T terminus of the 
E. coli 16S RNA ( Shine & Dalgarno, 1974; 1 975; Godson et al. 1 978). 
The 16S RNA forms part of the 30S ribosomal subunit which interacts 
with mRNA in concert with ribosomally associated proteins and 
initiation factors. Therefore Shine and Dalgarno postulated that the 
complementarity between 16S RNA and the so-called "Shine and
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Dalgarno” ( S.D.) sequence on the mRNA might trigger translational 
initiation at the nearby start codon; there is now a considerable body 
of evidence to support this hypothesis ( for review see Stormo, 1986). 
However whilst a S.D. sequence can promote the initiation of 
translation it is not a pre-requisite, since a number of genes lack an 
S.D.-like sequence and yet are efficiently translated, e.g. phage fd 
genes VII and IX, and the Lambda cl. gene. Furthermore, sequences 31 to 
the start codon have also been demonstrated to influence the 
efficiency with which translation is initiated ( Looman et. al, 1987).
Since so little is known about the sequence requirements of 
ribosome binding sites, a user defined weight matrix would be unlikely 
to prove succesful in identifying such sites in novel sequence, thus 
the powerful ’’perceptron” algorithm, with its inherent ’’learning” 
capabilities was applied. This algorithm was "introduced” to 124 known 
starts in an E. coli mRNA library, which it then scrutinised auto­
matically searching for recurrent sequence patterns, thus constructing 
its own weight matrix. The optimal matrix was found to be W101, 
comprising 101 nucleotides of sequence stretching from -60 to +40 
relative to the start codon. As with all matrix analyses, a 
significance level must be set such that a minimum number of spurious 
results are obtained; using W101 Stormo et. .al ( 1982) found that 124 
real gene starts within a 78,000 nucleotide library all scored above 
+2, whilst all other sequences scored less than +1. The ZPERTR0N 
program was employed to search for start sites using the U101 weight 
matrix ( Boyd, A. C., pers. comm.), both strands of XerA112 were 
analysed and those sites which scored above -100, and which would 
initiate translation of a sequence at least 20 codons in length, are 
listed in table 6.2. Only two sites returned perceptron ratings of >2, 
those being the PCSA start ( b.p 156) and an AUG codon at position 659 
on the plus strand; this latter start would initiate a 29 amino-acid 
polypeptide ( 3.2 KDa). On the minus strand the AUG start of ORF-B 
scored -35, whilst that of ORF-C went undetected. From this we can 
conclude that the AUG start of PGSA is situated within a sequence 
context similar to those of 124 known translational starts, therefore 
one would predict that it is likely to act as an initiation site for 
the translation of PCSA in vivo.
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Table 6.2 ZPERTRCH Analysis of XERA112
Plus Strand
Start 5*  CONTEXT — - 3’
coord.
156 CGGGTGACTT ATG CGA ... CTT TAA
659 GGCGGGGAAA ATG TTG ... CAA TGA
115 ATTCATCTGT ATG CAC ... AAC TAG
342 CAATGCCAAA ATG GAA ... CTT TAA
Minus Strand
Start 5f   CONTEXT  3f
coord.
452 CAGGGCTGGT ATG AAT ... AAG TAA
574 GTCTTTGACT GTG AAA ... GTA TGA
Stop Length Est. MW PERCEPTRON
coord, (codons) (kDa) rating
626 156 17.2K 48
748 29 3.2K 46
186 23 2.5K -87
626 94 10.3K -95
Stop Length Est. MW PERCEPTRON
coord, (codons) (kDa) rating
204 82 9.OK -35
449 41 4.5K -67
6.3.6 TRANSCRIPTIONAL INITIATION SITES: ZPROM ANALYSIS
Escherichia coli transcriptional initiation sites ( Promoters), 
have been highly characterised at the DMA sequence level; comparisons 
made between 112 known promoters has produced a ’’Promoter consensus 
sequence” comprising two relatively well conserved 6bp sequences, the 
so-called ”-35" and ”-10" regions, separated by an optimal distance of 
16-I8bp ( Hawley and McClure, 1983):
”-35” "-10"
TTGACA- 16-I8bp -TATAAT
Direct analysis of 16 mutations in the lac promoter region suggests 
that promoter "Up mutations" tend to increase similarity to the 
consensus sequence, whereas "Down mutations" reduce it ( Bujard, 1980; 
Reznikoff, 1 -984). Two weight matrices were composed by comparing 100 
known promoters and determining the frequency with which any given 
base appears at each of the 6 positions within the -35 and -10 regions 
respectively. The program ZPROM then searches for promoters by scoring 
for two statistical parameters; "Statistic I" scores for the degree of 
similarity to the -35 and -10 regions by using the weight matrices, 
then "Statistic II" incorporates an adjustment designed to provide a 
measure of the distance between the promoter homologies ( the spacing 
in known E. coli promoters varies from between 15~19bp and this has 
been suggested to be important for recognition by RNA polymerase ( 
Stefano & Grallan, 1982)). Therefore statistic II is more stringent in 
identifying promoter-like sequences. Using a control array of 
promoters, the significance levels of Stat' I >0.002 and Stat1 II 
>0.0002 were found to identify all real promoters with a minimum 
number of false positives ( Harr et al, 1983). ZPROM analysis was 
performed on both strands of XERA112 and the results printed for all 
those sequences which scored above threshold for at least one 
statistic ( Table 6.3). A score of 1 in both columns would be obtained 
by the "perfect" consensus sequence TTGACA-17-TATAAT. A total of 16 
potential promoters were found on the plus strand, with a further 10 
present on the minus strand. The best match by far is that starting at 
co-ordinate 39 on the plus strand (promoter P1), the position of P1 
would enable it to drive transcription of PCSA; a second candidate for 
a weaker PCSA promoter ( P2) is located at co-ordinate 95. The XERA112 
sequence is unusually rich in promoter-like sequences with a total of 
26 scoring sites in 926bp, compared with for example a total of 16 in
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Table 6.3 ZPROM Analysis of XERA112
Plus Strand
Pos. -35 -10
Statistic Statistic
I II Distance
21 GTTTCT CAATAACGAAATTTGA TAAAAT. 0.0017265 0.0002590 16
38 TTTGAT AAAATCCCGCTCTTTCA__ TAACAT. 0.0002097 0.0002097 17
39 TTGATA AAATCCCGCTCTTTCA TAACAT. 0.0313752 0.0047063 16
39 TTGATA AAATCCCGCTCTTTCAT__ AACATT. 0.0006129 0.0006129 17
39 TTGATA AAATCCCGCTCTTTCATAA CATTAT. 0.0063827 0.0001277 19
95 TTGCAT AAAAATTCATCTGTATG__ CACAAT. 0.0029424 0.0029424 17
195 TTTAAA GCATTACTTAAAGAAGA__ GAAATT. 0.0013198 0.0013198 17
490 TGGACT CACTGGGCAAAGCAGAAGG TATTCT. 0.0041449 0.0000829 19
599 TTTAGA GCTGTTCGACCAGGAGC__ TTTAAT. 0.0006488 0.0006488 17
720 TTTACT GCGACATGTCATTCA CACAAT. 0.0033957 0.0000679 15
731 ATGTCA TTCACACAATGAATACA__ TAAGGT. 0.0002153 0.0002153 17
782 TTCATT ATCTAATTGAAAAAAC TAGAAT. 0.0084931 0.0012740 16
■=r
oCO TAGAAT TAACGATAAATAACCG TATTTT. 0.0015508 0.0002326 16
826 TATTTT TAATTCTTTTTTGTTAT__ TAAAAT. 0.0002305 0.0002305 17
828 TTTTTA ATTCTTTTTTGTTAT TAAAAT. 0.0048770 0.0000975 15
848 TTAAAA TTCACATTTTTAACACT__ TAGTAT. 0.0008238 0.0008238 17
Minus Strand
Pos. -35 -1 0 II Distance
48 TTGATA CTAAG TG TTAAAAATG T__ GAATTT. 0.0013842 0.0013842 17
114 GTTAAT TCTAGTTTTTTCAATTA__ GATAAT. 0.0005922 0.0005922 17
127 TTTTCA ATTAGATAATGAATTTTG_ CATAAT. 0.0037054 0.0005558 18
128 TTTCAA TTAGATAATGAATTTTG__ CATAAT. 0.0015212 0.0015212 17
129 TTCAAT TAG ATAATGAATTTTG CATAAT. 0.0045043 0.0006756 16
198 TCGCAG TAAAACGCACTATTCGT__ TAAATT. 0.0004638 0.0004638 17
301 TTAAAG CTCCTGGTCGAACAGCTC_ TAAAAT. 0.0019863 0.0002979 18
383 GTGTCA TCGCCAGCGATGGTGCC__ CAGAAT. 0.0013019 0.0013019 17
618 TGGTCA ACATCCGCGAGACTT TAGACT. 0.0023882 0.0000478 15
907 ATGCCT GCGTCACGGCATGCGTA__ TACACT. 0.0005082 0.0005082 17
Note ’’Distance” indicates the number of base pairs between the 
-35 and -10 regions.
5804bp of the lac operon, or 14 in 2676bp of pUC8. This density of 
consensus-like sites would appear to be at least partly due to the 
exceedingly A:T rich nature of the XERA112 sequence from 700-926bp, 
coupled of course with the A:T richness of the consensus sequence 
itself; the XERA112 sequence is 74# A:T between base-pairs 700-926, 
compared with 52# A:T in the remainder of the sequence. A total of 13 
out of the 26 sites scored by ZPROM are situated in this 226bp of 
sequence. Furthermore, of the remaining 13 sites scored, four 
correspond to variants of P1, illustrating the extent of its 
conformity to the consensus sequence. The significance of the A:T 
richness of the region 3* to PCS-A is unclear.
6-R-7 TRANSCRIPTIONAL TERMINATION SITES: TERMINATOR ANALYSIS
Unlike transcriptional promoters, terminators exhibit rather 
diverse sequence characteristics, therefore our ability to predict 
them from sequence data alone is somewhat limited. Of the two major 
classes of terminator, those being factor-dependent and factor- 
independent, only the latter have a discerned sequence motif, that 
being a short palindrome followed by a T rich sequence on the non­
sense strand ( Platt, 1981). Using a similar approach to ZPERTRON, 
Brendel and Trifonov (1984), designed a program ( TERMINATOR) which 
searches for sequences similar to factor-independent terminators. The 
perceptron algorithm was "taught" from only 30 characterised 
termination sites, thus the predictive power of the derived weight 
matrix is limited. The authors found that a P statistic ( scoring for 
primary sequence) of >3.5 was optimal for discriminating real 
terminators from random sequences. The TERMINATOR analysis of XERA112 
identified a total of 9 sites scoring above threshold; 5 on the plus 
strand, and 4 on the minus strand ( Fig. 6.13)• The highest scoring 
site ( terminator T1, at co-ordinate 54) is upstream of PCSA, but 
overlapping with the promoter sequence P1. It is interesting to 
speculate that T1 is unlikely to attenuate transcription from the 
juxtaposed promoter P1, since the predicted P1 transcript will lack 
all, or most, of one arm of the dyad symmetry which defines T1. On the 
other hand T1 might be expected to terminate transcription emanating 
from upstream of P1, such organisation could in principle serve to 
protect downstream genes from expression via any transcription other 
than that initiated at P1. Similar overlapping promoter/terminator 
sequences have been identified in other situations including phage fd 
and phi X174 ( Rosenberg & Court, 1979). I will return to the
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Figure 6.13 TERMINATOR Analysis of XERA112
Plus Strand
-40 -35 -30 -25 -20 -15 -10 -5 -1+ +5 p
• • • • • • • • • • •
54=> TCTTTCATAACATTATTTCAGCCTTCTTCAGGGCTGACTGTTTGCATAAAA 5.14
751=> ACATAAGGTAAAAAAAGCACATTATGCAAAATTCATTATCTAATTGAAAAA 4.03
794=> TTGAAAAAACTAGAATTAACGATAAATAACCGTATTTTTAATTCTTTTTTG 4.42
804=> TAGAATTAACGATAAATAACCGTATTTTTAATTCTTTTTTGTTATTAAAAT 4.70
874=> TATCAACTGAAACAGTTAGCGCGGTATTAATTAGCTCAATAATTAGTGTAT 3.63
Minus Strand
-40 -35 -30 -25 -20 -15 -10 -5 -1+ +5 P
•  # *  •  ♦ •  •  • • • •
74=> TTTTAATAACAAAAAAGAATTAAAAATACGGTTATTTATCGTTAATTCTAG 3.62
83=> CAAAAAAGAATTAAAAATACGGTTATTTATCGTTAATTCTAGTTTTTTCAA 3.71
600=> TACGTACAGCACCAAACTTGGTCAACATCCGCGAGACTTTAGACTGATTAA 4.05
856=> AAATAATGTTATGAAAGAGCGGGATTTTATCAAATTTCGTTATTGAGAAAC 3.58
s
22
12
18
14
0
s
31
26
0
4
Primary structure (p) threshold = 3.50 
Secondary structure (s) threshold = 0
discussion of T1 shortly. This analysis also identified 3 clustered 
terminator-like sequences 3f to PCSA ( at co-ordinates 751 , 794, and 
804), any or all of which might act to terminate transcription running 
through PCSA. However, TERMINATOR failed to identify a very striking 
region of dyad symmetry immediately 3’ to the end of PCSA ( co­
ordinate 631 bp, fig 6.6).
6.3.8 PCS-A CORESPONDS TO THE xerA GENE
In order to formally eliminate ORFs B & C as candidates for the 
xerA gene, the 725bp Sstl/Dral fragment from mCS320 was cloned into 
pUC19 ( Sstl/HincII). thus generating pCS370. Plasmid pCS370 carries 
the XERA112 sequence from 198-923bp and thus includes both the intact 
ORF-B and ORF-C, however it lacks the N-terminal 14 codons of PCS-A. 
pCS370 fails to complement pCS202 resolution in CSX3 ( as defined in a 
gel resolution assay), on which basis it can be said to lack a 
functional xerA gene. Since PCS-A is the only ORF which is both 
disrupted by Tn5 in xerA3 and is truncated in pCS370, then one can 
conclude that it is very likely to represent the xerA gene; from this 
point onward PCS-A will be referred to as the xerA gene.
Sequence analyses have revealed that the xerA gene has all the 
hallmarks commonly associated with E. coli genes: i.e. a promoter, 
ribosome binding site, periodic base usage, biased codon usage, and 
even a number of potential transcriptional terminators downstream of 
the coding sequence. None of the other ORFs exhibit all of these 
features, and none appear to be strong candidates for computer- 
predicted genes; however, such sequence analyses could not, and should 
not, be used to make strong predictions regarding the rnon-expression” 
of any ORF. Therefore I cannot, at this stage, formally preclude the 
possibility that one ( or all) of the smaller ORFs might represent 
additional genes, perhaps expressing Xer-related functions.
6.4 D M  SEQUENCE COMPARISONS
The XERA112 sequence has been screened for any sequence identities 
within either the EMBL or GENBANK databases ( using the rapid-scanning 
VJORDSEARCH program ( Devereux et al, 1 984)), but no matches above 
random background were found. However, more painstaking one-to-one 
sequence comparisons have also been performed using ZDOTMAT, BESTFIT 
and GAP ( Boyd A.C., pers comm.; Devereux .et aJL, 1984), in order to 
pin-point both small regions of high similarity, and also any larger 
regions of only limited sequence similarity. This type of analysis is
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of course limited by the choice of sequences to which one compares 
XERA112 in detail.
6.4.1 COMPARISON TO ColE1: THE PRESENCE OF A CER-LIKE SITE
An obvious comparison to perform was to screen for any 
"homologies" between XERA112 and ColE1; this uncovered a short region 
of XERA112 which exhibits significant similarity to part of the cer 
locus. The optimal alignment includes 6lbp of XERA112 ( 304-364bp) and 
a 61 bp portion of cer which, with the insertion of two single basepair 
gaps into each sequence, results in a total of 40 out of 61 matches ( 
66$; See Fig. 6.14). The most striking feature of this alignment is 
that the 61 bp portion of cer sequence in question encompasses the 34bp 
region known to contain the cross-over site ( Summers ejb aJL, 1985). 
Recall that over the 34bp cross-over region one can align the sites 
from ColE1, pMB1, ColK, ColA, and CloDF13 such that 28 residues are 
perfectly "conserved" amongst all five sites; If one compares the xerA 
sequence to this "consensus" then I6? out of these 28 residues are 
found to be present ( Fig 6.14). This obviously raised the possibility 
that the "homologous" site found in the xerA gene might also act as a 
substrate for Xer dependent site-specific recombination. In order to 
test for intramolecular recombination at the "XerA-site" ( xas) of a 
type similar to that observed at cer. I constructed two pairs of test 
plasmids: the first carrying two copies of the XerA-site in either 
direct or inverted orientation ( pCS368 and pCS367 respectively, Fig 
6.15), the second pair of plasmids carrying a single XerA-site plus a 
cer site again in either direct or indirect relative orientation ( 
PCS361 and pCS360 respectively, Fig. 6.16). On the assumption that any 
Xer dependent recombination at xas would also be dependent on XerB, 
the plasmids described above were initially propagated in CSX4 ( 
xerB1). Plasmid DNA was recovered and their structures confirmed by 
digestion with EcoRI, Hindlll. AccI and Sphl. The plasmid DNA was then 
transformed into DS902 ( RecA“, Xer+), then individual transformants 
propagated overnight prior to the recovery of plasmid DNA. The 
structure of each plasmid after being passaged through DS902 was then 
compared with the "Parental form" recovered directly from CSX4 to 
ascertain whether or not any XerB-dependent rearrangements had 
occured. The products of any deletion reactions ought to be clearly 
visible as plasmid species of increased electrophoretic mobilities. 
Analysis of plasmid DMA recovered from DS902, revealed the presence of 
a single plasmid species indistinguishable in size from the parental
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Figure 6.15 Construction of pCS367 and pCS368
The 2.9Kb SphI xerA* fragment from pGS30 was cloned into 
the SphI site in pBR322, the resultant plasmids pCS365 and pCS366 
corresponding to the opposite orientations of the inserted fragment. A 
second xerA gene was then added by cloning the 959bp EcoRI/Hindlll 
fragment from mCS320 into the unique EcoRI and Hindlll sites in pCS365 
and pCS366 to generate pCS367 and pCS368 respectively. The structures 
of pCS367 and pCS368 are shown above; copies of the xerA structural 
gene are indicated by arrows, with the approximate co-ordinates of the 
embedded XAS sites clearly labelled. Obviously pCS367 carries two 
copies of XAS in inverted repeat, whilst pCS368 contains two copies in 
direct repeat.
304 364
COLE1 : TGAACGCGTTT-TAGCGGTGOGTACAATTMGGGA— TTATGGTAAATCCACTTACTGTCTGCC 
XERA : ...C.AA GGT..T..A .CGC. .T.CC-AAA. ..- GG-T C...
PMB1
COLK
COLA
CL0DF13
A.ACGTA...TAAT.
 A...CCGG ■
CC.GT..C. .AC.G ■
,CG C...TG...
. CGA.•. •. •. TG. • •..
 AC..A.A.A.GAC.G
 ATCT. CGAGT. TCAGG
FIGURE 6.14 Optimal alignment between the XERA112 sequence ( 304-364bp) and the 
cross-over region of cer. The sequences from pMB1, ColK, Col A, and CloDF13 are 
also presented in the same alignment with ColE1 ,as shown in Fig. 1.2. (.) 
indicates homology to ColE1; (-) indicates a gap inserted to maximise homology.
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Figure 6.16 Construction of pCS360 and pCS36l
The 959bp XerA+ EcoRI/Hindlll fragment from. mCS320 was 
cloned into the polylinker of pKS^51 and pKS450 to generate pCS360 and 
PCS361 respectively. The plasmids pKS451 and pKS^50 were constructed 
by cloning the 377bp Cer+ Hpall fragment from ColEI into the Narl site 
of pUC9; the two derivatives corresponding to opposite orientations of 
the inserted cer fragment ( D.K. Summers, pers. comm.). The 
orientation of cer fragment in pCS360 is given by an arrow as before. 
The co-ordinates of the BamHI and Hindlll sites are given, as are the 
approximate co-ordinates of the cer cross-over region ( 823bp) and the 
XAS region ( 17^7bp). Obviously pCS36l is identical to pCS360 except 
for the orientation of the cer fragment which thus places the cer 
cross-over region at approximately 708bp. The cer and XAS regions are 
in inverted repeat in pCS360, and in direct repeat in pCS36l.
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Table 6.4 Restriction predictions for various XAS-speeifie inversion 
products.
Plasmid Enzyme(s)
Predicted Restriction pattern ( Kb)
Parental plasmid Inversion product
PCS360
PCS361
BamHI/Hindlll 
n n
3.1, 0.95
3.1, 0.95
3.3, 0.7 
3.2, 0.8
PCS267
PCS368
Accl/Hindlll
SphI
2.1, 1.6, 3.1, 1.5 
2.9, 4.8, 0.5
2.1, 1.6, 3.7, 0.9  
7.0, 0.5, 0.7
plasmid as isolated from CSX4; this was true for pCS360, 361, 367, and 
368 ( data not shown). In order to test for cer/xas-specif ic
inversion, each DS902 derived plasmid prep’ was digested with suitable 
restriction enzymes, then its restriction profile compared with that 
of the parental construct. Table 6.4 lists the predicted restriction 
profiles for each of the four test plasmids, plus those of each 
putative cer/xas-specific inversion product. The plasmid restriction 
digests in question were electrophoresed through either agarose or 
poly-acrylamide gels as appropriate, whereupon EtBr stained bands were 
visualised under U.V.. In no case were there any bands detected other 
than those predicted for the parental form of each plasmid ( data not 
shown). There is therefore no evidence for any intra-molecular 
recombination between either two copies of the xas locus, or between 
xas and cer. However, rare recombination events might not have been 
detected in the assay system employed.
6.4.2 IHF BINDING SITE
E. coli IHF is a heterodimeric DNA binding protein which has 
been implicated in an apparently diverse range of processes including; 
enhancing site specific recombination, conjugal DNA transfer, and the 
regulation of gene expression ( see Introduction). One region of 
XerA112 (26l-273bp), exhibits strong "homology" ( 8 out of 9 bp) to 
the consensus IHF binding site T/CAANNNNTTGATA/T ( Leong et al. 1985).
IHF Consensus Sequence T/CAANNNNTTGATA/T 
XerA112 26l-273bp CAANNNNTTGAcA
It is particularly intriguing that such a close match to the IHF
binding site should occur within 30bp of the so-called XerA-site (
302-364), representing a similar spatial arrangement to that found 
between the lambda attP site and its proximal IHF binding sites H2 and 
H* ( Weisberg & Landy, 1983).
6.4.^ A nut-LIKE SITE 5' TO THE xerA CODING SEQUENCE
A somewhat surprising finding was that of the presence of a 
Lambda nut-like site between the -35 region of promoter P1, and the 
start of the xerA structural gene. The lambda nut sites ( nutL and 
nutR), are of course locations at which the lambda anti-termination 
protein, N, plus certain host factors, including NusA, become 
associated with transcribing RNA polymerase (RNAP), and in doing so
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render it resistant to downstream termination sites ( Friedman & 
Gottesman, 1983). This phenomenon is crucial to the lambda life-cycle 
since it delays the expression of certain phage genes situated beyond 
termination sites, until after sufficient lambda N protein has been 
synthesised to overcome those terminators. A number of phage nut-like 
sites have been identified in various bacteriophages including Lambda, 
P21 and P22, where in each case the sites can be aligned by virtue of 
three sequence motifs, namely the A-box, B-box, and C-box:
1. The consensus A-box is common to all locations at which the E. coli 
NusA factor is known to act; it is therefore believed to represent 
the NusA recognition sequence. However, recent evidence has 
demonstrated that the A-box can be deleted from one such location 
without affecting the capacity for NusA interaction ( Zuber et. al. 
1987).
2. The B-box is a region of hyphenated dyad symmetry whose sequence is 
variable; this sequence is apparently recognised specifically by 
the appropriate anti-termination protein, e.g. Lambda N recognises 
lambda nut, whilst lambda Q recognises lambda out etc..
3. The so-called C-box is highly conserved amongst all known nut-like 
sites, with the sole exception of lambda out. This sequence 
conservation infers a functional role for the C-box but this 
role remains to be uncovered.
Candidate A-, B-, and C- boxes are present in the XERA112 sequence 
which compare very well with the lambda nut sites ; it is particularly 
striking to note that the xerA B-box is in fact an almost perfect 
inverse of nutL B-box with a total of 14 out of 15 matching bases ( 
Fig. 6.18). Interestingly, the XERA112 B-box region is the same as 
that identified as the potential transcriptional terminator, T1 ( 
section 6.3.7)* Significantly, many EL. coli terminators are preceeded 
by a NusA box including those of the crp and trp operons, plus the 
attenuators of the his, trp. and ampC operons etc. ( Friedman and 
Gottesman, 1983). The NusA boxes from a number of such loci, plus 
those from phage nut-like sites, all appear to fit the consensus 
sequence T/CGCTCTT(T)A, to which the XER112 A-box conforms very well:
Consensus A-box T/CGCTCTTTA
XERA112 A-box CGCTCTTTc
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A-box B-box
nutL : ATGAAGGTGACGCTCTTAA AAATT AAGCCCTGAAGAAGGGCAGCATTCAAAGC
t I I I I I I I I I III I I I I I I I I I I I I I I I I II II I
I I I I I I I I I I III I I I I I I I I I I I I I I I I II II I
nutR : TAAATAACCCCGCTCTTAC ACATTC CAGCCCTGAAAAAGGGCATCAAATTAAAC
i i i i  i t i i i i i i i i i i I i i m i  m i  i i i t i i i
i i i i  i i i i i i i i i  i i i i  i i i i i i i i i i i i i i t
xerA : GATAAAATCCCGCTCTTTCATAACATTATTTCAG-CCTTCTTCAGGGCTGACTGTTTGCA
41 -------  -------
C-box
nutL : AGAAGGCTTTGGGGTGTGTGATACGAAACGAAGCATTGGC
i i i i i i i i i i it ii i i i i i i i i i i i  i
nutR : CACACCTAT GGTGTATGCATTTATTTGCATACATTCA
i i  i i i i i i i i i ii
i i  i i i i i i i i i it
xerA : TAAAAATTCATC— TGTATGCACAATAATGTTGTATCAAC
137
Figure 6,18 Comparison Between XERA112 and Phage Lambda nut Sites
The numbers refer to the XERA112 co-ordinates. Regions of 
hyphenated dyad symmetry representing the B-box are highlighted; 
notice that the sequence corresponding to the loop of the nutL B-box 
(GAAGA) is the inverse of that present in the xerA B-box ( TCTTC ). 
(-) represents an single-base gap inserted to maximise homology.
The role of NusA at terminators appears to be one involving the NusA 
dependent pausing of RNA polymerase, the stalled RNAP:NusA complex is 
then manifestly more susceptible to subsequent interactions with other 
termination factors, including Rho ( Greenblatt et. aJL, 1981). A 
similar NusA-induced pausing may also be essential at nut sites during 
the association of the phage antitermination protein. Whilst the XerA 
T1 site resembles a terminator, the additional presence of a consensus 
C-box provides the signature of an anti-termination locus. Similar 
signatures have been identified in all six of the E*_ coli rrn operons, 
and in the case of rrnG the site has been shown to function as an 
anti-terminator ( Li et al, 1984). If Xvre consider the location of the 
XERA112 site, then it is clear that it overlaps with the two 
previously identified promoter consensus sequences, P1 and P2; thus 
the NusA box would be outwith both the presumptive P1 and P2 
transcripts ( See Fig. 6.6). There is to date no precedent for NusA 
functioning via a recognition box which is outwith a transcript: 
indeed there is some evidence to suggest that NusA actually recognises 
the RNA ( Nakamura, 1 986). Thus any termination or anti-termination 
activity at the XerA site would have to either affect transcription 
initiated upstream of P1, or else involve a novel role for NusA during 
transcriptional initiation; it is interesting to note that NusA has 
been found to compete with the E. coli sigma subunit in binding to 
RNAP in vitro, however there is no evidence for the involvment of 
RNAP:NusA complexes in the initiation of transcription (Greenblatt & 
Li, 1981). If the XerA site has any nut-like function, and acts upon 
transcription emanating from upstream, then it might not affect the 
expression of XerA per se. since the lambda nut sites are not in 
themselves terminators, but simply serve to obviate downstream 
terminators. Whilst there are no obvious terminator-like structures 
within the xerA coding sequence, there are a number of potential 
terminators to its 3f side; however there are no candidate genes, 
within the available sequence, which might require anti-termination 
for their expression. Clearly the transcriptional organisation of the 
xerA locus is worthy of detailed investigation.
6.5 AMINO ACID SEQUENCE COMPARISONS
The xerA gene product is predicted to be a 156 amino acid poly­
peptide with a molecular x^eight of 17.2KDa. The entire primary 
structure of this protein can be inferred from the DNA sequence, and 
x*as presented in figure 6.6: the amino acid composition of XerA
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predicts a hydrophilic protein ( 30$ charged residues), which is 
probably acidic in nature ( containing a ratio of acidicrbasic 
residues equal to 21 :17; Table 6.5). The precise function of the XerA 
protein, with respect to cer-specific recombination is unknown; it may 
be the cer-specific recombinase, but on the other hand, might be 
either an accessory, or regulatory component of the system. In the 
absence of a direct assay for XerA activity, I sought to uncover some 
clues as to the nature of its function by comparing its primary 
structure to those of proteins with characterised biological 
activities. The XerA sequence was screened for similarity to existing 
protein sequences in the MBRF database, however no sequences were 
identified with above random sequence identities. More specifically I 
then scrutinised the XerA sequence for any similarities to the 
conserved sequence motifs identified within functionally related 
protein "families"; for example, there are no matches to the highly 
conserved "nucleotide binding site" motif associated with proteins 
which bind, and in most cases hydrolyse, ATP ( Walker ejt _al, 1982; 
Higgins et al, 1986):
Nucleotide binding site motif: G--- GKT/S
Other obvious motifs to screen for are the highly conserved regions 
found amongst "families" of site-specific recombinases. The resolvases 
from transposons Tn3, Tn21, Tn501, Tn1000, and Tn1721 plus the Hin, 
Gin, Cin, and Pin invertases, are all roughly equivalent in size ( 
approximately 20KDa), and all share several highly conserved regions ( 
Diver _et. al, 1983; Hiestand-Nauer & Iida, 1983; Newman & Grindley, 
1984; Michels ejb al, 1987). The most prominent conserved sequence 
being GlyTyr-X-ArgValSer ( X= Val, lie, or Ala), where the Serine has 
been identified as the "Active residue" in Tn1000 resolvase, i.e. that 
which is covalently modified during the recombination reaction ( Reed 
& Moser, 1984). However, none of the conserved regions observed 
amongst this group of recombinases have convincing "homologues" in the 
XerA sequence.
Another group of site-specific recombinases, the so-called 
"Integrase family", comprises the integrase proteins of phages P2, P4, 
186, P22, Lambda, Phi80, the Cre protein of P1, the E. coli FimB and 
FimE proteins, and the Flp protein encoded by the S. cerevisiae 2- 
micron circle. This family of recombinases is more diverse than the 
resolvase/invertase group, and exhibit only limited sequence
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Table 6.5 Amino Acid Composition of the XerA Polypeptide
Aromatic
F = 7 
VI = 0 
Y = 3
10
Weakly
Hydrophobic Hydrophobic Acidic Amide Basic Cysteine
L = 19 P = 5 D = 9 N = 6 K = 11
I = 9 A = 16 E = 12 Q = 7 R = 5
V = 11 6 = 10 (H = D
M = 4 S = 10
T = 10
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similarity over a 40 amino acid interval ( Fig. 6.19). Once again 
however this interval is of particular importance since it includes a 
completely conserved Tyrosine which is postulated to be the ’'Active 
residue” in this class of recombinases ( Argos et. aJL, 1 986; Dorman & 
Higgins, 1987). The XerA amino acid sequence contains no significant 
matches to the major "conserved” positions identified amongst the 
integrase family.
6.S.2 DNA BINDING MOTIFS
If the XerA protein is a site-specific recombinase then one 
might expect it to possess a DMA binding domain. A considerable amount 
of work has been done on the structure and properties of a number of 
DNA binding proteins; the most fully characterised to date being 
Lambda Cro, Lambda cl, and the E*. coli CAP protein; for each of which 
there is a substantial body of genetic and physical data which 
identifies the particular amino-acids involved in DNA binding. The 
availability of crystal structures for Cro, cl and CAP has enabled the 
structure of each DNA binding domain to be ascertained, and in each 
case it comprises two alpha-helices linked by a tight turn, the 
physical parameters of the ”Helix-Turn-Helix" structure being 
virtually identical in all three proteins ( for review see Pabo & 
Sauer, 1984). By aligning the amino acid sequences of these three 
proteins with those of 18 other DNA binding proteins, Pabo & Sauer ( 
1984), have proposed a Helix-Turn-Helix "sequence motif” spanning 20 
residues. More recently Dodd and Egan ( 1987), have extended the 
number of Helix-turn-helix sequence motifs to a total of 37, whose 
alignment has been used to develop a weight-matrix with which to 
systematically assess the significance of any match found in novel 
protein sequences. The XerA sequence was searched by eye for 
"bestfits" to the consensus sequence, whereupon the statistical score 
for each was calculated according to Dodd & Egan; however, no 
sequences were identified which are statistically similar to the 
Lambda Cro-like DNA binding domain.
An alternative type of DNA binding motif, the so-called "Cysteine- 
zinc DNA binding finger”, has been identified amongst a wide variety 
of eukaryotic transcriptional regulatory proteins ( Berg, 1986). 
Whilst it seems quite reasonable to suppose that prokaryotes might 
also employ this means of achieving faithful DNArProtein interaction, 
there is no such motif in XerA.
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6.6 SECONDARY STRUCTURE PREDICTIONS
The putative secondary structure of the XerA polypeptide was 
calculated by PEPTIDESTRUCTURE ( Devereux .et al, 1984), according to 
the method of Garnier et. al (1978). Because of the extremely 
speculative nature of such predictions, the data will be discussed 
only very briefly. The XerA secondary structure prediction has been 
summarised in a graphical form by PLOTSTRUCTURE ( Devereux, et al. 
1984; Fig. 6.20), with a additional graphical representation of the 
proteins hydropathy profile, generated by PEPPLOT, according to the 
method of Kyte and Doolittle (1982; Fig. 6.21). From consideration of 
figures 6.20 and 6.21, one can summarise the main characteristics of 
XerA as follows. The protein’s hydropathy profile is distinctly 
dichotomous, the N-terminal 65 amino-acids being very hydrophilic, 
whereas the remainder of the protein is weakly hydrophobic. This 
profile is entirely consistent with XerA being a water soluble, 
globular protein, whose major surface determinants are formed by the 
N-terminal half of the polypeptide, with the bulk of the remainder 
likely to be buried internally ( Kyte and Doolittle, 1982). The 
PLOTSTRUCTURE output suggests that the N-terminal end of XerA ( the 
65 hydrophilic amino-acids), are likely to form two major alpha- 
helices, linked by a number of turns and a short stretch of Beta- 
sheet. The remainder of the protein is then predicted to adopt a 
predominantly Beta-sheet conformation with a third major alpha-helix 
at the extreme C-terminus ( Fig.6.20).
6 . 7  CONCLUSIONS AND DISCUSSION
Perhaps the single most tantalising fact to arise from DNA 
sequence comparisons was that of the presence of a site very similar 
to the cer cross-over region. The existence of this site ( plus its 
associated IHF binding site ?), may be indicative of a chromosomal 
activity of the Xer recombination system, perhaps involving site- 
specific chromosomal re-arrangements; if so then recombination may 
occur between heterologous sites, thus explaining the failure of two 
XerA-sites to participate in efficient recombination. It would seem 
probable that any such re-arrangement between two chromosomal sites 
would involve inversion as opposed to deletion; this assumption being 
based upon a prejudice towards the conservation of chromosomal 
sequence: However, one should bear in mind the possibility that the 
xerA gene is infact part of some unknown lysogenised/integrated 
genetic element, in which case a "deletion"reaction might serve to
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excise that element. One could test for any specific re-arrangements 
centered on the xerA locus by screening for "Restriction Fragment 
Length Polymorphisms", using pGS30 as a probe against Southern blots 
of various restrictions of wild type chromosomal DMA.
It would seem apparent that recombination at the XerA-site would 
disrupt the XerA coding sequence, unless of course the partner-site 
with which it recombines can re-generate the xer A structural gene. 
Precedents exist for inversion systems with a site within a structural 
gene, such that inversion generates an altered coding sequence; e.g. 
the Mu gin system, or the Salmonella hin system ( van de Putte et. al.
1980; Simon .et al. 1980). However, the evidence suggests that XerA is 
essential to Xer-mediated recombination, such that an inversion i^ hich 
disrupted, or altered its coding sequence might be irreversible. Thus 
one might suppose that any inversion at the XerA site would re­
generate a gene whose product could serve to promote the reverse 
reaction. Interestingly, the reverse reaction might be catalysed by a 
variant form of Xer A; by way of a precedent, the JEL_ coli f imA 
inversion system requires both the fimB and fimE gene products, one of 
which promotes recombination in one direction, whereas the other 
promotes the reverse reaction. The FiraB and FimE proteins are highly 
homologous at the amino-acid level, and are encoded by tandem genes 
believed to be the products of a gene duplication event ( Klemn,
1986). An inversion system which alters the coding sequence of the 
invertase itself would represent an entirely novel DMA re-arrangement 
system.
Should inter-molecular recombination between a cer site and the 
chromosomal site be possible, then this could serve to integrate a 
cer* plasmid into the chromosome, a phenomenon which might contribute 
to the stabilising affect of cer. One could test this possibility by 
probing for chromosomally integrated copies of ColE1 in Southern 
blots.
An alternative interpretation as to the significance of the xer- 
site can be proposed which is of some considerable interest. The Xas 
sequence might not be a recombination site per se. but might represent 
a recombinational enhancer-like element analagous to the Fis binding 
sites identified in the Gin and Hin systems ( see Introduction). This 
possibility is particularly intriguing since the Gin and Hin enhancer 
sequences are present within the coding sequences of the respective 
recombinase genes. Given the Gin/Hin precedents, one ought to 
consider the possibility that the xerA-site stimulates recombination
y
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at a nearby site, perhaps outwith the xerA gene.
The DNA and. protein sequence analyses have failed to produce any 
clues as to the biochemical function of the XerA polypeptide. If XerA 
is indeed a site-specific recombinase then it may represent a novel 
class of such enzymes since it bears little or no similarity to either 
of the two curently recognised families of site-specific recombinases.
CHAPTER 7
SEQUENCE OF THE xerB GENE
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7-1 INTRODUCTION
The 1.9Kb Hindlll fragment encoding the xerB gene was sequenced 
for the same major reasons as those outlined for xerA in chapter 6. 
Once again the generation of ExoIII deletions played a crucial role in 
the sequencing strategy; the deletion substrates being the M13 mp19 
derivatives mCS112 and mCS113, corresponding to the two alternative 
orientations of the Hindlll fragment with respect to the vector's 
polylinker ( Fig 7.1)* Exonuclease III deletion time courses were 
performed on BamHI/SstI restricted mCS112 or mCS113 as described in 
chapter 6; again deletion clones were screened for their insert size 
by agarose gel electrophoresis after restriction of RF DNA with 
Hindlll. suitably sized clones were then selected for DNA sequence 
determination. The complete "First" strand was determined from mCS112 
plus 13 of its deletion derivatives, whereas the second strand was 
derived from mCS113, plus 6 specific sub-clones mCS1l4, 115, 116, 117, 
118, and 119 ( Fig 7.2), then completed with two raCS113 ExoIII
deletion clones ( Table 7.1). The complete sequence of the Hindlll 
fragment, XERBC0N1, is 1921bp in length, and is represented in a fully 
annotated form in figure 7.4.
7-2 MINICELL EXPRESSION STUDIES
Prior to a discussion of the sequence data it is instructive to 
consider the XERBC0N1-specific polypeptides expressed in minicells.
The 1.9Kb Hindlll fragment mCS112 was cloned into the unique Hindlll 
site in the ptac expression vector pBAD; pCS126 and pCS127 
coresponding to the opposite orientations of the cloned fragment with 
respect to the vector's tac promoter ( as identified by EcoRI 
restriction; Fig 7.3^). Plasmid encoded proteins were then identified 
by virtue of their de novo synthesis in minicells purified from DS944 
carrying either pBAD, pCS126, or pCS127. Minicells were purified, then 
incubated in the presence of 3:>S methionine, either in the presence or 
absence of IPTG ( see materials and methods). Figure 7.3b( lanes 6 + 
7) clearly shows that pBAD encodes three protein species, of 33, 29
and 27 KDa respectively. These three proteins correspond to 
different processed forms of beta-lactamase ( Dougan e_t al, 1979). As 
expected, both pCS126 and pCS127 were also found to express beta- 
lactamase ( Fig. 7.3b, lanes 1-4). The pCS127-containing minicells are 
relatively heavily contaminated with whole cells resulting in the 
appearence of a broad spectrum of protein species; however, none of 
the proteins present exhibit any detectable increase in intensity in
1 06
mCS112
and
mCSTI3
pCS111
HindlD
M13 mp19
Hind III
H”idI11_________________________ EcoRI H n ff l^ H T ..? ^ tIF ro fiI____
lac PO 1-9 Kb primer
Hind III EcoRI HindHI
i 1----------------------------------------------------- i.-.BamHL-Sstl EcoRI
1v9Kblac PO pnmer
Figure 7.1 Construction of mCS112 and dCS113
As before periods (.) are used to indicate the presence of 
additional polylinker sites.
Sub-Clone
mCST)9
mCStlS*
mCSH4
mCS116*
mCS117
mCS118
HindDI \  PvuII ESglll | fMluI HincII Kpnl AccI Hindlll
C onstruction
Hindlll (PvuII) pCS119 Sstl/PvuII
■Sstl I '-H indlll +MBmp18 Sstl/HincII
HindHI (Bo® pCSTE Hindlll/BqIII
1---------------------'—EcoRI + ,
M13mp19 HindlllfeomHI
Hindffi (Mlul) pCS124 Hindffl/SstI
i- - - - - - - - - - - '— Sstl* +
M13mp19 - /  "
Hindin HincII mCSTI3 HincII
1------------: '“ “ EcoRI Deletion
Hindlll Kpnl mCS113 Kpnl
•EcoRI Deletion
HindHI (AccI) mCS113 AccI
 EcoRI Deletion
Figure 7.2 Construction of a Range of Specific Sub-Clones for the 
Purposes of DNA Sequence Determination.
pCS126
Hindlll EcoRI Hind HI
p i~QC
EcoRI
1 -9Kb
P-CS127
ptoc
j
Hindlll EcoRI Hindlll
EcoRI— 1-------------------------------------------------   1-H
Figure 7-3CL: Orientation of the 1.9Kb Hindlll fragment relative to 
Ptac in pCS126 and pCS127.
Table 7.1 Derivation of the XEKBCQH1 Sequence
Plus Strand
XERBC0N1 Sub-sequence
Clone File-Name Co-ordinates Length Gel(s)
mCS112 XERB.MCS112 1-208 208 G,H
mCS112A2.B XERB.MCS112D23 175-375 201 G,H
it 5.2 it D52 269-455 187 G
11 7.5 it D75 303-492 190 G,H
ti 3.5 ti D35 398-571 174 G,H
t» 5.3 n D53 475-743 268 I,K,L
n 5.1 n D51 620-868 249 K,L
n 6.1 ti D61 859-1048 190 B,I,L
it 7.11 it D711 915-1225 311 0
it 8.3 t» D83 1121-1415 297 C,I,J
n 9.2 n D92 1239-1480 241 K,L
ti 9.15 it D915 1368-1565 203 M,N
it 7.7 ti D77 1524-1786 268 M,N
it 8.1 ti D81 1641-1921 280 I,J
Minus Strand
Clone File-Name
XERBC0N1
Co-ordinates
Sub-sequence 
Length Gel(s)
raCS113 MCS113.MCS113 1921-1623 299 P,Q
raCS1l8 n .DACC 1687-1453 235 S,T,Z
raCS117 n .DKPN 1467-1237 231 S,T
mCS113A6.9 it .D69 1346-1013 334 P,R,U
raCS116 it .DHINCII 1070-815 256 U,V,X«
mCS114 it .MLUI 832-618 215 U,V
mCS115 it .BGLII 626-430 197 W
mCS119 n .PVUII 477-227 251 W,Xf
mCS113A4.2 it .D42 255-1 255 P
Figure 7-^  The Annotated XERBC0N1 Sequence
XerB
Hindi S.D. Het
> AAGCTTGCAATTCTATCTGTAGCCACCGCCGTTGTCTTTAAGATTCAGGAGCGTAGTGCA
< TTCGAACGTTAAGATAGACATCGGTGGCGGCAACAGAAATTCTAAGTCCTCGCATCACGT
10 20 30 HO 50 60
GluPheSerValLysSerGlySerProGluLysGlnArgSerAlaCysIleValValGly
> TGGAGTTTAGTGTAAAAAGCGGTAGCCCGGAGAAACAGCGGAGTGCCTGCATCGTCGTGG
< ACCTCAAATCACATTTTTCGCCATCGGGCCTCTTTGTCGCCTCACGGACGTAGCAGCACC
70 80 90 100 110 120
ValPheGluProArgArgLeuSerProIleAlaGluGlnLeuAspLysIleSerAspGly
> GCGTCTTCGAACCACGTCGCCTTTCTCCGATTGCAGAACAGCTCGATAAAATCAGCGATG
< CGCAGAAGCTTGGTGCAGCGGAAAGAGGCTAACGTCTTGTCGAGCTATTTTAGTCGCTAC
130 1H0 150 160 170 180
TyrlleSerAlaLeuLeuArgArgGlyGluLeuGluGlyLysProGlyGlnThrLeuLeu
> GGTACATCAGCGCCCTGCTACGTCGGGGCGAACTGGAAGGAAAACCGGGGCAGACATTGT
< CCATGTAGTCGCGGGACGATGCAGCCCCGCTTGACCTTCCTTTTGGCCCCGTCTGTAACA
190 200 210 220 230 2H0
EcoRI
LeuHisHisV alProAsnValLeuSerGluArglleLeuLeuIleGlyCysGlyLysGlu
> TGCTGCACCATGTTCCGAATGTACTTTCCGAGCGAATTCTCCTTATTGGTTGCGGCAAAG
< ACGACGTGGTACAAGGCTTACATGAAAGGCTCGCTTAAGAGGAATAACCAACGCCGTTTC
250 260 270 280 290 300
ArgGluLeuAspGluArgGlnTyrLysGlnVallleGlnLysThrlleAsnThrLeuAsn
> AACGTGAGCTGGATGAGCGTCAGTACAAGCAGGTTATTCAGAAAACCATTAATACGCTGA
< TTGCACTCGACCTACTCGCAGTCATGTTCGTCCAATAAGTCTTTTGGTAATTATGCGACT
310 320 330 3^0 350 360
AspThrGlySerHetGluAlaValCysPheLeuThrGluLeuHisValLysGlyArgAsn
> ATGATACTGGCTCAATGGAAGCGGTCTGCTTTCTGACTGAGCTGCACGTTAAAGGCCGTA
< TACTATGACCGAGTTACCTTCGCCAGACGAAAGACTGACTCGACGTGCAATTTCCGGCAT
370 380 390 H00 h10 ^20
Fig. 7.4 cont.
AsnTyrTrpLysValArgGlnAlaValGluThrAlaLysGluThrLeuTyrSerPheAsp
> ACAACTACTGGAAAGTGCGTCAGGCTGTCGAGACGGCAAAAGAGACGCTCTACAGTTTCG
< TGTTGATGACCTTTCACGCAGTCCGACAGCTCTGCCGTTTTCTCTGCGAGATGTCAAAGC
430 440 450 • 460 470 480
GlnLeuLysThrAsnLysSerGluProArgArgProLeuArgLysMetValPheAsnVal
> ATCAGCTGAAAACGAACAAGAGCGAACCGCGTCGTCCGCTGCGTAAGATGGTGTTCAACG
< TAGTCGACTTTTGCTTGTTCTCGCTTGGCGCAGCAGGCGACGCATTCTACCACAAGTTGC
490 500 510 520 530 540
ProThrArgArgGluLeuThrSerGlyGluArgAlalleGlnHisGlyLeuAlalleAla
> TGCCGACCCGCCGTGAACTGACCAGCGGTGAGCGCGCGATCCAGCACGGTCTGGCGATTG
< ACGGCTGGGCGGCACTTGACTGGTCGCCACTCGCGCGCTAGGTCGTGCCAGACCGCTAAC
550 560 570 580 590 600
AlaGlylleLysAlaAlaLysAspLeuGlyAsnMetProProAsnlleCysAsnAlaAla
> CCGCCGGGATTAAAGCAGCAAAAGATCTCGGCAATATGCCGCCGAATATCTGTAACGCCG
< GGCGGCCCTAATTTCGTCGTTTTCTAGAGCCGTTATACGGCGGCTTATAGACATTGCGGC
610 620 630 640 650 660
TyrLeuAlaSerGlnAlaArgGlnLeuAlaAspSerTyrSerLysAsnVallleThrArg
> CTTACCTCGCTTCACAAGCGCGCCAGCTGGCTGACAGCTACAGCAAGAATGTCATCACCC
< GAATGGAGCGAAGTGTTCGCGCGGTCGACCGACTGTCGATGTCGTTCTTACAGTAGTGGG
670 680 690 700 710 720
VallleGlyGluGlnGlnMetLysGluLeuGlyMetHisSerTyrLeuAlaValGlyGln
> GCGTTATCGGCGAACAGCAGATGAAAGAGCTGGGGATGCATTCCTATCTGGCGGTCGGTC
< CGCAATAGCCGCTTGTCGTCTACTTTCTCGACCCCTACGTAAGGATAGACCGCCAGCCAG
730 740 750 • 760 770 780
GlySerGlnAsnGluSerLeuMetSerVallleGluTyrLysGlyAsnAlaSerGluAsp
> AGGGTTCGCAAAACGAATCGCTGATGTCGGTGATTGAGTACAAAGGCAACGCGTCGGAAG
< TCCCAAGCGTTTTGCTTAGCGACTACAGCCACTAACTCATGTTTCCGTTGCGCAGCCTTC
790 800 810 820 830 840
AlaArgProIleValLeuValGlyLysGlyLeuThrPheAspSerGlyGlylleSerlle
> ATGCACGCCCAATCGTGCTGGTGGGTAAAGGTTTAACCTTCGACTCCGGCGGTATCTCGA
< TACGTGCGGGTTAGCACGACCACCCATTTCCAAATTGGAAGCTGAGGCCGCCATAGAGCT
850 860 870 880 890 900
Fig 7.4 cont.
I-----------------------------------
LysProSerGluGlyHetAspGluMetLysTyrAspMetCysGlyAlaAlaAlaValTyr
> TCAAGCCTTCAGAAGGCATGGATGAGATGAAGTACGATATGTGCGGTGCGGCAGCGGTTT
< AGTTCGGAAGTCTTCCGTACCTACTCTACTTCATGCTATACACGCCACGCCGTCGCCAAA
910 920 930 940 950 960
_____________________Hydrophobic______________________
GlyValMetArgHetValAlaGluLeuGlnLeuProIleAsnVallleGlyValLeuAla
> ACGGCGTGATGCGGATGGTCGCGGAGCTACAACTGCCGATTAACGTTATCGGCGTGTTGG
< TGCCGCACTACGCCTACCAGCGCCTCGATGTTGACGGCTAATTGCAATAGCCGCACAACC
970 980 990 1000 1010 1020
 1
GlyCysGluAsnMetProGlyGlyArgAlaTyrArgProGlyAspValLeuThrThrMet
> CAGGCTGCGAAAACATGCCTGGCGGACGAGCCTATCGTCCGGGCGATGTGTTAACCACCA
< GTCCGACGCTTTTGTACGGACCGCCTGCTCGGATAGCAGGCCCGCTACACAATTGGTGGT
1030 1040 1050 1060 1070 1080
SerGlyGlnThrValGluValLeuAsnThrAspAlaGluGlyArgLeuValLeuCysAsp
> TGTCCGGTCAAACCGTTGAAGTGCTGAACACCGACGCTGAAGGCCGCCTGGTACTGTGCG
< ACAGGCCAGTTTGGCAACTTCACGACTTGTGGCTGCGACTTCCGGCGGACCATGACACGC
1090 1100 1110 1120 1130 1140
 Hydro -
ValLeuThrTyrValGluArgPheGluProGluAlaVallleAspValAlaThrLeuThr
> ACGTGTTAACTTACGTTGAGCGTTTTGAGCCGGAAGCGGTGATTGACGTGGCGACGCTGA
< TGCACAATTGAATGCAACTCGCAAAACTCGGCCTTCGCCACTAACTGCACCGCTGCGACT
1150 1160 1170 1180 1190 1200
-phobic _________ ^
GlyAlaCysVallleAlaLeuGlyHisHisIleThrGlyLeuMetAlaAsnHisAsnPro
> CCGGTGCCTGCGTGATCGCGCTGGGTCATCATATTACTGGTCTGATGGCGAACCATAATC
< GGCCACGGACGCACTAGCGCGACCCAGTAGTATAATGACCAGACTACCGCTTGGTATTAG
1210 1220 1230 1240 1250 1260
LeuAlaHisGluLeuIleAlaAlaSerGluGlnSerGlyAspArgAlaTrpArgLeuPro
> CGCTGGCCCATGAACTGATTGCCGCGTCTGAACAATCCGGTGACCGCGCATGGCGCTTAC
< GCGACCGGGTACTTGACTAACGGCGCAGACTTGTTAGGCCACTGGCGCGTACCGCGAATG
1270 1280 1290 1300 1310 1320
/
Fig. 7.4 cont.
LeuGlyAspGluTyrGlnGluGlnLeuGluSerAsnPheAlaAspMetAlaAsnlleGly
> CGCTGGGTGACGAGTATCAGGAACAACTGGAGTCCAATTTTGCCGATATGGCGAACATTG
< GCGACCCACTGCTCATAGTCCTTGTTGACCTCAGGTTAAAACGGCTATACCGCTTGTAAC
1330 1340 1350 1360 1370 1380
GlyArgProGlyGlyAlalleThrAlaGlyCysPheLeuSerArgPheThrArgLysTyr
> GCGGTCGTCCTGGTGGGGCGATTACCGCAGGTTGCTTCCTGTCACGCTTTACCCGTAAGT
< CGCCAGCAGGACCACCCCGCTAATGGCGTCCAACGAAGGACAGTGCGAAATGGGCATTCA
1390 1400 1410 1420 1430 1440
Kpnl Narl
AsnTrpAlaHisLeuAspIleAlaGlyThrAlaTrpArgSerGlyLysAlaLysGlyAla
> ACAACTGGGCGCACCTGGATATCGCCGGTACCGCCTGGCGTTCTGGTAAAGCAAAAGGCG
< TGTTGACCCGCGTGGACCTATAGCGGCCATGGCGGACCGCAAGACCATTTCGTTTTCCGC
1450 1460 1470 1480 1490 1500
ThrGlyArgProValAlaLeuLeuAlaGlnPheLeuLeuAsnArgAlaGlyPheAsnGly
> CCACCGGTCGTCCGGTAGCGTTGCTGGCACAGTTCCTGTTAAACCGCGCTGGGTTTAACG
< GGTGGCCAGCAGGCCATCGCAACGACCGTGTCAAGGACAATTTGGCGCGACCCAAATTGC
1510 1520 1530 1540 1550 1560
p p p  1
GluGlU***
> GCGAAGAGTAATTGCGTCAGGCAAGGCTGTTATTGCCGGATGCGGCGTGAACGCCTTATC
< CGCTTCTCATTAACGCAGTCCGTTCCGACAATAACGGCCTACGCCGCACTTGCGGAATAG
1570 1580 1590 1600 1610 . 1620
REP2
> cgacctacacagcactgaactcgtaggcctgataagacaEaacagcgtcgca'Tcaggcgc
< GCTGGATGTGTCGTGACTTGAGCATCCGGACTATTCTGTGTTGTCGCAGCGTAGTCCGCG
1630 1640 1650 1660 1670 1680
PCS-5
m AccI  MetLysAsnAla
> TGCGGTGTATACCTGATGCGTATTTAAATCCACCACAAGAAGCCCCATTTATGAAAAACG
< ACGCCACATATGGACTACGCATAAATTTAGGTGGTGTTCTTCGGGGTAAATACTTTTTGC
1690 1700 1710 1720 1730 1740
ThrPhaTyrLeuLeuAspAsnAspThrThrValAspGlyLeuSerAlaValGluGlnLeu
> CGACGTTCTACCTTCTGGACAATGACACCACCGTCGATGGCTTAAGCGCCGTTGAGCAAC
< GCTGCAAGATGGAAGACCTGTTACTGTGGTGGCAGCTACCGAATTCGCGGCAACTCGTTG
1750 1760 1770 1780 1790 1800
Fig. 7.4 cont.
ValCysGluIleAlaAlaGluArgTrpArgSerGlyLysArgValLeuIleAlaCysGlu
> TGGTGTGTGAAATTGCCGCAGAACGTTGGCGCAGCGGTAAGCGCGTGCTCATCGCCTGTG
< ACCACACACTTTAACGGCGTCTTGCAACCGCGTCGCCATTCGCGCACGAGTAGCGGACAC
1810 1820 1830 18*10 1850 1860
HindHI
AspGluLysGlnAlaTyrArgLeuAspGluAlaLeuTrpAlaArgProAlaGluSer
> AAGATGAAAAGCAGGCTTACCGGCTGGATGAAGCCCTGTGGGCGCGTCCGGCAGAAAGCTT
< TTCTACTTTTCGTCCGAATGGCCGACCTACTTCGGGACACCCGCGCAGGCCGTCTTTCGAA
1870 1880 -1890 1900 1910 1921
Figure 7 .4 : A number of pertinent restriction sites are indicated, as
is a potential Shine-Dalgarno (S.D.) sequence present upstream of the 
xerB initiation codon. Two regions of extreme ( mean) hydrophobicity 
within the XerB primary structure are highlighted ( see sect. 7.5.3). 
REP sequences are shown as broad arrows, whilst other regions of dyad 
symmetry are indicated by thin arrows.
/
Figure 7.3b Polypeptides expressed by pCS126 and pCS127 in minicells.
Lane Sample Lane Sample
1 pCS127 (+) 5 Molecular weight markers
2 pCS127 (-) 6 pBAD (+)
3 pCS126 (+) 7 pBAD (-)
4 pCS126 (-)
+/- in parentheses indicates the presence or absence of IPTG during 
the labelling of minicells. The sizes of bands are given in KDa.
the presence of IPTG. On the assumption that IPTG induction of these 
minicells resulted in an increased level of transcription of the 1.9Kb 
insert in pCS127, then it would seem unlikely that the insert encodes 
any protein-coding genes on the transcribed strand: note that any
proteins of less than 1 4KDa would not have been detected in this 
experiment. On the other hand, IPTG induction of pCS126-containing
minicells results in an increase in the expression of a number of
protein species. The major band having an apparent molecular weight 
equivalent to 54KDa; there are then at least nine other induced bands 
of 42, 40, 39, 33, 28.5, 28, 25, 15, & 14 KDa respectively ( Fig.
7.3b; lanes 3 & 4). This data will be discussed in the light of
potential genes identified by DNA sequence analyses.
7-3 D M  SEQUENCE ANALYSES
The same analytical procedures used in the study of the xerA gene 
sequence were applied to the XERBC0N1 sequence; having discussed the 
underlying principles in some detail in chapter 6 , I shall re­
introduce each only briefly.
7.3.2 OPEN READING FRAMES
The HYPOTHETICAL analysis of ORFs within XERBC0N1 revealed the 
presence of one large ORF, ORF-1, which extends from an ATG initiation 
codon to a TAA stop codon between co-ordinates 60-1569bp respectively, 
and which would encode a 503 amino acid polypeptide with a predicted 
molecular weight of 55*3KDa ( Figs. 7.4, 7.5). The strand encoding
ORF-1 ( the designated "plus" strand), is that whose transcription 
from ptac in pCS126 results in the translation of a 54KDa protein in 
considerable quantities. Therefore the minicell data presented in 
figure 7.3c provides convincing evidence that ORF-1 is expressed in 
vivo: ORF-1 has therefore been designated "Protein Coding Sequence-1", 
(PCS-1). There are no ORFs outwith PCS-1 which could encode a poly­
peptide larger than 9.4KDa ( see ORF-2; Fig. 7.5), and therefore it 
would appear likely that all those XERBC0N1-specific proteins observed 
in mini-cells must be products of ORF-1: however this assumes that no
major glycosylation of small polypeptides had taken place, a process 
which can result in a considerable decrease in a protein* s electro­
phoretic mobility. One could test for the presence of glyco-proteins 
by screening for any shifts in observed electrophoretic mobility after 
treatment with an endoglycosidase. If some, or all, of the smaller 
polypeptides observed in mini-cells are indeed products of ORF-1, then
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Figure 7-5 HYPOTHETICAL genes identified in the XERBOON1 sequence.
they might either represent specific cleavage products of the 5*JKDa 
protein, or might correspond to the products of either translational 
initiation, or termination, at secondary sites within PCS-1. One 
could potentially identify degradative products by performing a mini­
cell labelling experiment under "pulse-chase” conditions. Whereas any 
proteins produced by translational initiation at sites within PCS-1 
could be identified in minicell-analyses of various XERBC0N1 subclones 
which lack the primary initiation codon. The significance of these 
smaller polypeptides with respect to XerB activity is unknown.
The only other ORF for which there is evidence of expression is 
ORF-5 ( Fig. 7.5), the evidence coming not from mini-cells, but from 
the fact that strain JM101 ( lacZ delta M15) carrying mCS113 gives 
rise to blue plaques on X-Gal containing medium; this suggests that 
the inserted sequence has fortuitously generated an in-frame 
translational fusion with the vector’s lacZ1 coding sequence, which 
gives rise to a fusion polypeptide capable of effective intermolecular 
coraplemention. From inspection of the XERBC0N1 sequence it became 
clear that it is ORF-5 which is fused in-frame to lacZ’ in mCS113, and 
therefore the expression of the LacZ+ phenotype requires translational 
initiation at some site within ORF-5 in vivo: for this reason ORF-5 is 
also considered to be a bona fide protein coding sequence, PCS-5.
The complementation data discussed in chapter 5, which identified a 
1680bp Hindlll/AccI fragment as the minimum xerB1 complementing clone, 
provides convincing evidence that PCS-1 must represent the xerB gene ( 
Fig. 5.15). This conclusion being further corroborated by the 
restriction map of pXB1 ( Chapter 5) from which one can estimate that 
in the xerB.1 mutant locus, Tn5 is inserted between XERBC0N1 co­
ordinates 490-550bp, and would thus disrupt PCS-1.
7.3.3 BASE PERIODICITY: ZFICK ANALYSIS
The TESTCODE analysis of XERBC0N1 was performed using the 
program ZFICK ( Figs. 7.6, 7.7). The results indicate that the xerB
gene ( PCS-1), has a base periodicity characteristic of E. coli coding 
sequence ( Fig 7.6). Furthermore, the TESTCODE statistic also begins 
to peak in correspondence with the start of PCS-5, implying that it 
too may represent coding sequence. There is also a third region in 
which TESTCODE predicts coding sequence, that being the region between 
xerB and PCS-5; an ORF on the minus strand, 0RF-7, fits closely to 
this peak.
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Figure 7.6 ZFICK Analysis of the XERBCON1 Plus Strand
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Figure 7.7 ZFICK Analysis of the XERBCOH1 Minus Strand
7.^.4 CODOHPREFERENCE ANALYSIS
The CODONPREFERENCE output for XERBC0N1 reveals that both xerB. 
PCS-5 exhibit considerable codon bias, coupled with a striking 
scarcity of rare codons compared to all other reading frames ( Figs. 
7.8, 7.9). It is clear from figure 7 . 9  that ORF-7 resembles random
sequence; note that even poorly expressed genes tend to exhibit above­
random codon preference ( see chapter 7 ). Obviously ORF-4 contains 
predominantly preferred codons, but as before, this must be tempered 
with the fact that ORF-4 is in-phase with xerB. and that the 
corresponding region of xerB exhibits a higher codon preference than 
does ORF-4, thus the former would appear to represent the dominant 
"partner”.
It would therefore appear that ZFICK and CODONPREFERENCE 
contradict one another with respect to ORF-7; of course one can never 
escape the caveat that such poor codon bias might indicate that 
expression of ORF- 7 must be strictly curtailed, or that the DNA/RNA 
sequence is under some secondary selection pressure to maintain a 
given nucleotide sequence. As will be discussed shortly, there is 
reason to believe that ORF-7 niay be a fortuitous ORF, since this 
sequence ( i.e. between xerB and PCS-5), exhibits some of the 
characteristics of an intergenic space.
7.3.5 TRANSLATION INITIATION SITES: ZPERTROH ANALYSIS
The most common variant of the Shine and Dalgarno sequence found 
in naturally occurring JE^. coli genes is 5 ’-AGGAGG-31, situated 5-9 
nucleotides upstream of the initiation codon ( Stormo et. al, 1986). 
The xerB gene has a very good candidate S.D sequence in the 
pentanucleotide S’-AGGAG-B’, situated 9 nucleotides upstream of the 
predicted AUG start codon. In addition ZPERTROH analysis ( using the 
HI 01 weight matrix) identifies this particular ATG codon ( 6 0bp), as a 
probable translational start with a PERTRON score of +50 ( note that 
with ¥101, a score of > +2 is expected for genuine starts; Table 7.3). 
In addition the AUG "start" of ORF-2 ( 178bp), scores a noteable +1. 
Conversely, the highest PERTRON score returned for any of potential 
start codons within PCS-5 was found to be -145 for the AUG ( 1731 bp;
data not shown), and yet the evidence that PCS-5 is expressed in vivo 
is quite compelling. This highlights the major limitation of ZPERTROH 
analysis, this being that whilst it provides useful corroborative 
evidence to support a translational start, it cannot be used to rule- 
out any other sites.
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Table 7.3 ZPERTROH Analysis of XEHBC0H1
Plus Strand
Start 5 '-- CONTEXT  3'
coord.
60 AGCGTAGTGC ATG GAG ... GAG TAA
1080 GTTAACCACC ATG TCC ... GAG TAA
178 AAAATCAGCG ATG GGT ... CGC TGA
1035 CTGCGAAAAC ATG CCT ... GAG TAA
804 CGAATCGCTG ATG TCG ... GAG TAA
Minus Strand
Start 5'-- CONTEXT  3*
coord.
Stop Length Est. MW PERCEPTRON
coord, (codons) (kDa) rating
1571 503 55.3K 50
1571 163 17.9K 35
360 60 6.6K 1
1571 178 19.6K -25
1571 255 28.1K -55
Stop Length Est. MW PERCEPTRON
coord, (codons) (kDa) rating
1256 CCAGCGGATT ATG GTT ... AGT TAA 1146 36 4.OK -46
It is interesting to note that three alternative ATG codons within 
xerB are among the highest scores returned by ZPERTRON: this may help
to explain at least some of the minor translational products observed 
in the mini-cell analysis described in chapter 5. Whether or not any 
such "internal" initiation events are of any significance jln vivo
under wild-type conditions remains to be determined.
7.^.6 PROMOTERS: ZPROM ANALYSIS
Recall that ZPROM scrutinises DNA sequence windows and scores
for two statistical parameters which reflect the degree of
coincidence, for any given sequence window, with the consensus 
promoter sequence TTGACA-17-TATAAT; the empirically determined 
significance levels for these two parameters being
STAT’ I > 0.002 
STAT' II > 0.0002
On the basis of these significance levels, ZPROM detected no strong 
matches to the promoter consensus sequence on either strand of 
XERBC0N1 ( Table 7.4). There are certainly no candidates for a 
promoter which could drive transcription of the xerB gene; there is 
therefore a sound argument for extending the XERBC0N1 sequence further 
upstream of the xerB structural gene, 440bp 5’ to the Hindlll site are 
already sub-cloned in pCS111. Determination of this sequence might be 
considered a priority in future work on this project since it ought 
to either identify the xerB gene promoter, or alternatively would 
indicate whether or not there is a 5' coding sequence with which xerB 
might be co-transcribed. There are no strong candidates for a PCS-5 
promoter, a fact which one might also construe as being indicative of 
xerB/PCS-5 co-transcription. However one must temper this with the 
fact that ZPROM can detect only those promoters which are similar to 
the consensus sequence; whilst this should identify the majority of E. 
coli promoters, it should be noted that many of the positively 
regulated promoters identified to-date tend to exhibit very poor 
"homology" to the -35 box, and thus would score poorly in ZPROM ( 
Raibaud & Schwartz, 1984).
7.^.7 TRANSCRIPTIONAL TERMINATION SITES: TERMINATOR ANALYSIS
Computer searching of the XERBC0N1 sequence using the TERMINATOR 
program identified no convincing candidates for rho-independent 
terminator sites on the plus strand. The only strong candidate 
throughout the entire sequence being situated at 1532bp on the minus
1 10
Table 7*4 ZPROM Analysis of the XERBC0H1 Sequence
Plus Strand
Pos. -35 -10
Statistic
I
Statistic
II Distance
143 TTCTCC GATTGCAGAACAGCTCGA_ TAAAAT. 0.0031208 0.0004681 18
144 TCTCCG ATTGCAGAACAGCTCGA_ TAAAAT. 0.0004015 0.0004015 17
448 TCGAGA CGGCAAAAGAGACGCTC__ TACAGT. 0.0009392 0.0009392 17
598 TTGCCG CCGGGATTAAAGCAGCA__ AAAGAT. 0.0002919 0.0002919 17
814 TTGAGT ACAAAGGCAACGCGTCG__ GAAGAT. 0.0025560 0.0025560 17
1204 GTGCCT GCGTGATCGCGCTGGGT__ CATCAT. 0.0005273 0.0005273 17
linus Strand
Pos. -35 -10 I II Dist<
1488 TTTCCA GTAGTTGTTACGGCCTT__ TAACGT. 0.0009632 0.0009632 17-=rCO TTTTTA CACTAAACTCCATGCAC__ TACGCT. 0.0002676 0.0002676 17
1846 TTTACA CTAAACTCCATGCAC TACGCT. 0.0040584 0.0000812 15
1884 AAGACA ACGGCGGTGGCTACAGA__ TAGAAT. 0.0005112 0.0005112 17
Figure 7-10 TERMINATOR Analysis of XER8C0N1
Plus Strand
-40 -35 -30 -25 -20 -15 -10 -5 -1+ +5 p s
•  •  •  •  ♦ •  •  « • • •
742=> TGAAAGAGCTGGGGATGCATTCCTATCTGGCGGTCGGTCAGGGTTCGCAAA 3-72 0
1707=> AATCCACCAC'AAGAAGCCCCATTTATGAAAAACGCGACGTTCTACCTTCTG 3.31 0
Minus Strand
-40 -35 -30 -25 -20 -15 -10 -5 -1+ +5 p s
•  •  •  •  •  •  « •  t t  «
390=> CTGTGCCAGCAACGCTACCGGACGACCGGTGGCGCCTTTTGCTTTACCAGA 3.51 65
1171=> AGCTCTTTCATCTGCTGTTCGCCGATAACGCGGGTGATGACATTCTTGCTG 3.67 0
1807=> ACGATGCAGGCACTCCGCTGTTTCTCCGGGCTACCGCTTTTTACACTAAAC 3.58 0
Primary structure (p) threshold = 3.50 
Secondary structure (s) threshold = 0
strand ( Fig.7.10). Note that this "terminator” would be ideally 
placed to terminate transcription of ORF-7 ( stop codon, 1555bp); the 
presence of this motif associated with gene expression provides 
circumstantial evidence that ORF-7 might be expressed, but there is no 
direct experimental evidence to support this contention at this stage. 
Nonetheless, I should stress that the xerBI complementation data 
discussed in chapter 5 rules out ORFs 2, 7, 5 as encoding the xerBI
complementing function; however, the evidence does not preclude the 
possibility that any/all of these reading frames might encode 
associated Xer functions. Whilst no other sites were identified in 
TERMINATOR analysis, a number of noteable regions of dyad-symmetry 
were identified in the region between xerB and PCS-5 ( i.e within 0RF- 
7); Fig. 7.4).
7.3.8 xerft;lacZ .TM N SLAIIQNAL BBIQHS
As already intimated, a translational fusion between PCS-5 and 
the mp19 lacZ* coding sequence resulted in effective complementation 
of the chromosomal lacZ delta-M15 mutation in JM101. As described in 
figure 7*3, six specific sub-fragments from XERBC0N1 were cloned into 
M13. Of these sub-clones two ( mCS115 and mCS1l6) were also found to 
result in a blue-plaque phenotype in JM101 ( on X-Gal containing 
medium), indicative of the expression of a complementing fusion poly­
peptide; analysis of the insert/vector boundary sequences revealed 
that in both mCS115 and 116 it is the xerB coding sequence ( ORF-1),
which is fused in-frame with lacZ’. The mCS115 insert boundary is the 
xerB Belli site (623bp), thus fusing 188 codons of the xerB gene to 
the LacZ alpha fragment. Whereas, in mCS1l6 the boundary site is the 
HincII site (1070bp), thus fusing 337 codons of xerB in-frame with 
lacZ*. The remaining sub-clones generated for sequencing, mCS1l4, 117, 
118, and 119 all produced in white plaque phenotypes; in all but 
mCSH8 , the fusion boundary is within the xerB coding sequence, but is 
in an alternative reading frame.
In addition to the fortuitous translational fusions generated 
above, I also specifically fused the xerB coding sequence at the Narl 
site ( 1497bp), to each of the three translational fusion vectors,
pNM480, PNM481, and pNM482; these vectors carry the entire lacZ coding 
sequence but lack an in-frame start codon and ribosome binding site; 
the three,vectors are identical to one another except for the relative 
phase of their polylinker with respect to the LacZ reading frame 
(Minton ,e£ aJL, 1984). The 1.5Kb BaraHI/Narl fragment from pCS119 was
cloned into the compatible "sticky-ends" created by BamHI/AccI 
restriction of pNM480, 481 and 482. Each ligation was transformed into
DS947 ( delta lac/pro. SupO) and clones selected on L-agar-i- AP. The
desired clones were first identified by size on single-colony gels, 
then suitable candidates were confirmed by restriction of STET DNA
with either PstI or Hindlll. Thus the plasmids PCS140, pCSl41, and
PCS142 were isolated, corresponding to the 1.5Kb BamHI/.Narl fragment 
from pCS119 cloned into pHM430, 481 and 482 respectively. From
examination of the vector/insert boundaries it was predicted that xerB 
would be fused in-frame to lacZ in pCSl42. The LacZ phenotypes of 
DS947 carrying either pCSl40, 141 or 142 were then tested by plating 
each out onto L-agar + Ap+ X-Gal, followed by overnight incubation at 
37°C. Colonies arising from DS947+ PCS140, or DS947+ PCS141 were 
white, whereas those from DS947+ pCS142 were dark blue, thus 
confirming that the xerB reading frame is translated through the Narl 
site (I497bp). The pCS142-encoded fusion polypeptide is predicted to 
include the first 480 amino-acids of XerB, ( lacking only 23 residues 
from the C-terminus), and thus has a predicted molecular x%Teight of 
approximately l65KDa. Interestingly, pCS140, 141 and 142 were all
found to be unable to complement pCS202 resolution in CSX4, indicating 
that the C-terminal 23 residues of XerB are of vital significance to 
' its activity.
These gene-fusion results provide conclusive evidence that the 
xerB reading-frame is translated at three positions well seperated 
along its length; those being the Bglll site ( 623bp, mCS115), the
HincII site ( 1070bp, mCSH6) and the Narl site ( I497bp, pCSl42).
7.4 DNA SEQUENCE COMPARISONS
The XERBC0N1 sequence was screened against the GENBANK and EMBL 
sequence databases using the WORDSEARCH program, but no files were 
identified in either database with significant sequence "homology". 
The XERBC0N1 sequence has also been compared in fine detail with both 
XERA112 and ColE1, but again no significant sequence identities were 
found; more specifically, no equivalents to cer-. nut-, or IHF- like 
sites of XERA112 are present in XBC0N1.
7.4.2 IDENTIFICATION OF REP SEQUENCES
Two copies of the so-called REP ( Repetitive Extragenic Palin­
dromic) sequence are present in the XERBC0N1 sequence, both are 
situated between the end of xerB and the start of PCS-5, with the two
112
copies, REP-1 and REP-2, being present in inverted orientation 
relative to one another ( Fig. 7.4): both REP-1 and REP-2 exhibit
extensive ’’homology" to the consensus REP sequence ( Gilson e_t al, 
1987; Fig. 7.12).
To date 118 copies of the REP sequence have been identified within 
"databased" E^ _ coli sequences, their observed incidence predicts the 
presence of 500-1000 copies throughout the genome, thus accounting for 
some 1$ of Ek_ coli DNA. All known REP sequences are within 
transcription units, but none are within known coding sequences; they 
are present either between genes within an operon ( inter-cistronic), 
or in the 3* untranslated region of mRNA ( post-cistronic) ( Stern ejt 
al. 198*1; Gilson et al, 1987). In all cases where REPs are present 
between two genes whose relative expression levels are known, the 
upstream gene ( promoter proximal), is invariably expressed at a 
higher level than is the downstream gene ( Stern et al, 1984). This 
phenomenon may be explained, at least in part, in the light of recent 
findings which suggest that REP sequences act to stabilise upstream 
mRNA ( apparently by providing protection from 3’-5* exonucleolytic 
activity). The effective concentration of an mRNA has been found to' be 
increased by up to 10-fold in the presence of a 3T REP sequence ( 
Newbury et al, 1987). . It has also been suggested that REP sequences
might be involved in chromosomal organisation, perhaps providing 
nucleation points for condensation of the nucleoid. Alternatively they 
have been implicated in a potential "gene-shuffling" mechanism 
involving recombination between REPs within different operons. The 
presence, and position, of the REP sequences found in XERBC0N1 have a 
number of major implications.
1. They suggest an "operonic" organisation between xerB and PCS-5; 
such an organisation could explain the apparent absence of a PCS-5 
specific promoter sequence. If indeed xerB and PCS-5 are two cistrons 
within an operon, then it is very probable that PCS-5 encodes an Xer 
related function; there is therefore a strong case for extending the 
XERBC0N1 sequence into PCS-5. A role for PCS-5 in Xer recombination 
could then be investigated by gene-disruption in vitro, followed by 
the introduction of the mutagenised PCS-5 allele into the chromosome 
via gene-replacement, whereupon the Xer phenotype of the engineered 
mutant could be determined. If PCS-5 does encode an Xer function, then 
the apparent failure to isolate any PCS-5 mutants to date, might 
indicate that it encodes an essential function, in which case any 
attempted gene-replacements using a completely disrupted copy of PCS-5
Figure 7-12 Comparisons Between the REP Consensus Sequence and XERBC0N1
XERB REP1 
CONSENSUS REP 
XERB REP2
1592  » <  1628
ATTGCCGGATGCGGCGT.GA..ACGCCTTATCCGACCTAC
i i i ! t i  i i i i I i I i i t i i i i i i 11 i i i I )  i i t  i ii i i i i t i i i i i i i i i i i i i i i i i i i i i i i I i I I i
t G _  G C  G C  C
a tGCC GATGCG CG ....  CG CTTATC GGCCTAC
a T A T  A T  A
i m  1 1  i i i  t i  1 1  i i  i i  i I i i  i i i i i i i i  i i t ii i i i i i i i i i i i I i i i i i i i i i i i i I i 11 i i I
AGCGCCTGATGCGACGCTGTT.GTGTCTTATCAGGCCTAC 
1681    >  f ----------------------------  1649
Regions of hyphenated dyad symmetry within each element are highlighted. 
The numbers refer to base-pair co-ordinates in XERBC0N1.
would be likely to fail. Note that 8 out of 9 of the "XerB” mutants
which are complemented by pCS112 ( 1.9Kb Bindlll). have not been
tested with any of the pCS112 sub-clones; it is therefore plausible 
that some of these eight might in fact be complemented by an 
alternative xer genefs) within pCS112, possibly the truncated PCS-5 
product.
2. Since there are no precedents to-date for REP sequences within a 
coding sequence, then it would appear that ORF-7 does not resemble a 
typical JL. coli gene.
3. Finally, the REP sequences are likely to aid in the
stabilisation of xerB mRNA; this may prove a useful feature in 
facilitating the overexpression of XerB protein for the purpose of 
purification.
7.5 PROTEIN SEQUENCE ANALYSES
The inferred primary structures for XerB and for the N-terminal 
portion of PCS-5 are listed in figure 7.4. As previously, intimated, 
XerB is 503 amino acids in length, whilst only the first 63 amino- 
acids of PCS-5 can currently be predicted from the available DNA 
sequence. The amino acid composition of XerB reveals a considerable 
number of charged residues from which one would predict it to be a
weakly acidic protein ( Table 7.5).
The amino acid sequences of XerB, and that derived from PCS-5, 
were then employed in protein sequence comparisons. Once again, no 
significant matches to either sequence were found by WORDSEARCH when 
scanning the NBRF protein database. Detailed scrutiny of each sequence 
revealed no similarities to the highly conserved regions of either the 
"Integrase" or "Resolvase/Invertase" families of site-specific 
recombinases, nor does either exhibit a nucleotide binding site motif 
( see chapter 6).
The XerA, XerB and PCS-5 sequences were compared with one another 
using ZDOTMAT, GAP and BESTFIT, but no highly conserved sequences 
were identified either between all three proteins, or between any pair 
of proteins. Whilst a number of minor comparisons could be drawn, 
these relied heavily upon the presence of chemically similar amino- 
acids ( as defined by Davhoff et al, 1978), with very few exact 
matches. In no case was the observed degree of similarity any 
greater than would be expected by chance; indeed better quality
Table 7,5 Amino Acid Composition of tbe XerB Polypeptide
Aromatic
F = 12 
W = 4 
Y = 14
30
Weakly
Hydrophobic Hydrophobic Acidic Amide Basic Cysteine
L = 50 P = 20 D = 19 N = 23 K = 24 C = 9
I = 27 A = 48 E = 38 Q = 21 R = 32
V = 34 G = 49 (H = 10)
M = 16 S = 29
T = 24
127 170 57 44 56 9
(10)
alignments were achieved after "randomising" each sequence by 
shuffling their respective amino-acid compositions into novel (random) 
primary structures ( data not shown).
7.5.2 sm SIHPIKS .HQTIFS
Using the same procedures as described in chapter 6, the XerB 
primary sequence was searched for the presence of either a Lambda Cro- 
like DNA binding domain, or a Cysteine-zinc DNA binding finger, 
however no significant matches to either sequence motif were found.
7.5.3 XerB HYPROPATHT PROFILE AND 5ECQHPABY-STRUCTURE PREDICTIONS
A striking feature of the protein's hydropathy profile is the presence 
of clusters of either hydrophobic or hydrophil ic residues ( Figs. 
7.13). Obviously one would expect the hydrophiltic clusters to 
represent surface determinants of the protein, i.e. those, which 
interface with the aqueous environment. In addition to the 
concentrations of hydrophil*ic residues, there are two major clusters 
of hydrophobic amino acids situated between positions 300-320 and 375- 
390 respectively ( Fig. 7.13). Kyte and Doolitle ( 1982) studied the 
mean hydropathies of 20 residue segments from 30 water soluble, 
globular proteins, from which they chose the 20 most hydrophobic 
segments as representative of the extremes found in globular proteins. 
These 20 extremes were then compared to various membrane-spanning 
regions from a number of proteins in an effort to determine hydropathy 
parameters which could identify membrane-spanning regions within novel 
sequences. These comparisons led them to conclude that when the mean 
hydropathy of a 19 residue segment exceeds +1.6, then there is a high 
probability that it represents a membrane-spanning sequence; using 
these stricter parameters the XerB protein's hydropathy was re­
assessed: regions with extreme mean-hydropathies were superimposed 
upon a PLOTSTR0CTURE output of the Chou and Fasman predictions for the 
XerB secondary structure ( Fig 14a, 14b). This analysis clearly shows 
that there are two regions in XerB which exhibit the extreme mean 
hydrophobicity characteristic of membrane-spanning sequences ( Fig. 
7.14b); similar analyses revealed no such regions in XerA (156 
residues), Tn1000 transposase ( 1003 residues), Tn3 resolvase ( 185 
residues), or LacZ ( 1018 residues), whereas analagous hydrophobic 
regions were identified in the integral membrane protein, LacY ( 418 
residues; data not shown). Examination of the primary structures of 
these two hydrophobic regions reveals that both contain an
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uninterrupted stretch of hydrophobic amino-acids of at least 11 
residues ( see Fig. 7.4). In principle, 11 amino-acids in Beta-sheet 
conformation would be just sufficient to span the average lipid bi­
layer ( 3.6nm), whereas it requires 23 residues in alpha-helical 
conformation. The secondary-structure predictions for these two hydro- 
phobic regions certainly do not rule out the possibility that both 
might span a lipid bi-layer in beta sheet conformation.
7.6 CONCLUSIONS IN BRIEF
Having already discussed the results in this chapter in some 
detail I shall summarise them only very briefly. The sequence analyses 
suggest that the XerB gene product is a 503 residue polypeptide, which 
appears, likely to be capable of efficient translation due to the 
gene’s very good ribosome binding site, high codon-bias, and the 
presence of REP sequences which may stabilise the mRNA. It seems quite 
probable that the xerB gene is transcribed as part of an operon, but 
there is as yet no evidence that the downstream gene, PCS-5, is an xer 
gene.
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PURIFICATION OF THE XerB PROTEIN
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It rapidly became clear that the XerB protein could be readily 
purified by virtue of two contributory factors:
1. The IPTG induction of DS9^1 carrying pCS126 resultes in  ^
the overexpression of XerB to a level approaching 5-10% 
of total cell protein.
2. The XerB protein is insoluble at neutral pH except at 
high ionic strengths.
8.1.2 OTBfigXPRBSSIOfl 3E XsrB
It became clear in the mini-cell analyses described in chapter 7 
that the IPTG induction of mini-cells carrying pCS126 resulted in a 
high level of expression of the XerB protein; this has also been found 
to be the case with DS9^1 whole cells. An induction time-course 
performed on DS9^ 1+^ pCS126 revealed that near maximum levels of XerB 
were accumulated within two hours of induction, and that only a small 
increase in total XerB was observed if induction was continued over­
night ( Fig. 8.1); given the level of XerB accumulated by induced 
cells it is surprising to note that there is no significant difference 
in the growth rates of induced versus uninduced DS9^1+pCS126, nor is 
there any difference between the growth rates of DS9^1+pCS126 versus 
plasmid-free DS941 ( data not shown). The gel shown in figure 8.1 also 
includes protein extracts from DS9^1 and from CSX17 ( DS9^1 XerB1:
Appendix 1); there is, however, no obvious difference between the two 
protein profiles, suggesting that XerB is not a major cellular protein 
under standard growth conditions.
8.1.3 PUBIFICAXIflN PJROIQC.OL
The XerB protein was purified from DS941+pCS126 after a two hour 
induction with IPTG as shown in figure 8.2. The protocol is primitive, 
and yet extremely effective, and can be summarised as follows; Cells 
are lysed by sonication in "KPM" buffer ( see Fig. 8.2), in which XerB 
is relatively insoluble. The XerB precipitate sediments, together with 
the membrane fraction and cellular debris, upon centrifugation at 
*l6,000g, 30 mins.. The resultant pellet is then washed by vigorous
resuspension in the same buffer ( KPM), in order to remove 
contaminating KPM-soluble proteins. The suspension is then re-spun, 
and the pellet resuspended in Tris^Q00 buffer ( see Fig. 8.2); this 
treatment solubilises XerB, and will also strip the membrane fraction 
of its peripherally associated proteins. After one further spin, the
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Figure 8.1 Induction time course of pCS126-specified xerB expression. 20ml 
cultures grown with shaking at 37°C to an 0D^qq= 0.6, the culture was then 
split into two at T= zero, to one half was added IPTG ( 50 ug.ml- )^, then 
both cultures were returned to 37°C and samples taken after various incuba­
tion times. iJOOul samples were taken at each time point and their OD^qq 
determined, then the sample diluted as appropriate so as to standardise the 
amount loaded per track. Samples were prepared for electrophoresis as 
previously described ( 2.23); then run on an 8% Laemmli gel.
Lane Strain IP T G Incubation
1 DS941 - o/n
2 CSX 17 - o/n
3 DS941+pCS126 - o/n
4 tt ft - 120
5 tt ft + 70
6 ft ft + 120
7 tt ft + o/n
8 Mol. wt. markers
9 DS941+pBAD - 120
10 ft tt + 70
11 tt tt + 120
o/n signifies overnight incubation.
Figure 8.2 XerB purification protocol: The numbers in brackets refer 
to the fraction number. ( o/n = overnight).
Dilute o/n culture of DS94l+pCS126 1:100 in 400ml fresh L-broth + Ap 
(100ug.ml~1). Incubate with shaking, 37°C, and grow to an 0D^00 = 0.4.
Induce by the addition of IPTG (50ug.ral“ )^. Continue incubation for 2 
hours ( OD^qq approximately 1.4).
r
Harvest cells by centrifugation ( 7,000g, 5mins), wash in KPM buffer.
t
Resuspend cells in 6mls KPM buffer ( approx. 1g.3ml” )^
t
Sonicate 40sec on ice
f
Centrifuge sonicate 20,000g, 30 min.
Supernatant ( 1) Pellet ( 2)
T
Wash pellet by vigorous 
resuspension in KPM ( 6mls)
Re-spin ( 20,000g, 30min)
Supernatant (3) Pellet (4)
Pellet (4)
1
Resuspend in TrislOOO (6ml) and stand on ice, 10min. ^J
Centrifuge 20,000g, 30min.
Supernatant ( 6) Pellet (5)
▼
Dialyse o/n against KPM
r
Harvest precipitate 
( 12,000g, 10rain)
Supernatant (7) Pellet (8)
T
V/ash pellet in TrisO (6ml) 
and centifuge 12,000g, 10min
Supernatant (9) Re-dissolve pellet in TrislOOO,
and add 50* glycerol. Store -20°C 
(10)
Buffers:
KPM : 25mM KPi ( pH7.0), 5mM MgCl2, 1mM EDTA, 1mM DTT, 1 ,2raM PMSF,
and 1mM Benzamidine
TrisO : 50mM Tris.HCl ( pH8.5), 5raM MgCl2, 1mM EDTA, 1mM DTT, 1.2mM
PMSF, and 1mM Benzamidine.
TrislOOO : As TrisO but with 1M NaCl.
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form in the supernatant, and represents approximately 80-90$ of the 
total protein present within that fraction ( as estimated by eye from 
Coomassie-stained Laemmli gels; Fig. 8.3). To remove the majority of 
those proteins contaminating the Tris10QQ soluble fraction, it is
dialysed against fresh KPM buffer ( overnight, 4°C), this dialysis 
brings about the precipitation of XerB, after which the precipitate 
may be harvested by centrifugation at 12,000g, 10 mins., then the
pellet washed in KPM buffer and re-spun, whereupon the pellet may be 
readily solubilised in fresh Tris10Q0 buffer. The resultant material 
is adjudged to be electrophoretically pure by Coomassie stained gel 
analysis ( Fig. 8.M). Quantitatively, the procedure repeatedly 
recovers 5-10mg ( 10-20 nanoMoles) of highly purified XerB from 1.5g
{wet weight) of cells; Table 8.1 indicates the total protein present
in each fraction as determined by Bradford Assay ( Bradford, 1976). 
The protocol outlined above clearly relies on the physical presence of 
the 55KDa protein, in SDS-PAGE, as an assay with which to monitor 
purification; acording to this assay, it would appear as though 
approximately 10$ of the XerB present in whole cells is lost in the
initial KPM soluble phase ( Fig. 8.3, lane 9), whereas a further 10$ 
remains in the insoluble pellet even after treatment with Tris^QQQ ( 
Fig. 8.3, lanes 10 and 12). The 10$ of xerB protein which remains in 
the membrane/debris fraction could of course be integrally associated 
with membrane ( c.f. the potential membrane spanning sequences 
identified in chapter 7); however, the properties of the bulk of the 
XerB present would suggest that the 10$ lost within the debris is 
probaly "stuck" there, either inaccessible to Tris-jQQg, or in an 
irreversibly denatured form. Whilst one might argue that XerB could be 
peripherally membrane-associated due to its co-fractionation with 
membranes in KPM buffer, such an association with membrane is not
required to explain the observed co-sedimentation since purified XerB 
precipitates spontaneously in KPM buffer in the (presumptive) absence 
of significant quantities of lipid.
8.1.A SOLUBILITY CHARACTERISTICS i?F PSBIEIED XerB
A simple qualitative analysis was performed to gauge the degree 
to which XerB is soluble in various buffers. Equal quantities of 
precipitated XerB ( approx. 50ug) were collected in microfuge tubes by 
centrifugation of a fine suspension of XerB in KPM buffer. To each
tube was then added 100 microlitres of one of a number of buffers,
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Figure 8.3 Purification of XerB. This gel follows the purification of 
XerB as described in figure 8.2:
Lane Strain/source Fraction (see Fig. 8.2)
1
2
3
5
6
7
8 
9
10
11
12
DS9M + pBAD 
D S W  + pBAD
tt n
Mwt. Markers 
DsgJn + pcs^
Description
Whole cells 
KPM soluble phase 
TrislOOO insoluble 
TrislOOO soluble 
TrislOOO insoluble
Whole cells 
KPM soluble phase 
TrislOOO insoluble 
TrislOOO soluble 
TrislOOO insoluble
Mwt. Markers
1 - 2 3 4 5 6 7
- 6 6
- 4 5
- 3 6
- 2 9
- 2 4
~  20 
-14
Figure 8.4 Purification of XerB by precipitation in KPM:
Lane
1
2
3
4
5
6 
7
Strain/source
DS941+pCS126
DS94HpCS126
DS941+pBAD 
Mwt. Markers
Fraction Description
10 TrislOOO dissolution of KPM pellet (10ug)
1 0  "  "  rt n  (  !  u g )
9 S/N from TrisO wash of KPM' pellet
7 S/N after KPM precipitation
6 TrislOOO soluble phase
6 TrislOOO soluble phase
S/N= Supernatant
Table 8.1 Quantitation of XerB purification: For fraction number, see 
purification protocol ( Fig. 8.2). /
Fraction
Number Description Vol.(ml) conc.(mg/ml)
Total 
Protein (mg)
Crude sonicate 
1 KPM soluble
3 KPM wash
6 TrislOOO soluble
7 KPM dialysate
10 TrislOOO soluble-
7.0 
5.5
6.0 
6.0 
7.3 
2.0
40.7
40.0
2.3
1.3 
0.2
3.4
285
220
14.0
7.9
1.5
6.8
Table 8.2 Qualitative analysis on the solubility of XerB
a)
Buffer
Degree of dissolution with varying [NaCl]mM 
0 500 1000 1500
25mM KPi pH 6.0 
25mM Tris.HCl pH 8 .0 
25mM Gly/NaOH pH 10.0
+/-
+++
+/- +/-
- M - + +++
all buffers were made 1raM EDTA, 1raM DTT.
b)
Buffer
Degree of dissolution with varying [NaCl]mM 
0 50 100 150 200
25mM Tris.HCl pH8.5 
1niM EDTA, 1rcM DTT
++ +++ +++
Code: +++ = pellet completely dissolved
ell t e r  w n x u i l  m e  p e i i e u  Wets ( e s u o ^ c u u e u  u y v u m >u a x i i 5  kuui U U 5 1 1 J . J  . n..*.
5 rains, on ice, the tubes were re-spun ( 12,000g, 5 rains.), and the
pellet size used to estimate the degree of protein dissolution. The 
various buffers tested and the solubility of XerB in each are listed 
in tables 8.2a, and 8.2b. It is clear that XerB is highly soluble in a 
Tris buffer at pH8.5, in the presence of 150mM NaCl, but is virtually 
insoluble at pH7.0, or pH6.0.
If whole cells are sonicated in Tris^000 buffer, then XerB is 
recovered entirely within the soluble fraction after centrifugation of 
the initial sonicate ( data not shown). On the other hand, when cells 
are sonicated in Tris^QQ then the vast majority of XerB is found as a 
precipitate, despite the fact that the purified protein is highly 
soluble in this buffer; this discrepancy between the solubilities of 
XerB in purified form versus crude extracts may simply be the result 
jof the presence of many additional factors in the crude sonicates ( 
e.g. a very high total protein concentration etc.).
8.2 THE N-TERMINAL AMINO ACID SEQUENCE OF XerB
XerB protein has been purified to a sufficient degree, and in 
sufficient quantities to enable its N-terminal sequence to be 
determined. The amino-acid sequence of the purified protein can 
furnish two key pieces of information; firstly it can unequivocally 
identify the purified protein as being the product of the xerB gene, 
and secondly it can identify the actual translational start of the 
gene. A 5 nanoMole sample of XerB was dialysed free from buffer salts 
against 1mM DTT, a procedure which results in the precipitation of the 
protein as expected. The precipitate was washed in the same buffer, 
after which it was harvested by centrifugation, drained, then vacuum 
dried overnight. The dried-down sample was then forwarded to, and 
sequenced by, J. E. Fothergill at the Department of Biochemistry, 
University of Aberdeen.
The first 20 residues of XerB were analysed, 13 of which could be 
identified unequivocally, five positions were assigned ambiguously, 
and two residues were unresolved. The five ambiguous positions were 
each assigned to one of three groups of residues, His,Met & Pro; Ser & 
Thr; or Arg & Phe; the ambiguity arising out of the fact that the 
residues within each group all produce highly similar elution
profiles, which could not be distinguished under the conditions
employed. When one compares the determined protein sequence with that
inferred from the DNA sequence, then one finds that all 13
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/Figure 8.5 N-terminal amino acid sequence of XerB: derived vs. inferred.
Pro Pro
His Arg ThrHis Arg
Derived Seq. : MetGluPheSerValLysSerGlySerMetGluLysGlnPhe ? Ala ? IleValVal
Inferred Seq. : MetGluPheSerValLysSerGlySerProGluLysGlnArgSerAlaCysIleValVal
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
unequivocally identified residues nave precise correspondents m  tne 
inferred amino-acid sequence ( Fig. 8.5). Furthermore, at the five
"ambiguous" positions the group of two or three unresolved 
alternatives always includes the residue predicted by the DNA sequence 
( e.g. residue 9 is identified as being either Ser or Thr, in turn 
the DNA sequence predicts a serine). The amino acid residues at
positions 15 and 17 could not be identified chromatographically. The 
DNA sequence predicts a Ser at position 15, and a Cys at 17, both Ser 
and Cys being residues which are notoriously difficult to identify
chemically; however I should add that the elution profiles obtained 
for residues 15 and 17 are not inconsistent with their being Ser and 
Cys respectively.
8.3 JBHA BINDING ACTIYITY QL PURIFIED IscB
The natural extension of this work is to ascertain whether XerA 
and/or XerB play direct or indirect roles in promoting recombination 
between cer sites. Ideally, this goal would be pursued via the 
development of an in vitro recombination assay, however, due to the 
limitations of time I have not attempted to develop such a system. An 
alternative approach to ascribing some role to the two Xer proteins is 
to determine whether or not either, or both, exhibit a DNA binding
activity, particularly one which is specific to the cer sequence. A
very simple, yet elegant, technique for the detection of DNA:protein 
interactions is that of "Gel Retardation", i.e. the observed reduction 
in the electrophoretic mobility of a small DNA fragment, as a
consequence of its association with protein molecule(s). This approach 
has been successfully employed in a number of systems including CAP, 
Fis, Lac Repressor, & Tn3 Resolvase ( Fried & Crothers, 1981; Koch & 
Kahmann, 1987; Kramer £t al, 1987; M. Boocock, pers. comm.).
In the short time available to me, I concentrated on gel
retardation experiments using XerB. Purified XerB was found to retard 
an end-labelled *131 bp fragment carrying the complete cer site, however 
it apparently does so non-specifically since the retardation is 
eliminated by the addition of small quantities of sonicated Calf 
Thymus DNA ( C.T. DNA) as a non-specific competitor ( Fig. 8.6). 
Furthermore, similar retardation profiles are observed when XerB is 
incubated with various end-labelled "non-cer" fragments (from pUC8; 
data not shown). These results would suggest that XerB may be capable 
of binding DNA non-specifically ( under the conditions tested), but do 
not indicate whether or not XerB is a true DNA binding protein, or
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Figure 8.6 Non-specific binding of XerB to a 431 bp cer~*~ fragment. The
431 bp EcoRI/PvuII cer+ fragment from pKS492 was gel-purified and then 
end-labelled with alpha-^^p dATP using Klenow. All binding reactions 
were performed in 20ul volumes in the following reaction buffer 25mM 
Tris pH8.5, 50mM MaCl, 1055 glycerol, 1 ng end-labelled fragment, 
500ug/ml BSA. Reactions were initiated by the addition of protein, 
after which they were mixed then incubated at 37°C for 10mins. Samples 
were then electrophoresed on a 5$ polyacrylamide gel as described by 
Bushman e_t jlI (1984). Lanes 1-6 represent varying amounts of XerB 
protein in the absence of any carrier DNA: 1ug, lane 1; 500ng, lane 2; 
250ng, lane 3; 125ng, lane 4; 63ng, lane 5; No XerB added, lane 6. The 
samples loaded in lanes 7-11 were all incubated in the presence of 1ug 
of XerB protein, but with varying amounts of sonicated calf-thymus 
DNA: 0, lane 7; 50ng, lane 8; 100ng, lane 9; 150ng, lane 10; 200ng, 
lane 11. The sample in lane 12 was incubated with 0 XerB, 200ng calf 
thymus DNA.
simply a protein .which "sticks” to large poly-anions. Furthermore, I 
should emphasise the relatively large amounts of XerB required to 
effect the observed retardation; it requires 63ng of protean to 
partially retard 1 ng of end-labelled DNA fragment ( equivalent to a 
>300-fold molar excess of XerB:DNA). This might indicate that XerB 
binding is relatively weak, or that only a small proportion of the 
protein preparation is responsible for the observed retardation; if 
the latter is true then this could either signify the presence of a 
minor contaminating protein species which effects retardation, or that 
only a small fraction of the XerB protein has been recovered in an 
active state. Finally, one should note that in most cases where 
significant gel retardation of a Protein:DNA complex has been 
observed, it is almost certainly due to a conformational change ( 
bend) in the DNA fragment as a consequence of protein binding, and 
apparently not a simple function of increased molecular weight. 
Therefore, in cases where protein binds DNA but does not induce a 
significant bend, then one might not expect to observe gel 
retardation. If this were the case with XerB, then specific DNA 
binding may occur but go undetected, the observed retardation being 
the result of non-specific protein:DNA aggregation at very high 
protein concentrations ( in this regard note that whilst at low 
protein concentration Tn3 Resolvase binds specifically to the res 
sequence, at high concentration it exhibits a relatively non-specific 
binding activity which results in protein:DNA aggregates which fail to 
enter the gel ( M. Boocock, pers. comm.)). It would therefore be 
prudent to examine protein binding via an alternative route which does 
not require a conformational change, e.g. DNAasel footprinting, or co- 
immunoprecipitation of Protein:DNA complexes.
8.4 RAISING REAGENT ANTI-BODIES TO PURIFIED XerB
Since the XerB purification protocol involves the use of an over­
producing strain from which the protein is recovered in an insoluble 
state, and in the absence of an assay for XerB activity, then it would 
seem wise to question the active status of the purified protein; for 
example the Hin recombihase may be purified in an active form when 
over-expressed to a level of 0.1$ of total cell protein, however 
increased levels of over-expression lead to less active extracts ( 
Johnson e£. al, 1986). Furthermore, cer-specific recombination requires 
at least one other protein ( XerA), and perhaps many others together 
with unknown co-factors, in the absence of which XerB might be
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rendered impoten-t; such problems might be surmounted by the (initial) 
analysis of Xer activity in crude extracts from wild-type cells. The 
study of XerB at wild-type levels could be greatly assisted by>the 
availability of anti-XerB anti-serum; to this end two New Zealand 
white rabbits have been immunised with purified XerB as described in 
figure 8 .7 .
On the assumption that high avidity anti-XerB antibodies are 
(ultimately) raised, then they may be used in a number of very 
interesting, and potentially highly informative experiments e.g.:
1. Determination of the cellular location of XerB in wild-type 
cells, i.e. does it segregate with the soluble or membrane 
fractions.
2. The assay of XerB protein levels in each XerB~ mutant ( with 
the two spontaneous mutants, DSX1 and DSX2, being of particular 
interest). The levels of XerB expressed in XerA“ mutants is also 
of key interest.
3. One could assay XerB binding to the cer sequence in wild-type 
extracts by immunoprecipitation of XerB in the presence of end- 
labelled DNA; co-immunoprecipitation of nucleic acid with a 
specific binding protein ( by, of course, anti-protein anti-serum) 
has been observed in a number of systems including the replication 
initiator protein of R6K ( Bastia & Patel, in press). This 
approach to XerB:DNA "binding" has the advantage that it does not 
necessarily require that XerB binds DNA directly, since one might 
reasonably expect to detect any stable association between XerB 
and DNA mediated by other proteins.
i|. In an extension of the preceeding experiment, one might seek to 
identify any proteins with which XerB forms stable complexes, by a 
similar co-immunoprecipitation assay; either from crude extracts 
of proteins labelled in vivo, or from unlabelled extracts 
whereupon precipitated proteins might be visualised after 1*125 
iodination.
5. One could also employ anti-XerB anti-serum to conduct a survey 
of other enterobacteriacea in order to determine the ubiquity of 
XerB-like polypeptides.
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Figure 8.7 Immunisation Schedule:
18/7 /8 7 :
Day 1 
(28/7/87)
Week 5 
(1/9/87)
Week 7
/
Prior to immunisation, collect 20ml whole blood from each 
rabbit and recover serum after clotting ( 37oC> 1hour;
then l^°C o/n), and centrifugation ( 3,000g, 10min). Store 
serum frozen -20°C.
Immunise two New Zealand white rabbits with 250ug each of 
purified XerB in 1ml Freund’s complete adjuvant. Inject
0.5ml of suspension ( 125ug XerB) intramuscularly into 
each hind limb.
Boost both rabbits with 200ug XerB in Freund’s incomlete 
adjuvant ( 1ml); again given in two intramuscular
injections
Collect 40ml of whole blood from each rabbit and recover 
and store serum as described above.
A protocol has been established which enables tne rapid 
preparation of substantial quantities of electrophoretically pure 
XerB. The purified material has an apparent molecular weight equal to 
55KDa ( as measured by SDS-PAGE), and thus would appear to represent 
the full-length translational product of the XerB gene. The N-terminal 
peptide sequence of the first 20 residues of this protein has been 
determined, the derived sequence confirms that:
1. The protein preparation is homogeneous.
2. The purified protein is the product of the putative XerB gene 
identified by DNA sequence analysis.
3. The XerB translational start is indeed at the AUG codon identified 
,by ZPERTRON as the most probable initiation codon ( 60bp; chapter 
7).
4. The purified protein has undergone no N-terminal proteolytic 
cleavage events ( e.g. Signal Peptide cleavage); however, given 
the extent of XerB over-expression, one cannot preclude the 
possibility that the 55KDa species represents an accumulated un­
processed form. Any significant post-translational modifications 
might be better identified in wild-type extracts, using specific 
anti-serum to detect the XerB protein.
There is to-date no functional assay for the purified XerB protein; 
whilst it appears capable of binding DNA there is no evidence of any 
cer-sequence specific DNA binding. Thus the biochemical activity if 
XerB remains elusive. It is hoped that rabbit anti-serum raised 
against the purified protein will react, with high avidity, to the 
native XerB protein in crude extracts from wild-type cells; If so, 
then some of the experiments outlined in section 8.4 could be 
undertaken, the results of which might provide some long-awaited clues 
as to the expression and function(s) of XerB. I have since 
recovered anti-sera which immunoprecipitate purified XerB in a 
standard gel-immunoprecipitation assay, indicating that anti-XerB 
antibodies have been raised ( data not shown).
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independent xer mutants, then to use these mutants to clone and 
characterise the wild-type xer genes by genetic complementation. In 
the course of this work, I have isolated a total of nine independent 
xer mutants, bringing the total number of mutants in our collection to
11. Of the nine novel mutants isolated, six of the xer lesions are 
genetically linked to an inserted copy of the mutagen Tn5, the 
remaining three mutants have yet to be tested for such linkage.
The 11 mutants have been found to fall into two complementation 
groups, designated xerA and xerB. with two mutants belonging to the 
xerA group, and the remaining nine comprising the xerB group. The xerA 
gene was cloned, in collaboration with Gill Stewart, by taking 
advantage of information derived from the xerA3::Tn5 mutant allele 
'cloned in pCS300. On the other hand, xerB was cloned by screening 
directly for complementation using the highly sensitive pCS210 colony- 
colour test for Xer phenotype.
The xerA Gene and its Product
The xerA complementing function has been de-lineated to within 
a 920bp SphI/AccI fragment. The DNA sequence of this fragment has been 
determined, and the xerA gene identified as a 156 codon protein-coding 
gene which encodes a polypeptide of predicted molecular weight equal 
to 17.2 KDa. The polypeptide product of this gene has been observed in 
minicell expression studies and has an apparent molecular weight of 
16.5KDa. The xerA locus maps to 70.5mins. on the K12 linkage map, as 
does argR ( arginine repressor; Bachmann, 1983). The argR sequence has 
not been published to date, however since writing this thesis I have 
received a copy of a pre-print from Lim .et jlL, in which they present 
the sequence of the argR gene. This has revealed that the xerA and 
argR genes are in fact one and the same. Lim .et al. report the 
sequencing of an 880bp Sphl/AccI fragment ( compared to the 920bp 
SphI/AccI restriction fragment cloned in mCS320), and they present 
only 818 bp of this sequence running from the SphI site towards the 
AccI site. This 818bp of sequence is identical to the appropriate 
portion of the XERA112 sequence with the exception of 5 additional 
base-pairs in the XERA112 sequence at co-ordinates 766, 781, 803, 805, 
and 808 respectively; each position has been triple-checked and the 
extra base confirmed on both strands of the XERA112 sequence. There
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are no sequence differences within the xerA structural gene. Lin jJL 
have unequivocally identified the product of the 156 codon ORF as 
being the arginine repressor. ArgR ( plus the co-repressor, L- 
arginine), negatively regulates a number of genes in the arginine 
regulon by binding to "Operator" sites which usually overlap with the 
repressed gene's promoter. In all known cases, the Arg operator 
comprises two loosely conserved copies of an 18bp "ArgR box" ( for 
review see Glansdorf, 1987). There are two such ArgR boxes upstream of 
xerA/argRf which overlap with the promoter designated P2 ( chapter 6), 
and to which ArgR ( + arginine) has been shown to bind ( Lim .al, in 
press). Intriguingly, there is also a very close match to an ArgR box 
within cer: this sequence aligns very well with the consensus ArgR box 
with 15/18 matches, this compares with the two ArgR binding sites 
identified upstream of xerA/argR which exhibit 15/18 and 14/18 matches 
• respectively:
Cer (3795-3812) : 
ArgR-Box consensus :
Note that the ArgR box within cer overlaps with the -35 region of the 
promoter P1, this might indicate that transcriptional initiation at P1 
is regulated by ArgR. It is most interesting to recall the data on cer 
deletion derivatives ( chapter 1), in which the sequence_from ColE1 
co-ordinates 3793-3966bp maintained the ability to recombine with a 
wild-type copy of cerf but the sequence from 3800-3966bp did not; note 
that a major portion of the ArgR box has been deleted in the latter 
case. Obviously determining whether or not ArgR/XerA binds to this 
site within cer would be an immediate priority in any future work on 
this project. If indeed it does, then its affect upon recombination 
might be mediated through regulation of P1 transcription, and/or might 
be a function of binding per se. It seems rather unlikely that ArgR is 
the specific recombinase, however its binding at this site within 
cer may be involved in the assembly of a higher order structure 
necessary to promote efficient strand exchange in the cross-over
-35
3795 3800 3812
GTTGCATAGGTATTCATA
aa a
aNTGNaTN tATTCAT 
tt t
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note that, in its native state, ArgR is found as an oligomer. This 
oligomer usually binds two adjacent copies of the ArgR box present at 
Arg operators. An interesting speculation is that an ArgR oligomer may 
bind the single ArgR box within cer and then, in a plasmid dimer, 
might bring the two cer sites into a synaptic complex by association 
with the ArgR box in the second cer site.
It would appear that a novel role in cer:-specific recombination 
has been uncovered for the JjjL. coli ArgR transcriptional repressor 
protein. This is particularly interesting since the same "duality" of 
function has been noted for IHF which regulates the val. ilv. and xvl 
genes etc., but was first discovered as an accessory factor in lambda 
Int-specific recombination. This might indicate that episomal elements 
such as ColE1 and phage Lambda, have evolved to exploit the properties 
of pre-existing host DNA-binding proteins as accessory elements in 
their site-specific recombination systems.
The xerB Gene and its Product
A comprehensive deletion analysis has unequivocally identified 
the xerB gene as a 1509bp sequence which encodes a 503 residue poly­
peptide with a predicted molecular weight of 55.3KDa; the minimum 
functional xerB clone being a I687bp Hindlll/AccI fragment in pCS130. 
DNA sequence analyses have identified the start of a second gene, PCS- 
5, I60bp downstream of the xerB stop codon; the proximity of the two 
genes, coupled with the presence of two REP sequences in the 
intergenic region provides the signature of an operon. Whether or not 
PCS-5 encodes an Xer-related function is a question which ought to be 
addressed in any extension to this work.
A protocol has been established for the purification of XerB to 
homogeneity. The N-terminal sequence of the purified material has 
confirmed its identity, and in turn has identified the translational 
start of the xerB gene. There are, as yet, no clues as to the role of 
XerB in cer-specific recombination. Attempts to demonstrate cer- 
sequence specific DNA binding using a gel-retardation assay have 
proved unsuccessful; however, under the conditions tested, the 
purified protein does appear to exhibit a non-specific DNA binding 
activity. In order to study XerB at wild-type levels the purified 
protein has been used to raise anti-XerB antisera which provide a
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antisera may be used to investigate a number of important features of 
XerB including its expression, processing, and cellular location(s). 
High avidity antiserum might also prove a powerful tool in the 
investigation of any intermolecular complexes with which XerB 
associates ( e.g. proteinrDNA, or protein:protein etc.).
This work has identified and characterised two host encoded 
functions which are essential to cer-specific recombination; one of 
these functions has been identified as the transcriptional repressor 
ArgR, thus exposing an entirely novel role for this extensively 
studied protein. Assuming a direct involvement for ArgR/XerA and/or 
XerB in the recombination process, then their identification may 
greatly assist in the development of an in vitro cer recombination 
„system. Such a system could, in turn, elucidate the precise role(s) 
that each protein performs, and thus enhance our understanding of an 
apparently novel site-specific recombination mechanism.
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o^rain constructions; An arrow oetween strains indicates tne pi co­
transduction of xer~ with Kmr. The transductanct strain name is given, 
followed by the parental strain plus mutant allele designation in brackets 
(). Finally the original lab-name, where appropriate is given in square 
brackets []. A
1. xerA3
CSX1
CSX2
(CSH26 x.erA3) 
[X3.2]
CSX3
(DS903 xerA3) 
[X3.D]
CSX14,CSX15
(DS903 xerA3)
CSX16
(JM101 x$r.A3)
2. xerB1
CSX4
(DS9^7 xerBI) 
[XB1 ]
CSX 18CSX17
(DS9^1 xerBI) (JM101 xerB1)
[XB1.A]
4. xerB* 5. xsrB5
CSX5
(DS947 xer£2) 
CXI.6]
CSX20
(DS941 xerB2) 
[X1.6A]
CSX7
(DS947 xerB4) 
[X3.5]
CSX21
(DS941 xerB4) 
[X3.5A]
CSX8
(DS947 Xg.rB5) 
[X4.3]
CSX22
(DS9M1 xerB5) 
[X4.3A]
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